Patent Grant
11739372
One of every four men will die of cancer. Further statistics from the American Cancer Society predict that one of every five women will suffer the same fate. Treatments are available for many cancers. However, success for most relies on early detection.
Cancer is now said to be a disease of the genome. Many oncologists and cancer researchers hope that advances in genomic analysis tools will provide early detection and a path to treatment. However, these tools are more prominent in research labs having not yet matured to the level of being readily available to the vast majority of oncologists. Improvements are needed.
It has been said that at the time of diagnosis, all cancer patients are mosaics. They are mosaics because they have at least two distinct genomes: the genome they were born with, and the genome that they unwillingly acquired via cancer. Furthermore, as tumors grow, distinct populations of cancer cells become apparent. Leading to even more complex mosaics within the tumor. This cancer cell heterogeneity often results in subpopulations of cells that respond differently to cancer therapies. The end result is often an initial positive response of one subpopulation of cells, resulting in the observation of the patient's tumor shrinking, only to be followed by regrowth of tumor tissue, and in some cases metastasis. Despite early detection of the tumor, an inability to identify the subpopulation of cells that are resistant to the treatment can result in loss of time needed to treat an aggressive cancer. This creates adverse consequences for the patient both emotionally and physically.
There is a need for genomic tools that can distinguish subpopulations of cancer cells in tumors. The present disclosure addresses this need and provides other advantages as well.
The present disclosure provides a method for spatially tagging nucleic acids of a biological specimen. The method can include steps of (a) providing a solid support comprising a plurality of different nucleic acid probes that are randomly located on the solid support, wherein the different nucleic acid probes each includes a barcode sequence that is different from the barcode sequence of other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to locate the barcode sequences on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen that are proximal to the randomly located probes; and (e) modifying the randomly located probes that are hybridized to the target nucleic acids, thereby producing modified probes that include the barcode sequences and a target specific modification, thereby spatially tagging the nucleic acids of the biological specimen.
This disclosure further provides a method for spatially tagging nucleic acids of a biological specimen, the method including steps of (a) attaching different nucleic acid probes to a solid support to produce randomly located probes on the solid support, wherein the different nucleic acid probes each includes a barcode sequence, and wherein each of the randomly located probes includes different barcode sequences from other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to determine the barcode sequences of the randomly located probes on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen that are proximal to the randomly located probes; and (e) extending the randomly located probes to produce extended probes that include the barcode sequences and sequences from the target nucleic acids, thereby spatially tagging the nucleic acids of the biological specimen.
Also provided is a method for spatially tagging nucleic acids of a biological specimen that includes the steps of (a) providing a plurality of nucleic acid primers attached to a solid support, wherein the nucleic acid primers in the plurality include a universal primer sequence that is common to the nucleic acid primers in the plurality; (b) binding a population of nucleic acid probes to the plurality of nucleic acid primers, wherein the nucleic acid probes include a universal primer binding sequence that hybridizes to the universal primer sequence, a target capture sequence and a barcode sequence that differs from barcode sequences of other nucleic acid probes in the population, thereby attaching the different nucleic acid probes at randomly located positions on the solid support; (c) amplifying the different nucleic acid probes by extension of the nucleic acid primers, thereby producing nucleic acid clusters having copies of the barcode sequence and target capture sequence at the randomly located positions on the solid support; (d) performing a sequencing reaction to determine the barcode sequences at the randomly located positions on the solid support; (e) contacting a biological specimen with the nucleic acid clusters on the solid support; (f) hybridizing the target capture sequences of the clusters to target nucleic acids from portions of the biological specimen that are proximal to the clusters; and (g) extending the target capture sequences to produce extended probes that include sequences from the target nucleic acids and the copies of the barcode sequences, thereby tagging the nucleic acids of the biological specimen.
This disclosure further provides a method for spatially tagging nucleic acids of a biological specimen, the method including steps of (a) providing an array of beads on a solid support, wherein different nucleic acid probes are attached to different beads in the array, wherein the different nucleic acid probes each include a barcode sequence, wherein each bead includes a different barcode sequence from other beads on the solid support, and wherein each of the different nucleic acid probes includes a target capture sequence; (b) performing a decoder probe hybridization reaction on the solid support to determine the barcode sequences at the randomly located probes on the solid support; (c) contacting a biological specimen with the array of beads; (d) hybridizing the different nucleic acid probes to target nucleic acids from portions of the biological specimen that are proximal to the beads; and (e) extending the different nucleic acid probes to produce extended probes that include sequences from the target nucleic acids and the barcode sequences, thereby tagging the nucleic acids of the biological specimen.
The present disclosure provides compositions, apparatus and methods for preserving spatial information when performing multiplex nucleic acid analyses of biological specimens. A variety of tools are available for multiplex nucleic acid analyses including, for example, nucleic acid microarrays and so-called “next generation” sequencing platforms. Such tools allow for parallel detection of very large and complex collections of nucleic acids, including for example, DNA collections that represent all or nearly all of the genetic material of an organism (i.e. the ‘genome’), RNA (or cDNA) collections that represent all or nearly all of the complement of expressed genes (i.e. the ‘transcriptome’) for an organism, and in some cases the collections can include several genomes and/or transcriptomes from several different organisms (e.g. a metabolome or biome from a community or ecosystem). Although these tools provide a vast amount of information about what nucleic acid sequences are present in a biological specimen being evaluated, they do not inherently distinguish where any particular nucleic acid resided in the biological specimen. Indeed the vast majority of samples applied to multiplex nucleic acid analysis tools are homogenates derived from mixtures of many different cells from a biological specimen. As a result, spatial information is lost and the results obtained from these tools constitute an average transcriptome or average genome for the specimen, important differences between individual cells being lost.
In particular embodiments, the present disclosure provides new and useful modifications to existing multiplex nucleic acid analysis tools to allow for the preservation of spatial information for biological specimens from which the nucleic acids are obtained. For example, solid supports that are usually used for multiplex sequencing-by-synthesis (SBS) techniques can be modified for use in capturing and spatially tagging nucleic acids from a biological specimen. In an alternative example, arrays of beads, such as those used for genotyping or gene expression analysis, can be used for capturing and spatially tagging nucleic acids from a biological specimen. As set forth in examples below, the solid supports used for an SBS or BeadArray™ platform commercialized by Illumina (San Diego, Calif.) can be modified for spatial tagging. However, it will be understood that any of a variety of solid supports can be made and used in accordance with the teaching herein. The spatially tagged nucleic acids can be removed from the solid support, pooled together and attached to a second solid support for detection in any of a variety of multiplex nucleic acid analysis systems including, for example, a sequencing platform or microarray platform set forth herein.
The spatial information provided by a method, composition or apparatus herein can include, for example, the location of one or more cells in a tissue (or other specimen) that has a particular allele at one or more locus (e.g. a genotype), has a particular structural variation in the genome (e.g. fusion, insertion, deletion, rearrangement etc.), has a particular epigenetic signature (e.g. methylation), expresses a particular gene, expresses a particular allele of a gene, expresses a particular splice variant of a gene or the like. In addition to identifying nucleic acids according to their spatial location in a biological specimen, a method, composition or apparatus of the present disclosure can be used to quantify one or more nucleic acids according to spatial location. For example, the spatial information for one or more cells in a tissue (or other specimen) can include the amount of a particular allele or chromosomal region in a genome (e.g. ploidy); the amount of epigenetic modification of a genetic locus (e.g. methylation); expression level for a particular gene, allele or splice variant; or the like. The amounts can be absolute amounts or relative amounts in accordance with similar measurements obtained in the art for mixed or non-spatially tagged samples.
A method set forth herein can be used for localized detection of a nucleic acid in a biological specimen. In some embodiments, a method can be used for identifying or characterizing all of the transcriptome or genome of a biological specimen. Alternatively, a method can be used to identify or characterize only a part of a specimen's transcriptome or genome. A subset of transcripts or genes evaluated in a method herein can be related to a particular disease or condition.
A method set forth herein can be used for localized or spatial detection of nucleic acids, whether DNA or RNA, in a biological specimen. Thus one or more RNA or DNA molecules can be located with respect to its native position or location within a cell or tissue or other biological specimen. For example, one or more nucleic acids can be localized to a cell or group of adjacent cells, or type of cell, or to particular regions of areas within a tissue sample. The native location or position of individual RNA or DNA molecules can be determined using a method, apparatus or composition of the present disclosure.
Terms used herein will be understood to take on their ordinary meaning in the relevant art unless specified otherwise. Several terms used herein and their meanings are set forth below.
As used herein, the term “amplicon,” when used in reference to a nucleic acid, means the product of copying the nucleic acid, wherein the product has a nucleotide sequence that is the same as or complementary to at least a portion of the nucleotide sequence of the nucleic acid. An amplicon can be produced by any of a variety of amplification methods that use the nucleic acid, or an amplicon thereof, as a template including, for example, polymerase extension, polymerase chain reaction (PCR), rolling circle amplification (RCA), multiple displacement amplification (MDA), ligation extension, or ligation chain reaction. An amplicon can be a nucleic acid molecule having a single copy of a particular nucleotide sequence (e.g. a PCR product) or multiple copies of the nucleotide sequence (e.g. a concatameric product of RCA). A first amplicon of a target nucleic acid is typically a complimentary copy. Subsequent amplicons are copies that are created, after generation of the first amplicon, from the target nucleic acid or from the first amplicon. A subsequent amplicon can have a sequence that is substantially complementary to the target nucleic acid or substantially identical to the target nucleic acid.
As used herein, the term “array” refers to a population of features or sites that can be differentiated from each other according to relative location. Different molecules that are at different sites of an array can be differentiated from each other according to the locations of the sites in the array. An individual site of an array can include one or more molecules of a particular type. For example, a site can include a single target nucleic acid molecule having a particular sequence or a site can include several nucleic acid molecules having the same sequence (and/or complementary sequence, thereof). The sites of an array can be different features in a substrate, beads (or other particles) in or on a substrate, projections from a substrate, ridges on a substrate or channels in a substrate. The sites of an array can be separate substrates each bearing a different molecule. Different molecules attached to separate substrates can be identified according to the locations of the substrates on a surface to which the substrates are associated or according to the locations of the substrates in a liquid or gel. Exemplary arrays in which separate substrates are located on a surface include, without limitation, those having beads in wells.
As used herein, the term “attached” refers to the state of two things being joined, fastened, adhered, connected or bound to each other. For example, an analyte, such as a nucleic acid, can be attached to a material, such as a gel or solid support, by a covalent or non-covalent bond. A covalent bond is characterized by the sharing of pairs of electrons between atoms. A non-covalent bond is a chemical bond that does not involve the sharing of pairs of electrons and can include, for example, hydrogen bonds, ionic bonds, van der Waals forces, hydrophilic interactions and hydrophobic interactions.
As used herein, the term “barcode sequence” is intended to mean a series of nucleotides in a nucleic acid that can be used to identify the nucleic acid, a characteristic of the nucleic acid, or a manipulation that has been carried out on the nucleic acid. The barcode sequence can be a naturally occurring sequence or a sequence that does not occur naturally in the organism from which the barcoded nucleic acid was obtained. A barcode sequence can be unique to a single nucleic acid species in a population or a barcode sequence can be shared by several different nucleic acid species in a population. For example, each nucleic acid probe in a population can include different barcode sequences from all other nucleic acid probes in the population. Alternatively, each nucleic acid probe in a population can include different barcode sequences from some or most other nucleic acid probes in a population. For example, each probe in a population can have a barcode that is present for several different probes in the population even though the probes with the common barcode differ from each other at other sequence regions along their length. In particular embodiments, one or more barcode sequences that are used with a biological specimen are not present in the genome, transcriptome or other nucleic acids of the biological specimen. For example, barcode sequences can have less than 80%, 70%, 60%, 50% or 40% sequence identity to the nucleic acid sequences in a particular biological specimen.
As used herein, the term “biological specimen” is intended to mean one or more cell, tissue, organism or portion thereof. A biological specimen can be obtained from any of a variety of organisms. Exemplary organisms include, but are not limited to, a mammal such as a rodent, mouse, rat, rabbit, guinea pig, ungulate, horse, sheep, pig, goat, cow, cat, dog, primate (i.e. human or non-human primate); a plant such as Arabidopsis thaliana, corn, sorghum, oat, wheat, rice, canola, or soybean; an algae such as Chlamydomonas reinhardtii; a nematode such as Caenorhabditis elegans; an insect such as Drosophila melanogaster, mosquito, fruit fly, honey bee or spider; a fish such as zebrafish; a reptile; an amphibian such as a frog or Xenopus laevis; a Dictyostelium discoideum; a fungi such as Pneumocystis carinii, Takifugu rubripes, yeast, Saccharamoyces cerevisiae or Schizosaccharomyces pombe; or a Plasmodium falciparum. Target nucleic acids can also be derived from a prokaryote such as a bacterium, Escherichia coli, Staphylococci or Mycoplasma pneumoniae; an archae; a virus such as Hepatitis C virus or human immunodeficiency virus; or a viroid. Specimens can be derived from a homogeneous culture or population of the above organisms or alternatively from a collection of several different organisms, for example, in a community or ecosystem.
As used herein, the term “cleavage site” is intended to mean a location in a nucleic acid molecule that is susceptible to bond breakage. The location can be specific to a particular chemical, enzymatic or physical process that results in bond breakage. For example, the location can be a nucleotide that is abasic or a nucleotide that has a base that is susceptible to being removed to create an abasic site. Examples of nucleotides that are susceptible to being removed include uracil and 8-oxo-guanine as set forth in further detail herein below. The location can also be at or near a recognition sequence for a restriction endonuclease such as a nicking enzyme.
As used herein, the term “cluster,” when used in reference to nucleic acids, refers to a population of the nucleic acids that is attached to a solid support to form a feature or site. The nucleic acids are generally members of a single species, thereby forming a monoclonal cluster. A “monoclonal population” of nucleic acids is a population that is homogeneous with respect to a particular nucleotide sequence. Clusters need not be monoclonal. Rather, for some applications, a cluster can be predominantly populated with amplicons from a first nucleic acid and can also have a low level of contaminating amplicons from a second nucleic acid. For example, when an array of clusters is to be used in a detection application, an acceptable level of contamination would be a level that does not impact signal to noise or resolution of the detection technique in an unacceptable way. Accordingly, apparent clonality will generally be relevant to a particular use or application of an array made by the methods set forth herein. Exemplary levels of contamination that can be acceptable at an individual cluster include, but are not limited to, at most 0.1%, 0.5%, 1%, 5%, 10%, 5 25%, or 35% contaminating amplicons. The nucleic acids in a cluster are generally covalently attached to a solid support, for example, via their 5′ ends, but in some cases other attachment means are possible. The nucleic acids in a cluster can be single stranded or double stranded. In some but not all embodiments, clusters are made by a solid-phase amplification method known as bridge amplification. Exemplary configurations for clusters and methods for their production are set forth, for example, in U.S. Pat. No. 5,641,658; U.S. Patent Publ. No. 2002/0055100; U.S. Pat. No. 7,115,400; U.S. Patent Publ. No. 2004/0096853; U.S. Patent Publ. No. 2004/0002090; U.S. Patent Publ. No. 2007/0128624; and U.S. Patent Publ. No. 2008/0009420, each of which is incorporated herein by reference.
As used herein, the term “different”, when used in reference to nucleic acids, means that the nucleic acids have nucleotide sequences that are not the same as each other. Two or more nucleic acids can have nucleotide sequences that are different along their entire length. Alternatively, two or more nucleic acids can have nucleotide sequences that are different along a substantial portion of their length. For example, two or more nucleic acids can have target nucleotide sequence portions that are different for the two or more molecules while also having a universal sequence portion that is the same on the two or more molecules. Two beads can be different from each other by virtue of being attached to different nucleic acids.
As used herein, the term “each,” when used in reference to a collection of items, is intended to identify an individual item in the collection but does not necessarily refer to every item in the collection. Exceptions can occur if explicit disclosure or context clearly dictates otherwise.
As used herein, the term “extend,” when used in reference to a nucleic acid, is intended to mean addition of at least one nucleotide or oligonucleotide to the nucleic acid. In particular embodiments one or more nucleotides can be added to the 3′ end of a nucleic acid, for example, via polymerase catalysis (e.g. DNA polymerase, RNA polymerase or reverse transcriptase). Chemical or enzymatic methods can be used to add one or more nucleotide to the 3′ or 5′ end of a nucleic acid. One or more oligonucleotides can be added to the 3′ or 5′ end of a nucleic acid, for example, via chemical or enzymatic (e.g. ligase catalysis) methods. A nucleic acid can be extended in a template directed manner, whereby the product of extension is complementary to a template nucleic acid that is hybridized to the nucleic acid that is extended.
As used herein, the term “feature” means a location in an array for a particular species of molecule. A feature can contain only a single molecule or it can contain a population of several molecules of the same species. Features of an array are typically discrete. The discrete features can be contiguous or they can have spaces between each other. The size of the features and/or spacing between the features can vary such that arrays can be high density, medium density or lower density. High density arrays are characterized as having sites separated by less than about 15 μm. Medium density arrays have sites separated by about 15 to 30 μm, while low density arrays have sites separated by greater than 30 μm. An array useful herein can have, for example, sites that are separated by less than 100 μm, 50 μm, 10 μm, 5 μm, 1 μm, or 0.5 μm. An apparatus or method of the present disclosure can be used to detect an array at a resolution sufficient to distinguish sites at the above densities or density ranges.
As used herein, the term “fluidic mixture” is intended to mean two or more different items that are simultaneously present in a solution. Typically, the two or more items are freely diffusible in the solution. The two or more items can be different types of items (e.g. a nucleic acid and a protein which are different types of molecules) or they can be different species of the same type of items (e.g. two nucleic acid molecules having different sequences). Exemplary items that can be in a fluidic mixture include, but are not limited to, molecules, cells or beads.
As used herein, the term “flow cell” is intended to mean a vessel having a chamber where a reaction can be carried out, an inlet for delivering reagents to the chamber and an outlet for removing reagents from the chamber. In some embodiments the chamber is configured for detection of the reaction that occurs in the chamber. For example, the chamber can include one or more transparent surfaces allowing optical detection of biological specimens, optically labeled molecules, or the like in the chamber. Exemplary flow cells include, but are not limited to those used in a nucleic acid sequencing apparatus such as flow cells for the Genome Analyzer®, MiSeq®, NextSeq® or HiSeq® platforms commercialized by Illumina, Inc. (San Diego, Calif.); or for the SOLiD™ or Ion Torrent™ sequencing platform commercialized by Life Technologies (Carlsbad, Calif.). Exemplary flow cells and methods for their manufacture and use are also described, for example, in WO 2014/142841 A1; U.S. Pat. App. Pub. No. 2010/0111768 A1 and U.S. Pat. No. 8,951,781, each of which is incorporated herein by reference.
As used herein, the term “gel” is intended to mean a semi-rigid material that is permeable to liquids and gases. Typically, gel material can swell when liquid is taken up and can contract when liquid is removed by drying. Exemplary gels include, but are not limited to those having a colloidal structure, such as agarose; polymer mesh structure, such as gelatin; or cross-linked polymer structure, such as polyacrylamide, SFA (see, for example, US Pat. App. Pub. No. 2011/0059865 A1, which is incorporated herein by reference) or PAZAM (see, for example, US Pat. App. Publ. No. 2014/0079923 A1, which is incorporated herein by reference).
Particularly useful gel material will conform to the shape of a well or other concave feature where it resides.
As used herein, the terms “nucleic acid” and “nucleotide” are intended to be consistent with their use in the art and to include naturally occurring species or functional analogs thereof. Particularly useful functional analogs of nucleic acids are capable of hybridizing to a nucleic acid in a sequence specific fashion or capable of being used as a template for replication of a particular nucleotide sequence. Naturally occurring nucleic acids generally have a backbone containing phosphodiester bonds. An analog structure can have an alternate backbone linkage including any of a variety of those known in the art. Naturally occurring nucleic acids generally have a deoxyribose sugar (e.g. found in deoxyribonucleic acid (DNA)) or a ribose sugar (e.g. found in ribonucleic acid (RNA)). A nucleic acid can contain nucleotides having any of a variety of analogs of these sugar moieties that are known in the art. A nucleic acid can include native or non-native nucleotides. In this regard, a native deoxyribonucleic acid can have one or more bases selected from the group consisting of adenine, thymine, cytosine or guanine and a ribonucleic acid can have one or more bases selected from the group consisting of uracil, adenine, cytosine or guanine. Useful non-native bases that can be included in a nucleic acid or nucleotide are known in the art. The terms “probe” or “target,” when used in reference to a nucleic acid or sequence of a nucleic acid, are intended as semantic identifiers for the nucleic acid or sequence in the context of a method or composition set forth herein and does not necessarily limit the structure or function of the nucleic acid or sequence beyond what is otherwise explicitly indicated. The terms “probe” and “target” can be similarly applied to other analytes such as proteins, small molecules, cells or the like.
As used herein, the term “pitch,” when used in reference to features of an array, is intended to refer to the center-to-center spacing for adjacent features. A pattern of features can be characterized in terms of average pitch. The pattern can be ordered such that the coefficient of variation around the average pitch is small or the pattern can be random in which case the coefficient of variation can be relatively large. In either case, the average pitch can be, for example, at least about 10 nm, 0.1 μm, 0.5 μm, 1 μm, 5 μm, 10 μm, 100 μm or more. Alternatively or additionally, the average pitch can be, for example, at most about 100 μm, 10 μm, 5 μm, 1 μm, 0.5 μm 0.1 μm or less. Of course, the average pitch for a particular pattern of features can be between one of the lower values and one of the upper values selected from the ranges above.
As used herein, the term “poly Tor poly A,” when used in reference to a nucleic acid sequence, is intended to mean a series of two or more thiamine (T) or adenine (A) bases, respectively. A poly T or poly A can include at least about 2, 5, 8, 10, 12, 15, 18, 20 or more of the T or A bases, respectively. Alternatively or additionally, a poly T or poly A can include at most about, 30, 20, 18, 15, 12, 10, 8, 5 or 2 of the Tor A bases, respectively.
As used herein, the term “random” can be used to refer to the spatial arrangement or composition of locations on a surface. For example, there are at least two types of order for an array described herein, the first relating to the spacing and relative location of features (also called “sites”) and the second relating to identity or predetermined knowledge of the particular species of molecule that is present at a particular feature. Accordingly, features of an array can be randomly spaced such that nearest neighbor features have variable spacing between each other. Alternatively, the spacing between features can be ordered, for example, forming a regular pattern such as a rectilinear grid or hexagonal grid. In another respect, features of an array can be random with respect to the identity or predetermined knowledge of the species of analyte (e.g. nucleic acid of a particular sequence) that occupies each feature independent of whether spacing produces a random pattern or ordered pattern. An array set forth herein can be ordered in one respect and random in another. For example, in some embodiments set forth herein a surface is contacted with a population of nucleic acids under conditions where the nucleic acids attach at sites that are ordered with respect to their relative locations but ‘randomly located’ with respect to knowledge of the sequence for the nucleic acid species present at any particular site. Reference to “randomly distributing” nucleic acids at locations on a surface is intended to refer to the absence of knowledge or absence of predetermination regarding which nucleic acid will be captured at which location (regardless of whether the locations are arranged in an ordered pattern or not).
As used herein, the term “solid support” refers to a rigid substrate that is insoluble in aqueous liquid. The substrate can be non-porous or porous. The substrate can optionally be capable of taking up a liquid (e.g. due to porosity) but will typically be sufficiently rigid that the substrate does not swell substantially when taking up the liquid and does not contract substantially when the liquid is removed by drying. A nonporous solid support is generally impermeable to liquids or gases. Exemplary solid supports include, but are not limited to, glass and modified or functionalized glass, plastics (including acrylics, polystyrene and copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethanes, Teflon™, cyclic olefins, polyimides etc.), nylon, ceramics, resins, Zeonor, silica or silica-based materials including silicon and modified silicon, carbon, metals, inorganic glasses, optical fiber bundles, and polymers. Particularly useful solid supports for some embodiments are located within a flow cell apparatus. Exemplary flow cells are set forth in further detail herein.
As used herein, the term “spatial tag” is intended to mean a nucleic acid having a sequence that is indicative of a location. Typically, the nucleic acid is a synthetic molecule having a sequence that is not found in one or more biological specimen that will be used with the nucleic acid. However, in some embodiments the nucleic acid molecule can be naturally derived or the sequence of the nucleic acid can be naturally occurring, for example, in a biological specimen that is used with the nucleic acid. The location indicated by a spatial tag can be a location in or on a biological specimen, in or on a solid support or a combination thereof. A barcode sequence can function as a spatial tag.
As used herein, the term “tissue” is intended to mean an aggregation of cells, and, optionally, intercellular matter. Typically the cells in a tissue are not free floating in solution and instead are attached to each other to form a multicellular structure. Exemplary tissue types include muscle, nerve, epidermal and connective tissues.
As used herein, the term “universal sequence” refers to a series of nucleotides that is common to two or more nucleic acid molecules even if the molecules also have regions of sequence that differ from each other. A universal sequence that is present in different members of a collection of molecules can allow capture of multiple different nucleic acids using a population of universal capture nucleic acids that are complementary to the universal sequence. Similarly, a universal sequence present in different members of a collection of molecules can allow the replication or amplification of multiple different nucleic acids using a population of universal primers that are complementary to the universal sequence. Thus, a universal capture nucleic acid or a universal primer includes a sequence that can hybridize specifically to a universal sequence. Target nucleic acid molecules may be modified to attach universal adapters, for example, at one or both ends of the different target sequences.
The embodiments set forth below and recited in the claims can be understood in view of the above definitions.
The present disclosure provides a method for spatially tagging nucleic acids of a biological specimen. The method can include the steps of (a) attaching different nucleic acid probes to a solid support to produce randomly located probes on the solid support, wherein the different nucleic acid probes each includes a barcode sequence, and wherein each of the randomly located probes includes different barcode sequences from other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to determine the barcode sequences of the randomly located probes on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen that are proximal to the randomly located probes; and (e) extending the randomly located probes to produce extended probes that include the barcode sequences and sequences from the target nucleic acids, thereby spatially tagging the nucleic acids of the biological specimen.
Any of a variety of solid supports can be used in a method, composition or apparatus of the present disclosure. Particularly useful solid supports are those used for nucleic acid arrays. Examples include glass, modified glass, functionalized glass, inorganic glasses, microspheres (e.g. inert and/or magnetic particles), plastics, polysaccharides, nylon, nitrocellulose, ceramics, resins, silica, silica-based materials, carbon, metals, an optical fiber or optical fiber bundles, polymers and multiwell (e.g. microtiter) plates. Exemplary plastics include acrylics, polystyrene, copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethanes and Teflon™. Exemplary silica-based materials include silicon and various forms of modified silicon.
In particular embodiments, a solid support can be within or part of a vessel such as a well, tube, channel, cuvette, Petri plate, bottle or the like. A particularly useful vessel is a flow-cell, for example, as described in WO 2014/142841 A1; U.S. Pat. App. Pub. No. 2010/0111768 A1 and U.S. Pat. No. 8,951,781 or Bentley et al., Nature 456:53-59 (2008), each of which is incorporated herein by reference. Exemplary flow-cells are those that are commercially available from Illumina, Inc. (San Diego, Calif.) for use with a sequencing platform such as a Genome Analyzer®, MiSeq®, NextSeq® or HiSeq® platform. Another particularly useful vessel is a well in a multiwell plate or microtiter plate.
Optionally, a solid support can include a gel coating. Attachment of nucleic acids to a solid support via a gel is exemplified by flow cells available commercially from Illumina Inc. (San Diego, Calif.) or described in US Pat. App. Pub. Nos. 2011/0059865 A1, 2014/0079923 A1, or 2015/0005447 A1; or PCT Publ. No. WO 2008/093098, each of which is incorporated herein by reference. Exemplary gels that can be used in the methods and apparatus set forth herein include, but are not limited to, those having a colloidal structure, such as agarose; polymer mesh structure, such as gelatin; or cross-linked polymer structure, such as polyacrylamide, SFA (see, for example, US Pat. App. Pub. No. 2011/0059865 A1, which is incorporated herein by reference) or PAZAM (see, for example, US Pat. App. Publ. Nos. 2014/0079923A1, or 2015/0005447 A1, each of which is incorporated herein by reference).
In some embodiments, a solid support can be configured as an array of features to which nucleic acids can be attached. The features can be present in any of a variety of desired formats. For example, the features can be wells, pits, channels, ridges, raised regions, pegs, posts or the like. In some embodiments, the features can contain beads. However, in particular embodiments the features need not contain a bead or particle. Exemplary features include wells that are present in substrates used for commercial sequencing platforms sold by 454 LifeSciences (a subsidiary of Roche, Basel Switzerland) or Ion Torrent (a subsidiary of Life Technologies, Carlsbad Calif.). Other substrates having wells include, for example, etched fiber optics and other substrates described in U.S. Pat. Nos. 6,266,459; 6,355,431; 6,770,441; 6,859,570; 6,210,891; 6,258,568; 6,274,320; us Pat app. Publ. Nos. 2009/0026082 A1; 2009/0127589 A1; 2010/0137143 A1; 2010/0282617 A1 or PCT Publication No. WO 00/63437, each of which is incorporated herein by reference. In some embodiments, wells of a substrate can include gel material (with or without beads) as set forth in US Pat. App. Publ. No. 2014/0243224 A1, which is incorporated herein by reference.
The features on a solid support can be metal features on a non-metallic surface such as glass, plastic or other materials exemplified above. A metal layer can be deposited on a surface using methods known in the art such as wet plasma etching, dry plasma etching, atomic layer deposition, ion beam etching, chemical vapor deposition, vacuum sputtering or the like. Any of a variety of commercial instruments can be used as appropriate including, for example, the FlexAL®, OpAL®, Ionfab 300Plus®, or Optofab 3000® systems (Oxford Instruments, UK). A metal layer can also be deposited by e-beam evaporation or sputtering as set forth in Thornton, Ann. Rev. Mater. Sci. 7:239-60 (1977), which is incorporated herein by reference. Metal layer deposition techniques, such as those exemplified above, can be combined with photolithography techniques to create metal regions or patches on a surface. Exemplary methods for combining metal layer deposition techniques and photolithography techniques are provided in U.S. Pat. No. 8,895,249 or US Pat App. Pub. No. 2014/0243224 A1, each of which is incorporated herein by reference.
Features can appear on a solid support as a grid of spots or patches. The features can be located in a repeating pattern or in an irregular, non-repeating pattern. Particularly useful repeating patterns are hexagonal patterns, rectilinear patterns, grid patterns, patterns having reflective symmetry, patterns having rotational symmetry, or the like. Asymmetric patterns can also be useful. The pitch can be the same between different pairs of nearest neighbor features or the pitch can vary between different pairs of nearest neighbor features.
High density arrays are characterized as having average pitch of less than about 15 μm. Medium density arrays have average pitch of about 15 to 30 μm, while low density arrays have average pitch greater than 30 μm. An array useful in the invention can have average pitch that is less than 100 μm, 50 μm, 10 μm, 5 μm, 1 μm or 0.5 μm. The average pitch values and ranges set forth above or elsewhere herein are intended to be applicable to ordered arrays or random arrays.
In particular embodiments, features on a solid support can each have an area that is larger than about 100 nm2, 250 nm2, 500 nm2, 1 μm2, 2.5 μm2, 5 μm2, 10 μm2, 100 μm2, or 500 μm2. Alternatively or additionally, features can each have an area that is smaller than about 1 mm2, 500 μm2, 100 μm2, 25 μm2, 10 μm2, 5 μm2, 1 μm2, 500 nm2, or 100 nm2. The above ranges can describe the apparent area of a bead or other particle on a solid support when viewed or imaged from above.
In particular embodiments, a solid support can include a collection of beads or other particles. The particles can be suspended in a solution or they can be located on the surface of a substrate. Examples of arrays having beads located on a surface include those wherein beads are located in wells such as a BeadChip array (Illumina Inc., San Diego Calif.), substrates used in sequencing platforms from 454 LifeSciences (a subsidiary of Roche, Basel Switzerland) or substrates used in sequencing platforms from Ion Torrent (a subsidiary of Life Technologies, Carlsbad Calif.). Other solid supports having beads located on a surface are described in U.S. Pat. Nos. 6,266,459; 6,355,431; 6,770,441; 6,859,570; 6,210,891; 6,258,568; or 6,274,320; US Pat. App. Publ. Nos. 2009/0026082 A1; 2009/0127589 A1; 2010/0137143 A1; or 2010/0282617 A1 or PCT Publication No. WO 00/63437, each of which is incorporated herein by reference. Several of the above references describe methods for attaching nucleic acid probes to beads prior to loading the beads in or on a solid support. As such, the collection of beads can include different beads each having a unique probe attached. It will however, be understood that the beads can be made to include universal primers, and the beads can then be loaded onto an array, thereby forming universal arrays for use in a method set forth herein.
As set forth previously herein, the solid supports typically used for bead arrays can be used without beads. For example, nucleic acids, such as probes or primers can be attached directly to the wells or to gel material in wells. Thus, the above references are illustrative of materials, compositions or apparatus that can be modified for use in the methods and compositions set forth herein.
Accordingly, a solid support used in a method set forth herein can include an array of beads, wherein different nucleic acid probes are attached to different beads in the array. In this embodiment, each bead can be attached to a different nucleic acid probe and the beads can be randomly distributed on the solid support in order to effectively attach the different nucleic acid probes to the solid support.
Optionally, the solid support can include wells having dimensions that accommodate no more than a single bead. In such a configuration, the beads may be attached to the wells due to forces resulting from the fit of the beads in the wells. It is also possible to use attachment chemistries or adhesives to hold the beads in the wells.
Nucleic acid probes that are attached to beads can include barcode sequences. A population of the beads can be configured such that each bead is attached to only one type of barcode and many different beads each with a different barcode are present in the population. In this embodiment, randomly distributing the beads to a solid support will result in randomly locating the nucleic acid probes (and their respective barcode sequences) on the solid support. In some cases there can be multiple beads with the same barcode sequence such that there is redundancy in the population. Randomly distributing a redundant population of beads on a solid support that has a capacity that is greater than the number of unique barcodes in the bead population will result in redundancy of barcodes on the solid support.
Alternatively, the number of different barcodes in a population of beads can exceed the capacity of the solid support in order to produce an array that is not redundant with respect to the population of barcodes on the solid support. The capacity of the solid support will be determined in some embodiments by the number of features (e.g. single-bead occupancy wells) that attach or otherwise accommodate a bead.
A solid support can include, or can be made by the methods set forth herein to attach, a plurality of different nucleic acid probes. For example, a solid support can include at least 10, 100, 1×103, 1×104, 1×105, 1×106, 1×107, 1×108, 1×109 or more different probes. Alternatively or additionally, a solid support can include at most 1×109, 1×108, 1×107, 1×106, 1×105, 1×104, 1×103, 100, or fewer different probes. It will be understood that each of the different probes can be present in several copies, for example, when the probes have been amplified to form a cluster. Thus, the above ranges can describe the number of different nucleic acid clusters on a solid support. It will also be understood that the above ranges can describe the number of different barcodes, target capture sequences, or other sequence elements set forth herein as being unique to particular nucleic acid probes. Alternatively or additionally, the ranges can describe the number of extended probes or modified probes created on a solid support using a method set forth herein.
Features, may be present on a solid support prior to contacting the solid support with nucleic acid probes. For example, in embodiments where probes are attached to a support via hybridization to primers, the primers can be attached at the features, whereas interstitial areas outside of the features substantially lack any of the primers. Nucleic acid probes can be captured at preformed features on a solid support, and optionally amplified on the solid support, using methods set forth in U.S. Pat. Nos. 8,895,249, 8,778,849, or US Pat App. Pub. No. 2014/0243224 A1, each of which is incorporated herein by reference. Alternatively, a solid support may have a lawn of primers or may otherwise lack features. In this case, a feature can be formed by virtue of attachment of a nucleic acid probe on the solid support. Optionally, the captured nucleic acid probe can be amplified on the solid support such that the resulting cluster becomes a feature. Although attachment is exemplified above as capture between a primer and a complementary portion of a probe, it will be understood that capture moieties other than primers can be present at pre-formed features or as a lawn. Other exemplary capture moieties include, but are not limited to, chemical moieties capable of reacting with a nucleic acid probe to create a covalent bond or receptors capable of biding non-covalently to a ligand on a nucleic acid probe.
A step of attaching nucleic acid probes to a solid support can be carried out by providing a fluid that contains a mixture of different nucleic acid probes and contacting this fluidic mixture with the solid support. The contact can result in the fluidic mixture being in contact with a surface to which many different nucleic acid probes from the fluidic mixture will attach. Thus, the probes have random access to the surface (whether the surface has pre-formed features configured to attach the probes or a uniform surface configured for attachment). Accordingly, the probes can be randomly located on the solid support.
The total number and variety of different probes that end up attached to a surface can be selected for a particular application or use. For example, in embodiments where a fluidic mixture of different nucleic acid probes is contacted with a solid support for purposes of attaching the probes to the support, the number of different probe species can exceed the occupancy of the solid support for probes. Thus, the number and variety of different probes that attach to the solid support can be equivalent to the probe occupancy of the solid support. Alternatively, the number and variety of different probe species on the solid support can be less than the occupancy (i.e. there will be redundancy of probe species such that the solid support may contain multiple features having the same probe species). Such redundancy can be achieved, for example, by contacting the solid support with a fluidic mixture that contains a number and variety of probe species that is substantially lower than the probe occupancy of the solid support.
Attachment of the nucleic acid probes can be mediated by hybridization of the nucleic acid probes to complementary primers that are attached to the solid support, chemical bond formation between a reactive moiety on the nucleic acid probe and the solid support (examples are set forth in U.S. Pat. Nos. 8,895,249, 8,778,849, or US Pat App. Pub. No. 2014/0243224 A1, each of which is incorporated herein by reference), affinity interactions of a moiety on the nucleic acid probe with a solid support-bound moiety (e.g. between known receptor-ligand pairs such as streptavidinbiotin, antibody-epitope, lectin-carbohydrate and the like), physical interactions of the nucleic acid probes with the solid support (e.g. hydrogen bonding, ionic forces, van der Waals forces and the like), or other interactions known in the art to attach nucleic acids to surfaces.
In some embodiments, attachment of a nucleic acid probe is non-specific with regard to any sequence differences between the nucleic acid probe and other nucleic acid probes that are or will be attached to the solid support. For example, different probes can have a universal sequence that complements surface-attached primers or the different probes can have a common moiety that mediates attachment to the surface. Alternatively, each of the different probes (or a subpopulation of different probes) can have a unique sequence that complements a unique primer on the solid support or they can have a unique moiety that interacts with one or more different reactive moiety on the solid support. In such cases, the unique primers or unique moieties can, optionally, be attached at predefined locations in order to selectively capture particular probes, or particular types of probes, at the respective predefined locations.
One or more features on a solid support can each include a single molecule of a particular probe. The features can be configured, in some embodiments, to accommodate no more than a single nucleic acid probe molecule. However, whether or not the feature can accommodate more than one nucleic acid probe molecule, the feature may nonetheless include no more than a single nucleic acid probe molecule. Alternatively, an individual feature can include a plurality of nucleic acid probe molecules, for example, an ensemble of nucleic acid probe molecules having the same sequence as each other. In particular embodiments, the ensemble can be produced by amplification from a single nucleic acid probe template to produce amplicons, for example, as a cluster attached to the surface.
A method set forth herein can use any of a variety of amplification techniques. Exemplary techniques that can be used include, but are not limited to, polymerase chain reaction (PCR), rolling circle amplification (RCA), multiple displacement amplification (MDA), or random prime amplification (RPA). In some embodiments the amplification can be carried out in solution, for example, when features of an array are capable of containing amplicons in a volume having a desired capacity. Preferably, an amplification technique used in a method of the present disclosure will be carried out on solid phase. For example, one or more primer species (e.g. universal primers for one or more universal primer binding site present in a nucleic acid probe) can be attached to a solid support. In PCR embodiments, one or both of the primers used for amplification can be attached to a solid support (e.g. via a gel). Formats that utilize two species of primers attached to a solid support are often referred to as bridge amplification because double stranded amplicons form a bridge-like structure between the two surface attached primers that flank the template sequence that has been copied. Exemplary reagents and conditions that can be used for bridge amplification are described, for example, in U.S. Pat. Nos. 5,641,658, 7,115,400, or 8,895,249; or U.S. Pat. Publ. Nos. 2002/0055100 A1, 2004/0096853 A1, 2004/0002090 A1, 2007/0128624 A1 or 2008/0009420 A1, each of which is incorporated herein by reference. Solid-phase PCR amplification can also be carried out with one of the amplification primers attached to a solid support and the second primer in solution. An exemplary format that uses a combination of a surface attached primer and soluble primer is the format used in emulsion PCR as described, for example, in Dressman et al., Proc. Natl. Acad. Sci. USA 100:8817-8822 (2003), WO 05/010145, or U.S. Pat. App. Publ. Nos. 2005/0130173 A1 or 2005/0064460 A1, each of which is incorporated herein by reference. Emulsion PCR is illustrative of the format and it will be understood that for purposes of the methods set forth herein the use of an emulsion is optional and indeed for several embodiments an emulsion is not used.
RCA techniques can be modified for use in a method of the present disclosure. Exemplary components that can be used in an RCA reaction and principles by which RCA produces amplicons are described, for example, in Lizardi et al., Nat. Genet. 19:225-232 (1998) and US Pat. App. Publ. No. 2007/0099208 A1, each of which is incorporated herein by reference. Primers used for RCA can be in solution or attached to a solid support. The primers can be one or more of the universal primers described herein.
MDA techniques can be modified for use in a method of the present disclosure. Some basic principles and useful conditions for MDA are described, for example, in Dean et al., Proc Natl. Acad. Sci. USA 99:5261-66 (2002); Lage et al., Genome Research 13:294-307 (2003); Walker et al., Molecular Methods for Virus Detection, Academic Press, Inc., 1995; Walker et al., Nucl. Acids Res. 20:1691-96 (1992); U.S. Pat. Nos. 5,455,166; 5,130,238; and 6,214,587, each of which is incorporated herein by reference. Primers used for MDA can be in solution or attached to a solid support at an amplification site. Again, the primers can be one or more of the universal primers described herein.
In particular embodiments a combination of the above-exemplified amplification techniques can be used. For example, RCA and MDA can be used in a combination wherein RCA is used to generate a concatameric amplicon in solution (e.g. using solution-phase primers). The amplicon can then be used as a template for MDA using primers that are attached to a solid support (e.g. universal primers). In this example, amplicons produced after the combined RCA and MDA steps will be attached to the solid support.
Nucleic acid probes that are used in a method set forth herein or present in an apparatus or composition of the present disclosure can include barcode sequences, and for embodiments that include a plurality of different nucleic acid probes, each of the probes can include a different barcode sequence from other probes in the plurality. Barcode sequences can be any of a variety of lengths.
Longer sequences can generally accommodate a larger number and variety of barcodes for a population. Generally, all probes in a plurality will have the same length barcode (albeit with different sequences), but it is also possible to use different length barcodes for different probes. A barcode sequence can be at least 2, 4, 6, 8, 10, 12, 15, 20 or more nucleotides in length. Alternatively or additionally, the length of the barcode sequence can be at most 20, 15, 12, 10, 8, 6, 4 or fewer nucleotides. Examples of barcode sequences that can be used are set forth, for example in, US Pat. App. Publ. No. 2014/0342921 A1 and U.S. Pat. No. 8,460,865, each of which is incorporated herein by reference.
A method of the present disclosure can include a step of performing a nucleic acid detection reaction on a solid support to determine barcode sequences of nucleic acid probes that are located on the solid support. In many embodiments the probes are randomly located on the solid support and the nucleic acid detection reaction provides information to locate each of the different probes. Exemplary nucleic acid detection methods include, but are not limited to nucleic acid sequencing of a probe, hybridization of nucleic acids to a probe, ligation of nucleic acids that are hybridized to a probe, extension of nucleic acids that are hybridized to a probe, extension of a first nucleic acid that is hybridized to a probe followed by ligation of the extended nucleic acid to a second nucleic acid that is hybridized to the probe, or other methods known in the art such as those set forth in U.S. Pat. No. 8,288,103 or 8,486,625, each of which is incorporated herein by reference.
Sequencing techniques, such as sequencing-by-synthesis (SBS) techniques, are a particularly useful method for determining barcode sequences. SBS can be carried out as follows. To initiate a first SBS cycle, one or more labeled nucleotides, DNA polymerase, SBS primers etc., can be contacted with one or more features on a solid support (e.g. feature(s) where nucleic acid probes are attached to the solid support). Those features where SBS primer extension causes a labeled nucleotide to be incorporated can be detected. Optionally, the nucleotides can include a reversible termination moiety that terminates further primer extension once a nucleotide has been added to the SBS primer. For example, a nucleotide analog having a reversible terminator moiety can be added to a primer such that subsequent extension cannot occur until a deblocking agent is delivered to remove the moiety. Thus, for embodiments that use reversible termination, a deblocking reagent can be delivered to the solid support (before or after detection occurs). Washes can be carried out between the various delivery steps. The cycle can then be repeated n times to extend the primer by n nucleotides, thereby detecting a sequence of length n. Exemplary SBS procedures, fluidic systems and detection platforms that can be readily adapted for use with a composition, apparatus or method of the present disclosure are described, for example, in Bentley et al., Nature 456:53-59 (2008), PCT Publ. Nos. WO 91/06678, WO 04/018497 or WO 07/123744; U.S. Pat. Nos. 7,057,026, 7,329,492, 7,211,414, 7,315,019 or 7,405,281, and US Pat. App. Publ. No. 2008/0108082, each of which is incorporated herein by reference.
Other sequencing procedures that use cyclic reactions can be used, such as pyrosequencing. Pyrosequencing detects the release of inorganic pyrophosphate (PPi) as particular nucleotides are incorporated into a nascent nucleic acid strand (Ronaghi, et al., Analytical Biochemistry 242(1), 84-9 (1996); Ronaghi, Genome Res. 11(1), 3-11 (2001); Ronaghi et al. Science 281(5375), 363 (1998); or U.S. Pat. Nos. 6,210,891, 6,258,568 or 6,274,320, each of which is incorporated herein by reference). In pyrosequencing, released PPi can be detected by being immediately converted to adenosine triphosphate (ATP) by ATP sulfurylase, and the level of ATP generated can be detected via luciferase-produced photons. Thus, the sequencing reaction can be monitored via a luminescence detection system. Excitation radiation sources used for fluorescence based detection systems are not necessary for pyrosequencing procedures. Useful fluidic systems, detectors and procedures that can be used for application of pyrosequencing to apparatus, compositions or methods of the present disclosure are described, for example, in PCT Pat. App. Publ. No. WO2012/058096, US Pat. App. Publ. No. 2005/0191698 A1, or U.S. Pat. No. 7,595,883 or 7,244,559, each of which is incorporated herein by reference.
Sequencing-by-ligation reactions are also useful including, for example, those described in Shendure et al. Science 309:1728-1732 (2005); or U.S. Pat. No. 5,599,675 or 5,750,341, each of which is incorporated herein by reference. Some embodiments can include sequencing-by-hybridization procedures as described, for example, in Bains et al., Journal of Theoretical Biology 135(3), 303-7 (1988); Drmanac et al., Nature Biotechnology 16, 54-58 (1998); Fodor et al., Science 251(4995), 767-773 (1995); or PCT Pat. App. Publ. No. WO 1989/10977, each of which is incorporated herein by reference. In both sequencing-by-ligation and sequencing-by-hybridization procedures, target nucleic acids (or amplicons thereof) that are present at sites of an array are subjected to repeated cycles of oligonucleotide delivery and detection. Compositions, apparatus or methods set forth herein or in references cited herein can be readily adapted for sequencing-by-ligation or sequencing-by-hybridization procedures. Typically, the oligonucleotides are fluorescently labeled and can be detected using fluorescence detectors similar to those described with regard to SBS procedures herein or in references cited herein.
Some sequencing embodiments can utilize methods involving the real-time monitoring of DNA polymerase activity. For example, nucleotide incorporations can be detected through fluorescence resonance energy transfer (FRET) interactions between a fluorophore-bearing polymerase and y-phosphate-labeled nucleotides, or with zeromode waveguides (ZMWs). Techniques and reagents for FRET-based sequencing are described, for example, in Levene et al. Science 299, 682-686 (2003); Lundquist et al. Opt. Lett. 33, 1026-1028 (2008); Korlach et al. Proc. Natl. Acad. Sci. USA 105, 1176-1181 (2008), each of which is incorporated herein by reference.
Some sequencing embodiments include detection of a proton released upon incorporation of a nucleotide into an extension product. For example, sequencing based on detection of released protons can use an electrical detector and associated techniques that are commercially available from Ion Torrent (Guilford, Conn., a Life Technologies and Thermo Fisher subsidiary) or sequencing methods and systems described in US Pat app. Publ. Nos. 2009/0026082 A1; 2009/0127589 A1; 2010/0137143 A1; or US 2010/0282617 A1, each of which is incorporated herein by reference.
Nucleic acid hybridization techniques are also useful method for determining barcode sequences. In some cases combinatorial hybridization methods can be used such as those used for decoding of multiplex bead arrays (see e.g. U.S. Pat. No. 8,460,865, which is incorporated herein by reference). Such methods utilize labelled nucleic acid decoder probes that are complementary to at least a portion of a barcode sequence. A hybridization reaction can be carried out using decoder probes having known labels such that the location where the labels end up on the solid support identifies the nucleic acid probes according to rules of nucleic acid complementarity. In some cases, pools of many different probes with distinguishable labels are used, thereby allowing a multiplex decoding operation.
The number of different barcodes determined in a decoding operation can exceed the number of labels used for the decoding operation. For example, decoding can be carried out in several stages where each stage constitutes hybridization with a different pool of decoder probes. The same decoder probes can be present in different pools but the label that is present on each decoder probe can differ from pool to pool (i.e. each decoder probe is in a different “state” when in different pools). Various combinations of these states and stages can be used to expand the number of barcodes that can be decoded well beyond the number of distinct labels available for decoding. Such combinatorial methods are set forth in further detail in U.S. Pat. No. 8,460,865 or Gunderson et al., Genome Research 14:870-877 (2004), each of which is incorporated herein by reference.
A method of the present disclosure can include a step of contacting a biological specimen with a solid support that has nucleic acid probes attached thereto. In some embodiments the nucleic acid probes are randomly located on the solid support. The identity and location of the nucleic acid probes may have been decoded prior to contacting the biological specimen with the solid support. Alternatively, the identity and location of the nucleic acid probes can be determined after contacting the solid support with the biological specimen.
In some embodiments the biological specimen is one or more cells. The cell(s) can be individual and free from any tissue or multicellular structure at the time contact is made with the solid support. For example, the cell(s) can be present in a fluid (e.g. when a plurality of different cells are present the fluid can be a fluidic mixture of the different cells) and the fluid can be contacted with the solid support to which the different probes are attached. Any of a variety of cells can be used including, for example, those from a prokaryote, archae or eukaryote. One or more cells used in a method, composition or apparatus of the present disclosure can be a single celled organisms or from a multicellular organism. Exemplary organisms from which one or more cell can be obtained include, but are not limited to a mammal, plant, algae, nematode, insect, fish, reptile, amphibian, fungi or Plasmodium falciparum. Exemplary species are set forth previously herein or known in the art.
Embodiments of the present disclosure can also use one or more subcellular components as a biological specimen. For example a fluidic mixture can include one or more nuclei, golgi apparatus, mitochondria, chloroplasts, membrane fractions, vesicles, endoplasmic reticulum, or other components known in the art.
Other useful types of biological specimens are one or more viruses or a viroids. It will be understood that a biological specimen can be a homogeneous culture or population of the above cells, subcellular components, viruses or viroids. Alternatively the biological specimen can be a non-homogenous collection of cells, subcellular components, viruses or viroids, for example, derived from several different organisms in a community or ecosystem. An exemplary community is the collection of bacteria present in the digestive system, lung or other organ of a multicellular organism such as a mammal.
One or more cells, subcellular components, viruses or viroids that are contacted with a solid support in a method set forth herein can be attached to the solid support. Attachment can be achieved using methods known in the art such as those exemplified herein with respect to attachment of nucleic acids to a solid support. In some embodiments, attachment is selective for specific types of cells, subcellular components, viruses or viroids. For example, the solid support can include antibodies or other receptors that are selective for epitopes or ligands present on one or a subset of different cells, subcellular components, viruses or viroids present in a fluidic mixture. In other embodiments, the attachment of cells, subcellular components, viruses or viroids can be mediated by non-selective moieties such as chemical moieties that are broadly reactive.
In particular embodiments, one or more cells, subcellular components, viruses or viroids that have been contacted with a solid support can be lysed to release target nucleic acids. Lysis can be carried out using methods known in the art such as those that employ one or more of chemical treatment, enzymatic treatment, electroporation, heat, hypotonic treatment, sonication or the like. Exemplary lysis techniques are set forth in Sambrook et al., Molecular Cloning: A Laboratory Manual, Third Ed., Cold Spring Harbor Laboratory, New York (2001) and in Ansubel et al., Current Protocols in Molecular Biology, John Wiley and Sons, Baltimore, Md. (1999).
In some embodiments the biological specimen is a tissue section. The tissue can be derived from a multicellular organism such as those exemplified above in regard to cells. A tissue section can be contacted with a solid support, for example, by laying the tissue on the surface of the solid support. The tissue can be freshly excised from an organism or it may have been previously preserved for example by freezing, embedding in a material such as paraffin (e.g. formalin fixed paraffin embedded samples), formalin fixation, infiltration, dehydration or the like.
Optionally, a tissue section can be attached to a solid support, for example, using techniques and compositions exemplified herein with regard to attaching nucleic acids, cells, viruses, beads or the like to a solid support. As a further option, a tissue can be permeabilized and the cells of the tissue lysed when the tissue is in contact with a solid support. Any of a variety of treatments can be used such as those set forth above in regard to lysing cells. Target nucleic acids that are released from a tissue that is permeabilized can be captured by nucleic acid probes on the surface.
A tissue can be prepared in any convenient or desired way for its use in a method, composition or apparatus herein. Fresh, frozen, fixed or unfixed tissues can be used. A tissue can be fixed or embedded using methods described herein or known in the art.
A tissue sample for use herein, can be fixed by deep freezing at temperature suitable to maintain or preserve the integrity of the tissue structure, e.g. less than −20° C. In another example, a tissue can be prepared using formalin-fixation and paraffin embedding (FFPE) methods which are known in the art. Other fixatives and/or embedding materials can be used as desired. A fixed or embedded tissue sample can be sectioned, i.e. thinly sliced, using known methods. For example, a tissue sample can be sectioned using a chilled microtome or cryostat, set at a temperature suitable to maintain both the structural integrity of the tissue sample and the chemical properties of the nucleic acids in the sample.
In some embodiments, a tissue sample will be treated to remove embedding material (e.g. to remove paraffin or formalin) from the sample prior to release, capture or modification of nucleic acids. This can be achieved by contacting the sample with an appropriate solvent (e.g. xylene and ethanol washes). Treatment can occur prior to contacting the tissue sample with a solid support set forth herein or the treatment can occur while the tissue sample is on the solid support. Exemplary methods for manipulating tissues for use with solid supports to which nucleic acids are attached are set forth in US Pat. App. Publ. No. 2014/0066318 A1, which is incorporated herein by reference.
The thickness of a tissue sample or other biological specimen that is contacted with a solid support in a method, composition or apparatus set forth herein can be any suitable thickness desired. In representative embodiments, the thickness will be at least 0.1 μm, 0.25 μm, 0.5 μm, 0.75 μm, 1 μm, 5 μm, 10 μm, 50 μm, 100 μm or thicker. Alternatively or additionally, the thickness of a biological specimen that is contacted with a solid support will be no more than 100 μm, 50 μm, 10 μm, 5 μm, 1 μm, 0.5 μm, 0.25 μm, 0.1 μm or thinner.
A particularly relevant source for a biological specimen is a human being.
The specimen can be derived from an organ, including for example, an organ of the musculoskeletal system such as muscle, bone, tendon or ligament; an organ of the digestive system such as salivary gland, pharynx, esophagus, stomach, small intestine, large intestine, liver, gallbladder or pancreas; an organ of the respiratory system such as larynx, trachea, bronchi, lungs or diaphragm; an organ of the urinary system such as kidney, ureter, bladder or urethra; a reproductive organ such as ovary, fallopian tube, uterus, vagina, placenta, testicle, epididymis, vas deferens, seminal vesicle, prostate, penis or scrotum; an organ of the endocrine system such as pituitary gland, pineal gland, thyroid gland, parathyroid gland, or adrenal gland; an organ of the circulatory system such as heart, artery, vein or capillary; an organ of the lymphatic system such as lymphatic vessel, lymph node, bone marrow, thymus or spleen; an organ of the central nervous system such as brain, brainstem, cerebellum, spinal cord, cranial nerve, or spinal nerve; a sensory organ such as eye, ear, nose, or tongue; or an organ of the integument such as skin, subcutaneous tissue or mammary gland. In some embodiments, a biological specimen is obtained from a bodily fluid or excreta such as blood, lymph, tears, sweat, saliva, semen, vaginal secretion, ear wax, fecal matter or urine.
A specimen from a human can be considered (or suspected) healthy or diseased when used. In some cases, two specimens can be used: a first being considered diseased and a second being considered as healthy (e.g. for use as a healthy control). Any of a variety of conditions can be evaluated, including but not limited to, an autoimmune disease, cancer, cystic fibrosis, aneuploidy, pathogenic infection, psychological condition, hepatitis, diabetes, sexually transmitted disease, heart disease, stroke, cardiovascular disease, multiple sclerosis or muscular dystrophy. Particularly relevant conditions are genetic conditions or conditions associated with pathogens having identifiable genetic signatures.
As set forth above, a flow cell provides a convenient apparatus for use in a method set forth herein. For example, a flow cell is a convenient apparatus for housing a solid support that will be treated with multiple fluidic reagents such as the repeated fluidic deliveries used for some nucleic acid sequencing protocols or some nucleic acid hybridization protocols. In some embodiments, a biological specimen can be delivered to a solid support in a flow cell, for example, when a fluidic mixture of cells, subcellular components, viruses or viroids is delivered to the solid support. In some embodiments it may be preferable to open a flow cell to expose a solid support inside or to remove the solid support from the flow cell in order to allow convenient delivery of a biological specimen to the solid support. For example, opening the flow cell or removing the solid support can allow a user or robotic device to lay a tissue section on the solid support. The opening of a flow cell or removal of a solid support from a flow cell can be temporary. Thus, the flow cell can subsequently be closed or the solid support returned to the flow cell to proceed with one or more subsequent steps of a method set forth herein.
In some embodiments, a flow cell can have a construction that allows it to be opened or taken apart. For example the flow cell can be in a closed state while performing a sequencing reaction, for example to decode barcodes. Then the flow cell can be taken apart so that tissue can be placed on the flow cell surface. The flow cell can be held together by adhesive such that one or more surface can be removed to open it. For example, a flow cell can have a spacer with adhesive surfaces on the top or bottom (akin to single-sided or double-sided sticky tape) and this spacer can occur between two solid supports. One or both of the solid supports can be configured to attach nucleic acids and support a biological specimen as set forth herein. The spacer can have open regions (e.g. created by laser cutting of the spacer material) that create fluidic channels bound by the two solid supports and the spacer. Thus, one or both of the solid supports can be non-permanently adhered to the spacer to allow one or both of them to be removed to allow access to the surface when placing a tissue or other specimen thereon.
A nucleic acid probe used in a composition, apparatus or method set forth herein can include a target capture moiety. In particular embodiments, the target capture moiety is a target capture sequence. The target capture sequence is generally complementary to a target sequence such that target capture occurs by formation of a probe-target hybrid complex. A target capture sequence can be any of a variety of lengths including, for example, lengths exemplified above in the context of barcode sequences.
In multiplex embodiments, a plurality of different nucleic acid probes can include different target capture sequences that hybridize to different target nucleic acid sequences from a biological specimen. Different target capture sequences can be used to selectively bind to one or more desired target nucleic acids from a biological specimen. In some cases, the different nucleic acid probes can include a target capture sequence that is common to all or a subset of the probes on a solid support. For example, the nucleic acid probes on a solid support can have a poly A or poly T sequence. Such probes or amplicons thereof can hybridize to mRNA molecules, cDNA molecules or amplicons thereof that have poly A or poly T tails.
Although the mRNA or cDNA species will have different target sequences, capture will be mediated by the common poly A or poly T sequence regions.
Any of a variety of target nucleic acids can be captured and analyzed in a method set forth herein including, but not limited to, messenger RNA (mRNA), copy DNA (cDNA), genomic DNA (gDNA), ribosomal RNA (rRNA) or transfer RNA (tRNA). Particular target sequences can be selected from databases and appropriate capture sequences designed using techniques and databases known in the art.
Other target capture moieties that are useful include, for example, the moieties set forth herein as useful for attaching nucleic acid probes to a solid support.
A method set forth herein can include a step of hybridizing nucleic acid probes, that are on a solid support, to target nucleic acids that are from portions of the biological specimen that are proximal to the probes. Generally, a target nucleic acid will diffuse from a region of the biological specimen to an area of the solid support that is in proximity with that region of the specimen. Here the target nucleic acid will interact with nucleic acid probes that are proximal to the region of the specimen from which the target nucleic acid was released. A target-probe hybrid complex can form where the target nucleic acid encounters a complementary target capture sequence on a nucleic acid probe. The location of the target-probe hybrid complex will generally correlate with the region of the biological specimen from where the target nucleic acid was derived. In multiplex embodiments, the solid support will include a plurality of nucleic acid probes, the biological specimen will release a plurality of target nucleic acids and a plurality of target-probe hybrids will be formed on the solid support. The sequences of the target nucleic acids and their locations on the support will provide spatial information about the nucleic acid content of the biological specimen. Although the example above is described in the context of target nucleic acids that are released from a biological specimen, it will be understood that the target nucleic acids need not be released. Rather, the target nucleic acids may remain in contact with the biological specimen, for example, when they are attached to an exposed surface of the biological specimen in a way that the target nucleic acids can also bind to appropriate nucleic acid probes on the solid support.
A method of the present disclosure can include a step of extending solid support-attached probes to which target nucleic acids are hybridized. In embodiments where the probes include barcode sequences, the resulting extended probes will include the barcode sequences and sequences from the target nucleic acids (albeit in complementary form). The extended probes are thus spatially tagged versions of the target nucleic acids from the biological specimen.
The sequences of the extended probes identify what nucleic acids are in the biological specimen and where in the biological specimen the target nucleic acids are located. It will be understood that other sequence elements that are present in the nucleic acid probes can also be included in the extended probes. Such elements include, for example, primer binding sites, cleavage sites, other tag sequences (e.g. sample identification tags), capture sequences, recognition sites for nucleic acid binding proteins or nucleic acid enzymes, or the like.
Extension of probes can be carried out using methods exemplified herein or otherwise known in the art for amplification of nucleic acids or sequencing of nucleic acids. In particular embodiments one or more nucleotides can be added to the 3′ end of a nucleic acid, for example, via polymerase catalysis (e.g. DNA polymerase, RNA polymerase or reverse transcriptase). Chemical or enzymatic methods can be used to add one or more nucleotide to the 3′ or 5′ end of a nucleic acid. One or more oligonucleotides can be added to the 3′ or 5′ end of a nucleic acid, for example, via chemical or enzymatic (e.g. ligase catalysis) methods. A nucleic acid can be extended in a template directed manner, whereby the product of extension is complementary to a template nucleic acid that is hybridized to the nucleic acid that is extended. In some embodiments, a DNA primer is extended by a reverse transcriptase using an RNA template, thereby producing a cDNA. Thus, an extended probe made in a method set forth herein can be a reverse transcribed DNA molecule. Exemplary methods for extending nucleic acids are set forth in US Pat. App. Publ. No. US 2005/0037393 A1 or U.S. Pat. No. 8,288,103 or 8,486,625, each of which is incorporated herein by reference.
All or part of a target nucleic acid that is hybridized to a nucleic acid probe can be copied by extension. For example, an extended probe can include at least, 1, 2, 5, 10, 25, 50, 100, 200, 500, 1000 or more nucleotides that are copied from a target nucleic acid. The length of the extension product can be controlled, for example, using reversibly terminated nucleotides in the extension reaction and running a limited number of extension cycles. The cycles can be run as exemplified for SBS techniques and the use of labeled nucleotides is not necessary.
Accordingly, an extended probe produced in a method set forth herein can include no more than 1000, 500, 200, 100, 50, 25, 10, 5, 2 or 1 nucleotides that are copied from a target nucleic acid. Of course extended probes can be any length within or outside of the ranges set forth above.
Although the methods of the present disclosure are exemplified by an embodiment where probes that are hybridized to target nucleic acids are extended to copy at least a portion of the target nucleic acid, it will be understood that the probes can be modified in alternative ways. The probes that are hybridized to target nucleic acids can be subjected to a reaction that creates a target specific modification of the probe. A target specific modification will result only when the probe interacts with a target nucleic acid, for example, via complementary based hybridization. In many embodiments, the target specific modification will be specific to the sequence of the particular target nucleic acid that interacts with the probe. Examples of useful target specific modifications, include but are not limited to, insertion or addition of a sequence by ligation or transposition (see, for example, US Pat. App. Publ. No. 2010/0120098 A1, incorporated herein by reference), chemical modifications such as psoralen crosslinking or addition of a detectable tag moiety, modifications by nucleic acid enzymes, ligation of a hairpin linker, or other modifications set forth in the nucleic acid assays of US Pat. App. Publ. No. US 2005/0037393 A1 or U.S. Pat. No. 8,288,103 or 8,486,625, each of which is incorporated herein by reference.
It will be understood that probes used in a method, composition or apparatus set forth herein need not be nucleic acids. Other molecules can be used such as proteins, carbohydrates, small molecules, particles or the like. Probes can be a combination of a nucleic acid component (e.g. having a barcode, primer binding site, cleavage site and/or other sequence element set forth herein) and another moiety (e.g. a moiety that captures or modifies a target nucleic acid).
A method set forth herein can further include a step of acquiring an image of a biological specimen that is in contact with a solid support. The solid support can be in any of a variety of states set forth herein. For example, the solid support can include attached nucleic acid probes or clusters derived from attached nucleic acid probes. Alternatively, the solid support may not include nucleic acid probes, instead being in a state that precedes attachment of nucleic acid probes or in a state that follows removal of nucleic acid probes from the solid support. Accordingly, an image can be obtained at any of a variety of points in a method set forth herein.
An image can be obtained using detection devices known in the art.
Examples include microscopes configured for light, bright field, dark field, phase contrast, fluorescence, reflection, interference, or confocal imaging. A biological specimen can be stained prior to imaging to provide contrast between different regions or cells. In some embodiments, more than one stain can be used to image different aspects of the specimen (e.g. different regions of a tissue, different cells, specific subcellular components or the like). In other embodiments, a biological specimen can be imaged without staining.
In particular embodiments, a fluorescence microscope (e.g. a confocal fluorescent microscope) can be used to detect a biological specimen that is fluorescent, for example, by virtue of a fluorescent label. Fluorescent specimens can also be imaged using a nucleic acid sequencing device having optics for fluorescent detection such as a Genome Analyzer®, MiSeq®, NextSeq® or HiSeq® platform device commercialized by Illumina, Inc. (San Diego, Calif.); or a SOLiD™ sequencing platform commercialized by Life Technologies (Carlsbad, Calif.). Other imaging optics that can be used include those that are found in the detection devices described in Bentley et al., Nature 456:53-59 (2008), PCT Publ. Nos. WO 91/06678, WO 04/018497 or WO 07/123744; U.S. Pat. Nos. 7,057,026, 7,329,492, 7,211,414, 7,315,019 or 7,405,281, and US Pat. App. Publ. No. 2008/0108082, each of which is incorporated herein by reference.
An image of a biological specimen can be obtained at a desired resolution, for example, to distinguish tissues, cells or subcellular components. Accordingly, the resolution can be sufficient to distinguish components of a biological specimen that are separated by at least 0.5 μm, 1 μm, 5 μm, 10 μm, 50 μm, 100 μm, 500 μm, 1 mm or more. Alternatively or additionally, the resolution can be set to distinguish components of a biological specimen that are separated by at least 1 mm, 500 μm, 100 μm, 50 μm, 10 μm, 5 μm, 1 μm, 0.5 μm or less.
A method set forth herein can include a step of correlating locations in an image of a biological specimen with barcode sequences of nucleic acid probes that are attached to a surface to which the biological specimen is, was or will be contacted. Accordingly, characteristics of the biological specimen that are identifiable in the image can be correlated with the nucleic acids that are found to be present in their proximity. Any of a variety of morphological characteristics can be used in such a correlation, including for example, cell shape, cell size, tissue shape, staining patterns, presence of particular proteins (e.g. as detected by immunohistochemical stains) or other characteristics that are routinely evaluated in pathology or research applications. Accordingly, the biological state of a tissue or its components as determined by visual observation can be correlated with molecular biological characteristics as determined by spatially resolved nucleic acid analysis.
A solid support upon which a biological specimen is imaged can include fiducial markers to facilitate determination of the orientation of the specimen or the image thereof in relation to probes that are attached to the solid support. Exemplary fiducials include, but are not limited to beads (with or without fluorescent moieties or moieties such as nucleic acids to which labeled probes can be bound), fluorescent molecules attached at known or determinable features, or structures that combine morphological shapes with fluorescent moieties. Exemplary fiducials are set forth in US Pat. App. Publ. No. 2002/0150909 A1 or U.S. patent application Ser. No. 14/530,299, each of which is incorporated herein by reference. One or more fiducials are preferably visible while obtaining an image of a biological specimen. Preferably, the solid support includes at least 2, 3, 4, 5, 10, 25, 50, 100 or more fiducial markers.
The fiducials can be provided in a pattern, for example, along an outer edge of a solid support or perimeter of a location where a biological specimen resides. In a preferred embodiment, one or more fiducials are detected using the same imaging conditions used to visualize a biological specimen. However if desired separate images can be obtained (e.g. one image of the biological specimen and another image of the fiducials) and the images can be aligned to each other.
Optionally, a biological specimen, can be removed from a solid support after an image has been obtained and after target nucleic acids have been captured by nucleic acid probes on the solid support. Thus, a method of the present disclosure can include a step of washing a solid support to remove cells, tissue or other materials from a biological specimen. Removal of the specimen can be performed using any suitable technique and will be dependent on the tissue sample. In some cases, the solid support can be washed with water. The water can contain various additives, such as surfactants (e.g. detergents), enzymes (e.g. proteases and collagenases), cleavage reagents, or the like, to facilitate removal of the specimen. In some embodiments, the solid support is treated with a solution comprising a proteinase enzyme. Alternatively or additionally, the solution can include cellulase, hemicelluase or chitinase enzymes (e.g. if desiring to remove a tissue sample from a plant or fungal source). In some cases, the temperature of a wash solution will be at least 30° C., 35° C., 50° C., 60° C. or 90° C. Conditions can be selected for removal of a biological specimen while not denaturing hybrid complexes formed between target nucleic acids and solid support-attached nucleic acid probes.
A method of the present disclosure can further include a step of removing one or more extended probes from a solid support. In particular embodiments, the probes will have included a cleavage site such that the product of extending the probes will also include the cleavage site. Alternatively, a cleavage site can be introduced into a probe during a modification step. For example a cleavage site can be introduced into an extended probe during the extension step.
Exemplary cleavage sites include, but are not limited to, moieties that are susceptible to a chemical, enzymatic or physical process that results in bond breakage. For example, the location can be a nucleotide sequence that is recognized by an endonuclease. Suitable endonucleases and their recognition sequences are well known in the art and in many cases are even commercially available (e.g. from New England Biolabs, Beverley Mass.; ThermoFisher, Waltham, Mass. or Sigma Aldrich, St. Louis Mo.). A particularly useful endonuclease will break a bond in a nucleic acid strand at a site that is 3′-remote to its binding site in the nucleic acid, examples of which include Type II or Type IIs restriction endonucleases. In some embodiments an endonuclease will cut only one strand in a duplex nucleic acid (e.g. a nicking enzyme). Examples of endonucleases that cleave only one strand include Nt.BstNBI and Nt.Alwl.
In some embodiments, a cleavage site is an abasic site or a nucleotide that has a base that is susceptible to being removed to create an abasic site. Examples of nucleotides that are susceptible to being removed to form an abasic site include uracil and 8-oxo-guanine. Abasic sites can be created by hydrolysis of nucleotide residues using chemical or enzymatic reagents. Once formed, abasic sites may be cleaved (e.g. by treatment with an endonuclease or other single-stranded cleaving enzyme, exposure to heat or alkali), providing a means for site-specific cleavage of a nucleic acid. An abasic site may be created at a uracil nucleotide on one strand of a nucleic acid. The enzyme uracil DNA glycosylase (UDG) may be used to remove the uracil base, generating an abasic site on the strand. The nucleic acid strand that has the abasic site may then be cleaved at the abasic site by treatment with endonuclease (e.g. EndolV endonuclease, AP lyase, FPG glycosylase/AP lyase, EndoVIII glycosylase/AP lyase), heat or alkali. In a particular embodiment, the USER™ reagent available from New England Biolabs is used for the creation of a single nucleotide gap at a uracil base in a nucleic acid.
Abasic sites may also be generated at non-natural/modified deoxyribonucleotides other than uracil and cleaved in an analogous manner by treatment with endonuclease, heat or alkali. For example, 8-oxo-guanine can be converted to an abasic site by exposure to FPG glycosylase. Deoxyinosine can be converted to an abasic site by exposure to AlkA glycosylase. The abasic sites thus generated may then be cleaved, typically by treatment with a suitable endonuclease (e.g. EndolV or AP lyase).
Other examples of cleavage sites and methods that can be used to cleave nucleic acids are set forth, for example, in U.S. Pat. No. 7,960,120, which is incorporated herein by reference.
Modified nucleic acid probes (e.g. extended nucleic acid probes) that are released from a solid support can be pooled to form a fluidic mixture. The mixture can include, for example, at least 10, 100, 1×103, 1×104, 1×105, 1×106, 1×107, 1×108, 1×109 or more different modified probes. Alternatively or additionally, a fluidic mixture can include at most 1×109, 1×108, 1×107, 1×106, 1×105, 1×104, 1×103, 100, 10 or fewer different modified probes. The fluidic mixture can be manipulated to allow detection of the modified nucleic acid probes. For example, the modified nucleic acid probes can be separated spatially on a second solid support (i.e. different from the solid support from which the nucleic acid probes were released after having been contacted with a biological specimen and modified), or the probes can be separated temporally in a fluid stream.
Modified nucleic acid probes (e.g. extended nucleic acid probes) can be separated on a solid support in a capture or detection method commonly employed for microarray-based techniques or nucleic acid sequencing techniques such as those set forth previously herein. For example, modified probes can be attached to a microarray by hybridization to complementary nucleic acids. The modified probes can be attached to beads or to a flow cell surface and optionally amplified as is carried out in many nucleic acid sequencing platforms. Modified probes can be separated in a fluid stream using a microfluidic device, droplet manipulation device, or flow cytometer. Typically, detection is carried out on these separation devices, but detection is not necessary in all embodiments.
A particularly useful droplet manipulation device is a droplet actuator as described for example in U.S. Pat. Nos. 8,637,242, 6,911,132, entitled “Apparatus for Manipulating Droplets by Electrowetting-Based Techniques,” issued on Jun. 28, 2005; Pamula et al., U.S. Patent Pub. No. 20060194331, entitled “Apparatuses and Methods for Manipulating Droplets on a Printed Circuit Board,” published on Aug. 31, 2006; Pollack et al., International Patent Pub. No. WO/2007/120241, entitled “Droplet-Based Biochemistry,” published on Oct. 25, 2007; Shenderov, U.S. Pat. No. 6,773,566, entitled “Electrostatic Actuators for Microfluidics and Methods for Using Same,” issued on Aug. 10, 2004; Shenderov, U.S. Pat. No. 25 6,565,727, entitled “Actuators for Microfluidics Without Moving Parts,” issued on May 20, 2003; Kim et al., U.S. Patent Pub. No. 20030205632, entitled “Electrowettingdriven Micropumping,” published on Nov. 6, 2003; Kim et al., U.S. Patent Pub. No. 20060164490, entitled “Method and Apparatus for Promoting the Complete Transfer of Liquid Drops from a Nozzle,” published on Jul. 27, 2006; Kim et al., U.S. Patent Pub. No. 20070023292, entitled “Small Object Moving on Printed Circuit Board,” published on Feb. 1, 2007; Shah et al., U.S. Patent Pub. No. 20090283407, entitled “Method for Using Magnetic Particles in Droplet Microfluidics,” published on Nov. 19, 2009; Kim et al., U.S. Patent Pub. No. 20100096266, entitled “Method and Apparatus for Real-time Feedback Control of Electrical Manipulation of Droplets on Chip,” published on Apr. 22, 2010; Velev, U.S. Pat. No. 7,547,380, entitled “Droplet Transportation Devices and Methods Having a Fluid Surface,” issued on Jun. 16, 2009; Sterling et al., U.S. Pat. No. 7,163,612, entitled “Method, Apparatus and Article for Microfluidic Control via Electrowetting, for Chemical, Biochemical and Biological Assays and the Like,” issued on Jan. 16, 2007; Becker et al., U.S. Pat. No. 7,641,779, entitled “Method and Apparatus for Programmable Fluidic Processing,” issued on Jan. 5, 2010; Becker et al., U.S. Pat. No. 6,977,033, entitled “Method and Apparatus for Programmable Fluidic Processing,” issued on Dec. 20, 2005; Deere et al., U.S. Pat. No. 7,328,979, entitled “System for Manipulation of a Body of Fluid,” issued on Feb. 12, 2008; Yamakawa et al., U.S. Patent Pub. No. 15 20060039823, entitled “Chemical Analysis Apparatus,” published on Feb. 23, 2006; Wu, U.S. Patent Pub. No. 20110048951, entitled “Digital Microfluidics Based Apparatus for Heat-exchanging Chemical Processes,” published on Mar. 3, 2011; Fouillet et al., U.S. Patent Pub. No. 20090192044, entitled “Electrode Addressing Method,” published on Jul. 30, 2009; Fouillet et al., U.S. Pat. No. 7,052,244, entitled “Device for Displacement of Small Liquid Volumes Along a Micro-catenary Line by Electrostatic Forces,” issued on May 30, 2006; Marchand et al., U.S. Patent Pub. No. 20080124252, entitled “Droplet Microreactor,” published on May 29, 2008; Adachi et al., U.S. Patent Pub. No. 20090321262, entitled “Liquid Transfer Device,” published on Dec. 31, 2009; Roux et al., U.S. Patent Pub. No. 20050179746, entitled “Device for Controlling the Displacement of a Drop Between Two or Several Solid Substrates,” published on Aug. 18, 2005; and Dhindsa et al., “Virtual Electrowetting Channels: Electronic Liquid Transport with Continuous Channel Functionality,” Lab Chip, 10:832-836 (2010), each of which is incorporated herein by reference.
Modified probes (e.g. extended nucleic acid probes) can be detected, for example, following separation from a fluidic mixture using methods set forth above or known in the art. In particular embodiments, modified probes that are separated on a second solid support (i.e. a solid support that is different from the first solid support where contact was made between probes and biological specimen) can be detected using microarray-based techniques or nucleic acid sequencing techniques such as those set forth previously herein. Probes that are separated in a fluid stream can be detected using optical, electrical or other detectors that are outfitted in known microfluidic devices, droplet manipulation devices, or flow cytometers. A detection method can be used to determine target nucleic acid sequences, barcode sequences or other sequence regions of extended probes.
Several embodiments have been exemplified with regard to removing modified probes from the solid support where the probes were produced. However, it will be understood that probes on a solid support can be contacted with a biological specimen, modified on the solid support in the presence of target nucleic acids from the specimen and then the modified probes can be detected on the solid support. In such an embodiment, the biological specimen can be removed from the solid support prior to the detection step.
In particular embodiments the present disclosure provides a method for spatially tagging nucleic acids of a biological specimen that includes the steps of (a) providing a plurality of nucleic acid primers attached to a solid support, wherein the nucleic acid primers in the plurality include a universal primer sequence that is common to the nucleic acid primers in the plurality; (b) binding a population of nucleic acid probes to the plurality of nucleic acid primers, wherein the nucleic acid probes include a universal primer binding sequence that hybridizes to the universal primer sequence, a target capture sequence and a barcode sequence that differs from barcode sequences of other nucleic acid probes in the population, thereby attaching the different nucleic acid probes at randomly located positions on the solid support; (c) amplifying the different nucleic acid probes by extension of the nucleic acid primers, thereby producing nucleic acid clusters having copies of the barcode sequence and target capture sequence at the randomly located positions on the solid support; (d) performing a sequencing reaction to determine the barcode sequences at the randomly located positions on the solid support; (e) contacting a biological specimen with the nucleic acid clusters on the solid support; (f) hybridizing the target capture sequences of the clusters to target nucleic acids from portions of the biological specimen that are proximal to the clusters; and (g) extending the target capture sequences to produce extended probes that include sequences from the target nucleic acids and the copies of the barcode sequences, thereby tagging the nucleic acids of the biological specimen.
As exemplified previously herein, a plurality of nucleic acid primers can be attached to a solid support, wherein the nucleic acid primers in the plurality include a universal primer sequence that is common to the nucleic acid primers in the plurality. In this embodiment, a second plurality of nucleic acid primers can be attached to the solid support, and the nucleic acid primers in the second plurality can have a second universal primer sequence that is common to the nucleic acid primers in the second plurality. In this embodiment, a plurality of different nucleic acid probes that is contacted with the support can include a universal primer binding sequence that hybridizes to the universal primer on the solid support, as set forth above, and the different nucleic acid probes can also include a second universal primer binding sequence that hybridizes to the second universal primer sequence. This configuration of universal primers and universal primer binding sites can be particularly useful for amplifying the different nucleic acid probes via bridge amplification, wherein the nucleic acid primers in the first and second plurality are extended.
Typically, when a nucleic acid probe contains first and second universal primer binding sites, they will be located at the ends of the probe. In some embodiments it may be desirable to remove at least one of the primer binding sites from the nucleic acid probe or from amplicons produced from the probe. Accordingly, the nucleic acid probes can optionally include a cleavage site between the target capture sequence and one of the universal primer binding sequence. In this case, a cleavage reaction can be performed to separate the universal primer binding site from the target capture sequence. Generally, the portion of the probe (or its amplicons) that contains the target capture sequence will be attached to the solid support resulting in removal of the primer binding site from the solid support and retention of the target capture sequence. Thus, the cleaved probe can be used for hybridizing target nucleic acids and the cleaved probe can be extended using method set forth previously herein.
In some embodiments, a nucleic acid probe will include two different cleavage sites. A first cleavage site will be located between a first primer binding site and one or more other sequence elements of the probe. A second cleavage site can be located between a second primer binding site and the one or more other sequence elements of the probe. The cleavage sites can be reactive to different cleavage reactions such that each one can be selectively cleaved without necessarily cleaving the other. Accordingly, the first cleavage site can be cleaved prior to modifying the probe (for example, prior to producing an extended probe), thereby separating the first primer binding site from the one or more other sequence elements that remain attached to a solid support. The second cleavage site can be cleaved after modifying the probe (for example, after producing the extended probe), thereby releasing the modified probe for subsequent detection.
Alternatively, a nucleic acid probe can include the first cleavage site and a primer that is used to capture or amplify the nucleic acid probe can include the second cleavage site. In this configuration, the first cleavage site can be located between a first primer binding site and one or more other sequence elements of the probe such that cleavage separates the first primer binding site from one or more other sequence elements of the probe that remain attached to a solid support. Again, this first cleavage step will typically be carried out prior to modifying the probe (for example, prior to producing an extended probe). A second cleavage step can be carried out to cleave the second cleavage site after modifying the probe (for example, after producing the extended probe), thereby releasing the modified probe for subsequent detection.
The two embodiments above exemplify a cleavage site located between a point of attachment of a nucleic acid probe (or modified nucleic acid probe) and one or more sequences of the probe (or modified probe) that contain information such as a spatial barcode or target sequence. Thus, this cleavage site is useful for release of modified probes (e.g. extended probes) to detect the sequence information and determine what sequences are present in a biological specimen and where the sequences are present in the specimen.
In some embodiments, one or more probes that are contacted with a solid support in a method set forth herein can include a sequencing primer binding site.
Accordingly, a modified probe (e.g. extended probe) can be detected in a sequencing technique that includes a step of hybridizing a sequencing primer to the sequencing primer binding site. The sequencing primer binding site can be located in the probe such that cleavage of a modified version of the probe (e.g. an extended probe) will yield a released probe that includes the sequencing primer binding site.
The sequencing primer binding site can be a universal sequencing primer binding site such that a plurality of different probes (e.g. having different barcode and/or target sequences) will have the same sequencing primer binding site.
This disclosure further provides a method for spatially tagging nucleic acids of a biological specimen, the method including steps of (a) providing an array of beads on a solid support, wherein different nucleic acid probes are attached to different beads in the array, wherein the different nucleic acid probes each include a barcode sequence, wherein each bead includes a different barcode sequence from other beads on the solid support, and wherein each of the different nucleic acid probes includes a target capture sequence; (b) performing a decoder probe hybridization reaction on the solid support to determine the barcode sequences at the randomly located probes on the solid support; (c) contacting a biological specimen with the array of beads; (d) hybridizing the different nucleic acid probes to target nucleic acids from portions of the biological specimen that are proximal to the beads; and (e) extending the different nucleic acid probes to produce extended probes that include sequences from the target nucleic acids and the barcode sequences, thereby tagging the nucleic acids of the biological specimen.
It will be understood that manipulations of solid supports or of nucleic acids attached to solid supports can be carried out using beads as solid supports. The beads can be attached to a surface (e.g. an array of wells as in a BeadArray™ from Illumina) before or after such manipulations are carried out. For example, nucleic acid probes can be captured on beads before or after the beads are distributed on an array, nucleic acid probes can be amplified to create amplicons on beads before or after the beads are distributed on an array etc.
Spatially Tagging mRNA from a Tissue Sample Using Illumina Flow Cells
A method for generating barcoded oligo-dT containing clusters, then revealing the barcoded oligo-dT with a restriction enzyme digest followed by sequencing is described in
Following bridge amplification and clustering the clusters were linearized by cleavage of 8-oxo-G in P7 primer using Formamidopyrimidine DNA glycosylase (Fpg) enzyme provided in the TruSeq PE Cluster kit. This was followed by restriction enzyme digest with 200 Units/ml BspH1 (NEB Cat #R0517L at 37° C. for 1 Smin to remove P7′ from the PS adapter anchored strand of the cluster to unveil the oligo-dT stretch for subsequent extension in the presence of an mRNA. Enzyme concentrations in the range of 100-400 U/ml have been tested for 15 or 30 min. The de-coding of the barcode was initiated by the SBS3 sequencing primer.
As shown in the bottom panel of
The availability of oligo dT capture sequence after the restriction enzyme digest with BspH1 was confirmed by hybridizing the linearized clusters with a Cy5 labeled poly A (24mer) as diagrammed in panel A of
The sequencing metrics of the flow cell described above with 3.2 μM of BODT-1 library is given in the table shown in
Cell Adhesion on Illumina Flow Cells Single cells were captured on a patterned flow cell (HiSeq X10 flow cell, Illumina). All reagent flow steps were performed using a peristaltic pump or the cBOT cluster generation instrument (Illumina). Briefly, nuclease free water was flowed on all lanes of the patterned flow cell followed by 30-70K Poly D Lysine Solution (100 μg/ml and 20 μg/ml) at a flow rate of 100 μl/min for 8 min. Heat inactivated Fetal Bovine Serum (Life Technologies #10082-139) was also tested as an adhesive. The adhesives were incubated on the flow cell lanes for 1 hr, followed by a 1×PBS+0.5% Pluronic F-68 (Life Technologies #24040-032) wash. Next, the cells were adhered to the coated flow cells by flowing 5 to 50 cells/μl or approximately 100-1000 cells per lane at a rate of 100 μl/min, followed by an incubation step for 60 min to bind the cells. The flow cell was washed with 1×PBS/0.5% pluronic at a rate of 75 μl/min. If cells were fixed on the flow cell, 1% Paraformaldehyde (PFA) was flowed on the flow cell after flowing the cells as described above and incubated for 1 Smin followed by the 1×PBS/0.5% pluronic was step. The flow cell was removed and the number of cells per lane counted using a microscope.
Spatially Localized Capture of Target mRNA by Probes Attached to a Gel Surface This example describes creation of a lawn of poly T probes on a gel coated slide, placement of tissue slices on top of a lawn of poly T probes, release of RNA from the tissue sections, capture of the released mRNA by the poly T probes, reverse transcription to Cy 3 label the poly T probes, removal of the tissue and imaging of the slide.
As shown in Panel B of
As shown in the image of
Spatially Localized Capture of Target mRNA by Probes Attached to a BeadArray™ Surface
This example describes placement of tissue slices on top of a BeadArray™ having poly T probes, release of RNA from the tissue sections, capture of the released mRNA by the poly T probes, reverse transcription to Cy5 label the poly T probes, removal of the tissue and imaging of the BeadArray™.
As shown in Panel A of
As shown in Panel B of
Throughout this application various publications, patents or patent applications have been referenced. The disclosure of these publications in their entireties are hereby incorporated by reference in this application.
The term “comprising” is intended herein to be open-ended, including not only the recited elements, but further encompassing any additional elements.
A number of embodiments have been described. Nevertheless, it will be understood that various modifications may be made. Accordingly, other embodiments are within the scope of the following claims.
This application is a continuation of U.S. patent application Ser. No. 17/834,474, filed on Jun. 7, 2022, which is a continuation of U.S. patent application Ser. No. 17/693,116, filed on Mar. 11, 2022 (issued as U.S. Pat. No. 11,390,912), which is a continuation of U.S. patent application Ser. No. 17/479,718, filed on Sep. 20, 2021 (issued as U.S. Pat. No. 11,299,774), which is a continuation of U.S. patent application Ser. No. 17/237,670, filed on Apr. 22, 2021 (issued as U.S. Pat. No. 11,162,132), which is a continuation of U.S. patent application Ser. No. 17/011,923, filed on Sep. 3, 2020, which is a divisional of U.S. patent application Ser. No. 15/565,637, filed on Nov. 15, 2018 (issued as U.S. Pat. No. 10,774,374), which is a § 371 of International Patent Application No. PCT/EP2016/057355, filed on Apr. 4, 2016, which claims the benefit of U.S. Provisional Patent Application No. 62/145,874, filed on Apr. 10, 2015.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4514388 | Psaledakis | Apr 1985 | A |
| 4574729 | Wells | Mar 1986 | A |
| 4683195 | Mullis | Jul 1987 | A |
| 4683202 | Mullis | Jul 1987 | A |
| 4800159 | Mullis | Jan 1989 | A |
| 4883867 | Lee | Nov 1989 | A |
| 4965188 | Mullis | Oct 1990 | A |
| 4968601 | Jacobson et al. | Nov 1990 | A |
| 4988617 | Landegren et al. | Jan 1991 | A |
| 5002882 | Lunnen | Mar 1991 | A |
| 5061049 | Hornbeck | Oct 1991 | A |
| 5130238 | Malek | Jul 1992 | A |
| 5183053 | Yeh et al. | Feb 1993 | A |
| 5308751 | Ohkawa | May 1994 | A |
| 5321130 | Yue | Jun 1994 | A |
| 5410030 | Yue | Apr 1995 | A |
| 5436134 | Haugland | Jul 1995 | A |
| 5455166 | Walker | Oct 1995 | A |
| 5472881 | Beebe et al. | Dec 1995 | A |
| 5494810 | Barany et al. | Feb 1996 | A |
| 5503980 | Cantor | Apr 1996 | A |
| 5512439 | Hornes | Apr 1996 | A |
| 5512462 | Cheng | Apr 1996 | A |
| 5559032 | Porneroy | Sep 1996 | A |
| 5582977 | Yue | Dec 1996 | A |
| 5589173 | O'Brien | Dec 1996 | A |
| 5599675 | Brenner | Feb 1997 | A |
| 5610287 | Nikiforov et al. | Mar 1997 | A |
| 5641658 | Adams | Jun 1997 | A |
| 5648245 | Fire et al. | Jul 1997 | A |
| 5658751 | Yue | Aug 1997 | A |
| 5695940 | Drmanac et al. | Dec 1997 | A |
| 5716825 | Hancock et al. | Feb 1998 | A |
| 5750341 | Macevicz | May 1998 | A |
| 5763175 | Brenner | Jun 1998 | A |
| 5807522 | Brown et al. | Sep 1998 | A |
| 5830711 | Barany et al. | Nov 1998 | A |
| 5837832 | Chee et al. | Nov 1998 | A |
| 5837860 | Anderson et al. | Nov 1998 | A |
| 5854033 | Lizardi | Dec 1998 | A |
| 5863753 | Haugland | Jan 1999 | A |
| 5866377 | Kim et al. | Feb 1999 | A |
| 5871921 | Landegren et al. | Feb 1999 | A |
| 5912148 | Eggerding | Jun 1999 | A |
| 5919626 | Shi et al. | Jul 1999 | A |
| 5925545 | Reznikoff et al. | Jul 1999 | A |
| 5928906 | Koester et al. | Jul 1999 | A |
| 5958775 | Wickstrom et al. | Sep 1999 | A |
| 5965443 | Reznikoff et al. | Oct 1999 | A |
| 6013440 | Lipshutz | Jan 2000 | A |
| 6027889 | Barany et al. | Feb 2000 | A |
| 6054274 | Sampson et al. | Apr 2000 | A |
| 6060240 | Kamb et al. | May 2000 | A |
| 6083761 | Kedar et al. | Jul 2000 | A |
| 6130073 | Eggerding | Oct 2000 | A |
| 6136592 | Leighton | Oct 2000 | A |
| 6143496 | Brown | Nov 2000 | A |
| 6153389 | Haarer | Nov 2000 | A |
| 6159736 | Reznikoff et al. | Dec 2000 | A |
| 6165714 | Lane et al. | Dec 2000 | A |
| 6172218 | Brenner | Jan 2001 | B1 |
| 6210891 | Nyren | Apr 2001 | B1 |
| 6210894 | Brennan | Apr 2001 | B1 |
| 6214587 | Dattagupta | Apr 2001 | B1 |
| 6221591 | Aerts | Apr 2001 | B1 |
| 6221654 | Quake | Apr 2001 | B1 |
| 6251639 | Kurn | Jun 2001 | B1 |
| 6258558 | Szostak | Jul 2001 | B1 |
| 6258568 | Nyren | Jul 2001 | B1 |
| 6261804 | Szostak | Jul 2001 | B1 |
| 6265552 | Schatz | Jul 2001 | B1 |
| 6266459 | Walt | Jul 2001 | B1 |
| 6268148 | Barany et al. | Jul 2001 | B1 |
| 6274320 | Rothberg | Aug 2001 | B1 |
| 6281804 | Haller | Aug 2001 | B1 |
| 6291180 | Chu | Sep 2001 | B1 |
| 6291187 | Kingsmore et al. | Sep 2001 | B1 |
| 6300063 | Lipshutz et al. | Oct 2001 | B1 |
| 6306597 | Macevicz | Oct 2001 | B1 |
| 6309824 | Drmanac | Oct 2001 | B1 |
| 6323009 | Lasken et al. | Nov 2001 | B1 |
| 6337472 | Garner et al. | Jan 2002 | B1 |
| 6344316 | Lockhart | Feb 2002 | B1 |
| 6344329 | Lizardi et al. | Feb 2002 | B1 |
| 6355431 | Chee | Mar 2002 | B1 |
| 6368801 | Faruqi | Apr 2002 | B1 |
| 6391937 | Beuhler et al. | May 2002 | B1 |
| 6401267 | Drmanac | Jun 2002 | B1 |
| 6404907 | Gilchrist | Jun 2002 | B1 |
| 6416950 | Lohse | Jul 2002 | B1 |
| 6432360 | Church et al. | Aug 2002 | B1 |
| 6485982 | Charlton | Nov 2002 | B1 |
| 6503713 | Rana | Jan 2003 | B1 |
| 6506561 | Cheval et al. | Jan 2003 | B1 |
| 6518018 | Szostak | Feb 2003 | B1 |
| 6534266 | Singer | Mar 2003 | B1 |
| 6544732 | Chee | Apr 2003 | B1 |
| 6544790 | Sabatini | Apr 2003 | B1 |
| 6565727 | Shenderov | May 2003 | B1 |
| 6573043 | Cohen et al. | Jun 2003 | B1 |
| 6579695 | Lambalot | Jun 2003 | B1 |
| 6620584 | Chee | Sep 2003 | B1 |
| 6632641 | Brennan | Oct 2003 | B1 |
| 6673620 | Loeffler | Jan 2004 | B1 |
| 6677160 | Stockman et al. | Jan 2004 | B1 |
| 6699710 | Kononen | Mar 2004 | B1 |
| 6737236 | Pieken et al. | May 2004 | B1 |
| 6770441 | Dickinson | Aug 2004 | B2 |
| 6773566 | Shenderov | Aug 2004 | B2 |
| 6773886 | Kaufman | Aug 2004 | B2 |
| 6787308 | Balasubramanian | Sep 2004 | B2 |
| 6797470 | Barany et al. | Sep 2004 | B2 |
| 6800453 | Labaer | Oct 2004 | B2 |
| 6812005 | Fan et al. | Nov 2004 | B2 |
| 6828100 | Ronaghi | Dec 2004 | B1 |
| 6833246 | Balasubramanian | Dec 2004 | B2 |
| 6852487 | Barany et al. | Feb 2005 | B1 |
| 6859570 | Walt | Feb 2005 | B2 |
| 6864052 | Drmanac | Mar 2005 | B1 |
| 6867028 | Janulaitis | Mar 2005 | B2 |
| 6872816 | Hall et al. | Mar 2005 | B1 |
| 6875572 | Prudent et al. | Apr 2005 | B2 |
| 6878515 | Landegren | Apr 2005 | B1 |
| 6890741 | Fan et al. | May 2005 | B2 |
| 6897023 | Fu | May 2005 | B2 |
| 6911132 | Pamula | Jun 2005 | B2 |
| 6911345 | Quake | Jun 2005 | B2 |
| 6913881 | Aizenstein et al. | Jul 2005 | B1 |
| 6913921 | Fischer | Jul 2005 | B2 |
| 6942968 | Dickinson et al. | Sep 2005 | B1 |
| 6969488 | Bridgham | Nov 2005 | B2 |
| 6969589 | Patil | Nov 2005 | B2 |
| 6977033 | Becker | Dec 2005 | B2 |
| 7001792 | Sauer et al. | Feb 2006 | B2 |
| 7011944 | Prudent et al. | Mar 2006 | B2 |
| 7052244 | Fouillet | May 2006 | B2 |
| 7057026 | Barnes | Jun 2006 | B2 |
| 7083980 | Reznikoff et al. | Aug 2006 | B2 |
| 7098041 | Kaylor et al. | Aug 2006 | B2 |
| 7115400 | Adessi | Oct 2006 | B1 |
| 7118883 | Inoue | Oct 2006 | B2 |
| 7128893 | Leamon et al. | Oct 2006 | B2 |
| 7163612 | Sterling | Jan 2007 | B2 |
| 7166431 | Chee et al. | Jan 2007 | B2 |
| 7192735 | Lambalot | Mar 2007 | B2 |
| 7211414 | Hardin | May 2007 | B2 |
| 7223371 | Hayenga et al. | May 2007 | B2 |
| 7229769 | Kozlov | Jun 2007 | B2 |
| 7244559 | Rothberg | Jul 2007 | B2 |
| 7255994 | Lao | Aug 2007 | B2 |
| 7258976 | Mitsuhashi | Aug 2007 | B2 |
| 7259258 | Kozlov et al. | Aug 2007 | B2 |
| 7264929 | Rothberg | Sep 2007 | B2 |
| 7270950 | Szostak | Sep 2007 | B2 |
| 7282328 | Kong et al. | Oct 2007 | B2 |
| 7297518 | Quake | Nov 2007 | B2 |
| 7315019 | Turner | Jan 2008 | B2 |
| 7328979 | Decre | Feb 2008 | B2 |
| 7329492 | Hardin | Feb 2008 | B2 |
| 7358047 | Hafner et al. | Apr 2008 | B2 |
| 7361488 | Fan et al. | Apr 2008 | B2 |
| 7375234 | Sharpless et al. | May 2008 | B2 |
| 7378242 | Hurt | May 2008 | B2 |
| 7393665 | Brenner | Jul 2008 | B2 |
| 7405281 | Xu | Jul 2008 | B2 |
| 7407757 | Brenner | Aug 2008 | B2 |
| 7427678 | Pieken et al. | Sep 2008 | B2 |
| 7462449 | Quake | Dec 2008 | B2 |
| 7473767 | Dimitrov | Jan 2009 | B2 |
| 7499806 | Kermani et al. | Mar 2009 | B2 |
| 7501245 | Quake | Mar 2009 | B2 |
| 7534991 | Miller et al. | May 2009 | B2 |
| 7537897 | Brenner | May 2009 | B2 |
| 7544473 | Brennan | Jun 2009 | B2 |
| 7547380 | Velev | Jun 2009 | B2 |
| 7555155 | Levenson et al. | Jun 2009 | B2 |
| 7563576 | Chee | Jul 2009 | B2 |
| 7579153 | Brenner | Aug 2009 | B2 |
| 7582420 | Oliphant et al. | Sep 2009 | B2 |
| 7595883 | El Gamal | Sep 2009 | B1 |
| 7601492 | Fu et al. | Oct 2009 | B2 |
| 7601498 | Mao | Oct 2009 | B2 |
| 7608434 | Reznikoff et al. | Oct 2009 | B2 |
| 7611869 | Fan | Nov 2009 | B2 |
| 7635566 | Brenner | Dec 2009 | B2 |
| 7641779 | Becker | Jan 2010 | B2 |
| 7655898 | Miller | Feb 2010 | B2 |
| 7666612 | Johnsson | Feb 2010 | B2 |
| 7674589 | Cohen et al. | Mar 2010 | B2 |
| 7674752 | He | Mar 2010 | B2 |
| 7700286 | Stroun et al. | Apr 2010 | B2 |
| 7709198 | Luo et al. | May 2010 | B2 |
| 7754429 | Rigatti | Jul 2010 | B2 |
| 7776547 | Roth | Aug 2010 | B2 |
| 7776567 | Mao | Aug 2010 | B2 |
| 7785869 | Belgrader et al. | Aug 2010 | B2 |
| 7803943 | Mao | Sep 2010 | B2 |
| 7844940 | Shin et al. | Nov 2010 | B2 |
| 7848553 | Hertel et al. | Dec 2010 | B2 |
| 7858321 | Glezer | Dec 2010 | B2 |
| 7888009 | Barany et al. | Feb 2011 | B2 |
| 7892747 | Barany et al. | Feb 2011 | B2 |
| 7910304 | Drmanac | Mar 2011 | B2 |
| 7914981 | Barany et al. | Mar 2011 | B2 |
| 7941279 | Hwang et al. | May 2011 | B2 |
| 7955794 | Shen et al. | Jun 2011 | B2 |
| 7960119 | Chee | Jun 2011 | B2 |
| 7960120 | Rigatti | Jun 2011 | B2 |
| 8003354 | Shen et al. | Aug 2011 | B2 |
| 8030477 | Cerrina et al. | Oct 2011 | B2 |
| 8076063 | Fan | Dec 2011 | B2 |
| 8092784 | Mao | Jan 2012 | B2 |
| 8124751 | Pierce et al. | Feb 2012 | B2 |
| 8148068 | Brenner | Apr 2012 | B2 |
| 8148518 | Buchanan | Apr 2012 | B2 |
| 8198028 | Rigatti et al. | Jun 2012 | B2 |
| 8199999 | Hoyt et al. | Jun 2012 | B2 |
| 8206917 | Chee | Jun 2012 | B2 |
| 8207093 | Szostak | Jun 2012 | B2 |
| 8268554 | Schallmeiner | Sep 2012 | B2 |
| 8278034 | Muraca | Oct 2012 | B2 |
| 8288103 | Oliphant | Oct 2012 | B2 |
| 8288122 | O'Leary et al. | Oct 2012 | B2 |
| 8330087 | Domenicali | Dec 2012 | B2 |
| 8337851 | Aukerman | Dec 2012 | B2 |
| 8343500 | Wraith | Jan 2013 | B2 |
| 8383338 | Kitzman | Feb 2013 | B2 |
| 8415102 | Geiss et al. | Apr 2013 | B2 |
| 8431691 | McKernan et al. | Apr 2013 | B2 |
| 8460865 | Chee | Jun 2013 | B2 |
| 8462981 | Determan et al. | Jun 2013 | B2 |
| 8481257 | Van Eijk | Jul 2013 | B2 |
| 8481258 | Church et al. | Jul 2013 | B2 |
| 8481292 | Casbon | Jul 2013 | B2 |
| 8481698 | Lieberman et al. | Jul 2013 | B2 |
| 8486625 | Gunderson | Jul 2013 | B2 |
| 8507204 | Pierce et al. | Aug 2013 | B2 |
| 8519115 | Webster et al. | Aug 2013 | B2 |
| 8551710 | Bernitz et al. | Oct 2013 | B2 |
| 8568979 | Stuelpnagel et al. | Oct 2013 | B2 |
| RE44596 | Stroun et al. | Nov 2013 | E |
| 8586310 | Mitra | Nov 2013 | B2 |
| 8597891 | Barany et al. | Dec 2013 | B2 |
| 8603743 | Liu et al. | Dec 2013 | B2 |
| 8604182 | Luo et al. | Dec 2013 | B2 |
| 8614073 | Van Eijk | Dec 2013 | B2 |
| 8624016 | Barany et al. | Jan 2014 | B2 |
| 8637242 | Shen | Jan 2014 | B2 |
| 8658361 | Wu et al. | Feb 2014 | B2 |
| 8685889 | Van Eijk | Apr 2014 | B2 |
| 8741564 | Seligmann | Jun 2014 | B2 |
| 8741606 | Casbon | Jun 2014 | B2 |
| 8748103 | Faham et al. | Jun 2014 | B2 |
| 8771950 | Church et al. | Jul 2014 | B2 |
| 8778849 | Bowen | Jul 2014 | B2 |
| 8785353 | Van Eijk | Jul 2014 | B2 |
| 8790873 | Namsaraev et al. | Jul 2014 | B2 |
| 8809238 | Livak et al. | Aug 2014 | B2 |
| 8815512 | Van Eijk | Aug 2014 | B2 |
| 8835358 | Fodor | Sep 2014 | B2 |
| 8865410 | Shendure | Oct 2014 | B2 |
| 8895249 | Shen | Nov 2014 | B2 |
| 8906626 | Oliphant et al. | Dec 2014 | B2 |
| 8911945 | Van Eijk | Dec 2014 | B2 |
| 8936912 | Mitra | Jan 2015 | B2 |
| 8951726 | Luo et al. | Feb 2015 | B2 |
| 8951728 | Rasmussen | Feb 2015 | B2 |
| 8951781 | Reed | Feb 2015 | B2 |
| 8986926 | Ferree et al. | Mar 2015 | B2 |
| 9005891 | Sinicropi et al. | Apr 2015 | B2 |
| 9005935 | Belyaev | Apr 2015 | B2 |
| 9023768 | Van Eijk | May 2015 | B2 |
| 9062348 | Van Eijk | Jun 2015 | B1 |
| 9080210 | Van Eijk | Jul 2015 | B2 |
| 9085798 | Chee | Jul 2015 | B2 |
| 9121069 | Lo | Sep 2015 | B2 |
| 9163283 | Chee et al. | Oct 2015 | B2 |
| 9194001 | Brenner | Nov 2015 | B2 |
| 9201063 | Sood et al. | Dec 2015 | B2 |
| 9217176 | Faham et al. | Dec 2015 | B2 |
| 9273349 | Nguyen et al. | Mar 2016 | B2 |
| 9290808 | Fodor | Mar 2016 | B2 |
| 9290809 | Fodor | Mar 2016 | B2 |
| 9309556 | Myllykangas et al. | Apr 2016 | B2 |
| 9328383 | Van Eijk | May 2016 | B2 |
| 9334536 | Van Eijk | May 2016 | B2 |
| 9340830 | Lipson | May 2016 | B2 |
| 9371563 | Geiss et al. | Jun 2016 | B2 |
| 9371598 | Chee | Jun 2016 | B2 |
| 9376716 | Van Eijk | Jun 2016 | B2 |
| 9376717 | Gao et al. | Jun 2016 | B2 |
| 9376719 | Van Eijk | Jun 2016 | B2 |
| 9404156 | Hicks | Aug 2016 | B2 |
| 9416409 | Hayden | Aug 2016 | B2 |
| 9447459 | Van Eijk | Sep 2016 | B2 |
| 9453256 | Van Eijk | Sep 2016 | B2 |
| 9493820 | Van Eijk | Nov 2016 | B2 |
| 9506061 | Brown | Nov 2016 | B2 |
| 9512422 | Barnard et al. | Dec 2016 | B2 |
| 9512487 | Faham et al. | Dec 2016 | B2 |
| 9518980 | Looger et al. | Dec 2016 | B2 |
| 9541504 | Hoyt | Jan 2017 | B2 |
| 9557330 | Siciliano et al. | Jan 2017 | B2 |
| 9574230 | Van Eijk | Feb 2017 | B2 |
| 9582877 | Fu | Feb 2017 | B2 |
| 9593365 | Frisen et al. | Mar 2017 | B2 |
| 9598728 | Barany et al. | Mar 2017 | B2 |
| 9624538 | Church et al. | Apr 2017 | B2 |
| 9644204 | Hindson et al. | May 2017 | B2 |
| 9657335 | Van Eijk | May 2017 | B2 |
| 9670542 | Van Eijk | Jun 2017 | B2 |
| 9694361 | Bharadwaj | Jul 2017 | B2 |
| 9702004 | Van Eijk | Jul 2017 | B2 |
| 9714446 | Webster et al. | Jul 2017 | B2 |
| 9714937 | Dunaway | Jul 2017 | B2 |
| 9727810 | Fodor et al. | Aug 2017 | B2 |
| 9745627 | Van Eijk | Aug 2017 | B2 |
| 9777324 | Van Eijk | Oct 2017 | B2 |
| 9778155 | Gradinaru et al. | Oct 2017 | B2 |
| 9783841 | Nolan et al. | Oct 2017 | B2 |
| 9790476 | Gloeckner et al. | Oct 2017 | B2 |
| 9816134 | Namsaraev | Nov 2017 | B2 |
| 9834814 | Peter et al. | Dec 2017 | B2 |
| 9850536 | Oliphant et al. | Dec 2017 | B2 |
| 9856521 | Stevens et al. | Jan 2018 | B2 |
| 9868979 | Chee et al. | Jan 2018 | B2 |
| 9879313 | Chee et al. | Jan 2018 | B2 |
| 9889422 | Smith et al. | Feb 2018 | B2 |
| 9896721 | Van Eijk | Feb 2018 | B2 |
| 9898576 | Van Eijk | Feb 2018 | B2 |
| 9898577 | Van Eijk | Feb 2018 | B2 |
| 9902950 | Church et al. | Feb 2018 | B2 |
| 9902991 | Sinicropi et al. | Feb 2018 | B2 |
| 9909167 | Samusik et al. | Mar 2018 | B2 |
| 9938566 | Shepard et al. | Apr 2018 | B2 |
| 9957550 | Yeakley et al. | May 2018 | B2 |
| 9958454 | Kozlov et al. | May 2018 | B2 |
| 9975122 | Masquelier et al. | May 2018 | B2 |
| 10002316 | Fodor et al. | Jun 2018 | B2 |
| 10011872 | Belgrader et al. | Jul 2018 | B1 |
| 10023907 | Van Eijk | Jul 2018 | B2 |
| 10030261 | Frisen et al. | Jul 2018 | B2 |
| 10032064 | Hoyt | Jul 2018 | B2 |
| 10035992 | Gloeckner et al. | Jul 2018 | B2 |
| 10041949 | Bendall et al. | Aug 2018 | B2 |
| 10049770 | Madabhushi et al. | Aug 2018 | B2 |
| 10053723 | Hindson et al. | Aug 2018 | B2 |
| 10059989 | Giresi et al. | Aug 2018 | B2 |
| 10059990 | Boyden et al. | Aug 2018 | B2 |
| 10071377 | Bharadwaj et al. | Sep 2018 | B2 |
| 10072104 | Winnik et al. | Sep 2018 | B2 |
| 10078895 | Madabhushi et al. | Sep 2018 | B2 |
| 10095832 | Van Eijk | Oct 2018 | B2 |
| 10126242 | Miller et al. | Nov 2018 | B2 |
| 10138509 | Church et al. | Nov 2018 | B2 |
| 10144966 | Cantor | Dec 2018 | B2 |
| 10179932 | Church et al. | Jan 2019 | B2 |
| 10196691 | Harkin et al. | Feb 2019 | B2 |
| 10221461 | Robins et al. | Mar 2019 | B2 |
| 10227639 | Levner et al. | Mar 2019 | B2 |
| 10246700 | Dunaway et al. | Apr 2019 | B2 |
| 10246752 | Faham et al. | Apr 2019 | B2 |
| 10266874 | Weissleder et al. | Apr 2019 | B2 |
| 10266876 | Cai et al. | Apr 2019 | B2 |
| 10266888 | Daugharthy et al. | Apr 2019 | B2 |
| 10267808 | Cai | Apr 2019 | B2 |
| 10273541 | Hindson et al. | Apr 2019 | B2 |
| 10308982 | Chee | Jun 2019 | B2 |
| 10309879 | Chen et al. | Jun 2019 | B2 |
| 10317321 | Tillberg et al. | Jun 2019 | B2 |
| 10357771 | Bharadwaj | Jul 2019 | B2 |
| 10364457 | Wassie et al. | Jul 2019 | B2 |
| 10370698 | Nolan et al. | Aug 2019 | B2 |
| 10405750 | Wang et al. | Sep 2019 | B2 |
| 10415080 | Dunaway et al. | Sep 2019 | B2 |
| 10457980 | Cai et al. | Oct 2019 | B2 |
| 10465235 | Gullberg et al. | Nov 2019 | B2 |
| 10472669 | Chee | Nov 2019 | B2 |
| 10480022 | Chee | Nov 2019 | B2 |
| 10480029 | Bent et al. | Nov 2019 | B2 |
| 10494662 | Church et al. | Dec 2019 | B2 |
| 10494667 | Chee | Dec 2019 | B2 |
| 10495554 | Deisseroth et al. | Dec 2019 | B2 |
| 10501777 | Beechem et al. | Dec 2019 | B2 |
| 10501791 | Church et al. | Dec 2019 | B2 |
| 10510435 | Cai et al. | Dec 2019 | B2 |
| 10526649 | Chen et al. | Jan 2020 | B2 |
| 10544403 | Gloeckner et al. | Jan 2020 | B2 |
| 10545075 | Deisseroth et al. | Jan 2020 | B2 |
| 10550429 | Harada et al. | Feb 2020 | B2 |
| 10580128 | Miller | Mar 2020 | B2 |
| 10612079 | Chee | Apr 2020 | B2 |
| 10619196 | Chee | Apr 2020 | B1 |
| 10633648 | Seelig et al. | Apr 2020 | B2 |
| 10640816 | Beechem et al. | May 2020 | B2 |
| 10640826 | Church et al. | May 2020 | B2 |
| 10655163 | Weissleder et al. | May 2020 | B2 |
| 10662467 | Chee | May 2020 | B2 |
| 10662468 | Chee | May 2020 | B2 |
| 10669569 | Gullberg et al. | Jun 2020 | B2 |
| 10697013 | Brenner et al. | Jun 2020 | B1 |
| 10724078 | Van Driel et al. | Jul 2020 | B2 |
| 10725027 | Bell | Jul 2020 | B2 |
| 10746981 | Tomer et al. | Aug 2020 | B2 |
| 10767223 | Brenner et al. | Sep 2020 | B1 |
| 10774372 | Chee et al. | Sep 2020 | B2 |
| 10774374 | Frisen et al. | Sep 2020 | B2 |
| 10787701 | Chee | Sep 2020 | B2 |
| 10794802 | Gradinaru et al. | Oct 2020 | B2 |
| 10802262 | Tomer et al. | Oct 2020 | B2 |
| 10815519 | Husain et al. | Oct 2020 | B2 |
| 10829803 | Terbrueggen et al. | Nov 2020 | B2 |
| 10844426 | Daugharthy et al. | Nov 2020 | B2 |
| 10858698 | Church et al. | Dec 2020 | B2 |
| 10858702 | Lucero et al. | Dec 2020 | B2 |
| 10872679 | Cai et al. | Dec 2020 | B2 |
| 10913975 | So et al. | Feb 2021 | B2 |
| 10914730 | Chee et al. | Feb 2021 | B2 |
| 10927403 | Chee et al. | Feb 2021 | B2 |
| 10961566 | Chee | Mar 2021 | B2 |
| 10962532 | Chee | Mar 2021 | B2 |
| 10964001 | Miller | Mar 2021 | B2 |
| 10982268 | Chee | Apr 2021 | B2 |
| 10983113 | Chee | Apr 2021 | B2 |
| 10995361 | Chen et al. | May 2021 | B2 |
| 10996219 | Chee et al. | May 2021 | B2 |
| 11001878 | Chee et al. | May 2021 | B1 |
| 11001879 | Chee et al. | May 2021 | B1 |
| 11008607 | Chee | May 2021 | B2 |
| 11008608 | Samusik et al. | May 2021 | B2 |
| 11046996 | Chee et al. | Jun 2021 | B1 |
| 11067567 | Chee | Jul 2021 | B2 |
| 11104936 | Zhang et al. | Aug 2021 | B2 |
| 11118216 | Koshinsky et al. | Sep 2021 | B2 |
| 11156603 | Chee | Oct 2021 | B2 |
| 11162132 | Frisen et al. | Nov 2021 | B2 |
| 11168350 | Nolan et al. | Nov 2021 | B2 |
| 11208684 | Chee | Dec 2021 | B2 |
| 11286515 | Chee et al. | Mar 2022 | B2 |
| 11293917 | Chee | Apr 2022 | B2 |
| 11299774 | Frisen et al. | Apr 2022 | B2 |
| 11313856 | Chee | Apr 2022 | B2 |
| 11332790 | Chell et al. | May 2022 | B2 |
| 11352659 | Frisen et al. | Jun 2022 | B2 |
| 11352667 | Hauling et al. | Jun 2022 | B2 |
| 11359228 | Chee et al. | Jun 2022 | B2 |
| 11365442 | Chee | Jun 2022 | B2 |
| 11371086 | Chee | Jun 2022 | B2 |
| 11384386 | Chee | Jul 2022 | B2 |
| 11390912 | Frisen et al. | Jul 2022 | B2 |
| 11401545 | Chee | Aug 2022 | B2 |
| 11407992 | Dadhwal | Aug 2022 | B2 |
| 11408029 | Katiraee et al. | Aug 2022 | B2 |
| 11434524 | Ramachandran Iyer et al. | Sep 2022 | B2 |
| 11447807 | Church et al. | Sep 2022 | B2 |
| 11479809 | Frisen et al. | Oct 2022 | B2 |
| 11479810 | Chee | Oct 2022 | B1 |
| 11492612 | Dadhwal | Nov 2022 | B1 |
| 11505828 | Chell et al. | Nov 2022 | B2 |
| 11512308 | Gallant et al. | Nov 2022 | B2 |
| 11519022 | Chee | Dec 2022 | B2 |
| 11519033 | Schnall-Levin et al. | Dec 2022 | B2 |
| 11530438 | Persson et al. | Dec 2022 | B2 |
| 11535887 | Gallant et al. | Dec 2022 | B2 |
| 11542543 | Chee | Jan 2023 | B2 |
| 11549138 | Chee | Jan 2023 | B2 |
| 11560587 | Chee | Jan 2023 | B2 |
| 11560592 | Chew et al. | Jan 2023 | B2 |
| 11560593 | Chell et al. | Jan 2023 | B2 |
| 11592447 | Uytingco et al. | Feb 2023 | B2 |
| 11608498 | Gallant et al. | Mar 2023 | B2 |
| 11608520 | Galonska et al. | Mar 2023 | B2 |
| 11613773 | Frisen et al. | Mar 2023 | B2 |
| 11618897 | Kim et al. | Apr 2023 | B2 |
| 11618918 | Chee et al. | Apr 2023 | B2 |
| 11624063 | Dadhwal | Apr 2023 | B2 |
| 11624086 | Uytingco et al. | Apr 2023 | B2 |
| 11634756 | Chee | Apr 2023 | B2 |
| 11649485 | Yin et al. | May 2023 | B2 |
| 11661626 | Katiraee et al. | May 2023 | B2 |
| 20010039029 | Nemori et al. | Nov 2001 | A1 |
| 20010055764 | Empendocles et al. | Dec 2001 | A1 |
| 20020006477 | Shishido et al. | Jan 2002 | A1 |
| 20020040275 | Cravatt | Apr 2002 | A1 |
| 20020045169 | Shoemaker et al. | Apr 2002 | A1 |
| 20020045272 | McDevitt et al. | Apr 2002 | A1 |
| 20020048766 | Doyle et al. | Apr 2002 | A1 |
| 20020051986 | Baez et al. | May 2002 | A1 |
| 20020055100 | Kawashima | May 2002 | A1 |
| 20020058250 | Firth | May 2002 | A1 |
| 20020064779 | Landegren | May 2002 | A1 |
| 20020086441 | Baranov et al. | Jul 2002 | A1 |
| 20020132246 | Kallioniemi et al. | Sep 2002 | A1 |
| 20020137031 | Wolber | Sep 2002 | A1 |
| 20020150909 | Stuelpnagel | Oct 2002 | A1 |
| 20020164611 | Bamdad | Nov 2002 | A1 |
| 20020168645 | Taylor | Nov 2002 | A1 |
| 20030017451 | Wang et al. | Jan 2003 | A1 |
| 20030022207 | Balasubramanian | Jan 2003 | A1 |
| 20030040035 | Slamon | Feb 2003 | A1 |
| 20030064398 | Barnes | Apr 2003 | A1 |
| 20030073086 | Guire et al. | Apr 2003 | A1 |
| 20030087232 | Christians | May 2003 | A1 |
| 20030096323 | James | May 2003 | A1 |
| 20030113713 | Glezer | Jun 2003 | A1 |
| 20030124595 | Lizardi | Jul 2003 | A1 |
| 20030134279 | Isola et al. | Jul 2003 | A1 |
| 20030138879 | Lambalot | Jul 2003 | A1 |
| 20030148335 | Shen et al. | Aug 2003 | A1 |
| 20030153850 | Davis et al. | Aug 2003 | A1 |
| 20030162216 | Gold | Aug 2003 | A1 |
| 20030165948 | Alsmadi et al. | Sep 2003 | A1 |
| 20030170637 | Pirrung et al. | Sep 2003 | A1 |
| 20030175844 | Nadler et al. | Sep 2003 | A1 |
| 20030175947 | Liu et al. | Sep 2003 | A1 |
| 20030190744 | McGarry et al. | Oct 2003 | A1 |
| 20030205632 | Kim et al. | Nov 2003 | A1 |
| 20030215936 | Kallioniemi et al. | Nov 2003 | A1 |
| 20030224419 | Corcoran | Dec 2003 | A1 |
| 20030232348 | Jones et al. | Dec 2003 | A1 |
| 20030232382 | Brennan | Dec 2003 | A1 |
| 20030235535 | Zhou | Dec 2003 | A1 |
| 20030235852 | Roberts | Dec 2003 | A1 |
| 20030235854 | Chan et al. | Dec 2003 | A1 |
| 20040002090 | Mayer et al. | Jan 2004 | A1 |
| 20040019005 | Van Ness | Jan 2004 | A1 |
| 20040023320 | Steiner et al. | Feb 2004 | A1 |
| 20040033499 | Ilsley et al. | Feb 2004 | A1 |
| 20040050699 | Goncalves | Mar 2004 | A1 |
| 20040067492 | Peng et al. | Apr 2004 | A1 |
| 20040067493 | Matsuzaki | Apr 2004 | A1 |
| 20040082059 | Webb | Apr 2004 | A1 |
| 20040096853 | Mayer | May 2004 | A1 |
| 20040106110 | Balasubramanian | Jun 2004 | A1 |
| 20040112442 | Maerkl | Jun 2004 | A1 |
| 20040121456 | Fischer | Jun 2004 | A1 |
| 20040175822 | Timperman et al. | Sep 2004 | A1 |
| 20040219588 | Furuta | Nov 2004 | A1 |
| 20040224326 | Kim et al. | Nov 2004 | A1 |
| 20040235103 | Reznikoff et al. | Nov 2004 | A1 |
| 20040248325 | Bukusoglu et al. | Dec 2004 | A1 |
| 20040259105 | Fan et al. | Dec 2004 | A1 |
| 20050003431 | Wucherpfennig | Jan 2005 | A1 |
| 20050014203 | Darfler et al. | Jan 2005 | A1 |
| 20050019776 | Callow et al. | Jan 2005 | A1 |
| 20050019842 | Prober et al. | Jan 2005 | A1 |
| 20050026188 | Van Kessel | Feb 2005 | A1 |
| 20050037362 | Remacle et al. | Feb 2005 | A1 |
| 20050037393 | Gunderson et al. | Feb 2005 | A1 |
| 20050042695 | Meares et al. | Feb 2005 | A1 |
| 20050048580 | Labaer | Mar 2005 | A1 |
| 20050064460 | Holliger et al. | Mar 2005 | A1 |
| 20050079520 | Wu | Apr 2005 | A1 |
| 20050095627 | Kolman et al. | May 2005 | A1 |
| 20050100900 | Kawashima et al. | May 2005 | A1 |
| 20050116161 | Hafeman et al. | Jun 2005 | A1 |
| 20050130173 | Leamon et al. | Jun 2005 | A1 |
| 20050130188 | Walt | Jun 2005 | A1 |
| 20050136414 | Gunderson et al. | Jun 2005 | A1 |
| 20050164292 | Farooqui | Jul 2005 | A1 |
| 20050179746 | Roux et al. | Aug 2005 | A1 |
| 20050191656 | Drmanac et al. | Sep 2005 | A1 |
| 20050191698 | Chee et al. | Sep 2005 | A1 |
| 20050196786 | Levy | Sep 2005 | A1 |
| 20050202433 | Van Beuningen | Sep 2005 | A1 |
| 20050227271 | Kwon | Oct 2005 | A1 |
| 20050239119 | Tsukada et al. | Oct 2005 | A1 |
| 20050239192 | Nasarabadi et al. | Oct 2005 | A1 |
| 20050244850 | Huang | Nov 2005 | A1 |
| 20050255548 | Lipovsek et al. | Nov 2005 | A1 |
| 20050257284 | Nakajima et al. | Nov 2005 | A1 |
| 20050260653 | LaBaer | Nov 2005 | A1 |
| 20050266417 | Barany et al. | Dec 2005 | A1 |
| 20060003394 | Song | Jan 2006 | A1 |
| 20060039823 | Yamakawa et al. | Feb 2006 | A1 |
| 20060046313 | Roth | Mar 2006 | A1 |
| 20060063160 | West et al. | Mar 2006 | A1 |
| 20060079453 | Sidney et al. | Apr 2006 | A1 |
| 20060084078 | Zhao | Apr 2006 | A1 |
| 20060105352 | Qiao et al. | May 2006 | A1 |
| 20060110739 | Heyduk | May 2006 | A1 |
| 20060134669 | Casasanta | Jun 2006 | A1 |
| 20060154286 | Kong et al. | Jul 2006 | A1 |
| 20060164490 | Kim et al. | Jul 2006 | A1 |
| 20060183150 | Cohen et al. | Aug 2006 | A1 |
| 20060188875 | Cox et al. | Aug 2006 | A1 |
| 20060188901 | Barnes et al. | Aug 2006 | A1 |
| 20060188906 | Kim et al. | Aug 2006 | A1 |
| 20060194331 | Pamula et al. | Aug 2006 | A1 |
| 20060199183 | Valat et al. | Sep 2006 | A1 |
| 20060199207 | Matysiak | Sep 2006 | A1 |
| 20060211001 | Yu et al. | Sep 2006 | A1 |
| 20060216721 | Kozlov et al. | Sep 2006 | A1 |
| 20060216775 | Burkart et al. | Sep 2006 | A1 |
| 20060228758 | Muchhal et al. | Oct 2006 | A1 |
| 20060240439 | Smith et al. | Oct 2006 | A1 |
| 20060263789 | Kincaid | Nov 2006 | A1 |
| 20060275782 | Gunderson et al. | Dec 2006 | A1 |
| 20060275799 | Banetjee et al. | Dec 2006 | A1 |
| 20060281109 | Barr Ost et al. | Dec 2006 | A1 |
| 20070003954 | Kodadek et al. | Jan 2007 | A1 |
| 20070014810 | Baker et al. | Jan 2007 | A1 |
| 20070020625 | Duchaud et al. | Jan 2007 | A1 |
| 20070020640 | McCloskey et al. | Jan 2007 | A1 |
| 20070020669 | Ericsson | Jan 2007 | A1 |
| 20070023292 | Kim et al. | Feb 2007 | A1 |
| 20070026430 | Andersen et al. | Feb 2007 | A1 |
| 20070036511 | Lundquist et al. | Feb 2007 | A1 |
| 20070048812 | Moravec et al. | Mar 2007 | A1 |
| 20070054288 | Su et al. | Mar 2007 | A1 |
| 20070087360 | Boyd | Apr 2007 | A1 |
| 20070099208 | Drmanac et al. | May 2007 | A1 |
| 20070116612 | Williamson | May 2007 | A1 |
| 20070128624 | Gormley et al. | Jun 2007 | A1 |
| 20070128656 | Agrawal | Jun 2007 | A1 |
| 20070134723 | Kozlov et al. | Jun 2007 | A1 |
| 20070141718 | Bui et al. | Jun 2007 | A1 |
| 20070161020 | Luo et al. | Jul 2007 | A1 |
| 20070161029 | Li et al. | Jul 2007 | A1 |
| 20070166705 | Milton et al. | Jul 2007 | A1 |
| 20070166725 | McBride et al. | Jul 2007 | A1 |
| 20070172873 | Brenner et al. | Jul 2007 | A1 |
| 20070178503 | Jiang | Aug 2007 | A1 |
| 20070207482 | Church et al. | Sep 2007 | A1 |
| 20070215466 | Okada | Sep 2007 | A1 |
| 20070231823 | McKernan | Oct 2007 | A1 |
| 20070243634 | Pamula et al. | Oct 2007 | A1 |
| 20070251824 | Patton | Nov 2007 | A1 |
| 20070254305 | Paik et al. | Nov 2007 | A1 |
| 20070264656 | Kawamura | Nov 2007 | A1 |
| 20070269805 | Hogers | Nov 2007 | A1 |
| 20070280517 | De La Torre-Bueno et al. | Dec 2007 | A1 |
| 20080003586 | Hyde et al. | Jan 2008 | A1 |
| 20080009420 | Schroth et al. | Jan 2008 | A1 |
| 20080032301 | Rank et al. | Feb 2008 | A1 |
| 20080038734 | Sorge et al. | Feb 2008 | A1 |
| 20080047835 | MacConnell | Feb 2008 | A1 |
| 20080071071 | LaBaer et al. | Mar 2008 | A1 |
| 20080108082 | Rank et al. | May 2008 | A1 |
| 20080108804 | Hayashizaki et al. | May 2008 | A1 |
| 20080124252 | Marchand et al. | May 2008 | A1 |
| 20080124810 | Terbrueggen et al. | May 2008 | A1 |
| 20080128627 | Lundquist et al. | Jun 2008 | A1 |
| 20080132429 | Perov et al. | Jun 2008 | A1 |
| 20080145616 | Gharib et al. | Jun 2008 | A1 |
| 20080153086 | Wong | Jun 2008 | A1 |
| 20080160580 | Adessi et al. | Jul 2008 | A1 |
| 20080199929 | Yeung et al. | Aug 2008 | A1 |
| 20080220434 | Thomas | Sep 2008 | A1 |
| 20080220981 | McGregor | Sep 2008 | A1 |
| 20080261204 | Lexow | Oct 2008 | A1 |
| 20080280773 | Fedurco et al. | Nov 2008 | A1 |
| 20080286795 | Kawashima et al. | Nov 2008 | A1 |
| 20080293046 | Allawi et al. | Nov 2008 | A1 |
| 20080293591 | Taussig et al. | Nov 2008 | A1 |
| 20080312103 | Nemoto et al. | Dec 2008 | A1 |
| 20090005252 | Drmanac et al. | Jan 2009 | A1 |
| 20090006002 | Honisch et al. | Jan 2009 | A1 |
| 20090018024 | Church et al. | Jan 2009 | A1 |
| 20090026082 | Rothberg et al. | Jan 2009 | A1 |
| 20090036323 | van Eijk et al. | Feb 2009 | A1 |
| 20090062148 | Goldberg | Mar 2009 | A1 |
| 20090082212 | Williams | Mar 2009 | A1 |
| 20090099041 | Church et al. | Apr 2009 | A1 |
| 20090105959 | Braverman et al. | Apr 2009 | A1 |
| 20090117573 | Fu et al. | May 2009 | A1 |
| 20090127589 | Rothberg et al. | May 2009 | A1 |
| 20090155781 | Drmanac et al. | Jun 2009 | A1 |
| 20090169089 | Hunt et al. | Jul 2009 | A1 |
| 20090170713 | van Eijk et al. | Jul 2009 | A1 |
| 20090192044 | Fouillet | Jul 2009 | A1 |
| 20090197326 | El Gamal et al. | Aug 2009 | A1 |
| 20090202998 | Schlumpberger et al. | Aug 2009 | A1 |
| 20090215633 | van Eijk et al. | Aug 2009 | A1 |
| 20090233802 | Bignell et al. | Sep 2009 | A1 |
| 20090239232 | Kurn | Sep 2009 | A1 |
| 20090253163 | Xie et al. | Oct 2009 | A1 |
| 20090253581 | van Eijk et al. | Oct 2009 | A1 |
| 20090253582 | Pena et al. | Oct 2009 | A1 |
| 20090264299 | Drmanac et al. | Oct 2009 | A1 |
| 20090280487 | Hung et al. | Nov 2009 | A1 |
| 20090283407 | Van Eijk | Nov 2009 | A1 |
| 20090289184 | Deininger | Nov 2009 | A1 |
| 20090291854 | Weisinger-Mayr et al. | Nov 2009 | A1 |
| 20090305237 | Cantor et al. | Dec 2009 | A1 |
| 20090312193 | Kim et al. | Dec 2009 | A1 |
| 20090321262 | Adachi et al. | Dec 2009 | A1 |
| 20100009871 | Reed et al. | Jan 2010 | A1 |
| 20100014537 | Jacquet et al. | Jan 2010 | A1 |
| 20100035249 | Hayashizaki et al. | Feb 2010 | A1 |
| 20100055733 | Lutolf et al. | Mar 2010 | A1 |
| 20100069263 | Shendure et al. | Mar 2010 | A1 |
| 20100096266 | Kim et al. | Apr 2010 | A1 |
| 20100099103 | Hsieh et al. | Apr 2010 | A1 |
| 20100105052 | Drmanac et al. | Apr 2010 | A1 |
| 20100105112 | Heltze et al. | Apr 2010 | A1 |
| 20100111768 | Banerjee et al. | May 2010 | A1 |
| 20100113302 | Williams | May 2010 | A1 |
| 20100120043 | Sood et al. | May 2010 | A1 |
| 20100120097 | Matz et al. | May 2010 | A1 |
| 20100120098 | Grunenwald et al. | May 2010 | A1 |
| 20100126862 | Sabin et al. | May 2010 | A1 |
| 20100129874 | Mitra et al. | May 2010 | A1 |
| 20100137143 | Rothberg et al. | Jun 2010 | A1 |
| 20100145037 | Makarov et al. | Jun 2010 | A1 |
| 20100151464 | Stuelpnagel et al. | Jun 2010 | A1 |
| 20100151511 | Gereenizer et al. | Jun 2010 | A1 |
| 20100159446 | Haff et al. | Jun 2010 | A1 |
| 20100173384 | Johnsson et al. | Jul 2010 | A1 |
| 20100184614 | Ye et al. | Jul 2010 | A1 |
| 20100184618 | Namsaraev et al. | Jul 2010 | A1 |
| 20100210475 | Lee et al. | Aug 2010 | A1 |
| 20100227329 | Cuppens | Sep 2010 | A1 |
| 20100267590 | Grudzien et al. | Oct 2010 | A1 |
| 20100273219 | May et al. | Oct 2010 | A1 |
| 20100273679 | Cuppoletti et al. | Oct 2010 | A1 |
| 20100282617 | Rothberg et al. | Nov 2010 | A1 |
| 20100303722 | Jin et al. | Dec 2010 | A1 |
| 20110024511 | Rietzler et al. | Feb 2011 | A1 |
| 20110027772 | Ahn et al. | Feb 2011 | A1 |
| 20110028685 | Purkayastha et al. | Feb 2011 | A1 |
| 20110033854 | Drmanac et al. | Feb 2011 | A1 |
| 20110045462 | Fu et al. | Feb 2011 | A1 |
| 20110048951 | Wu | Mar 2011 | A1 |
| 20110059436 | Hardin et al. | Mar 2011 | A1 |
| 20110059865 | Smith et al. | Mar 2011 | A1 |
| 20110086774 | Dunaway | Apr 2011 | A1 |
| 20110111409 | Sinicropi et al. | May 2011 | A1 |
| 20110151451 | Lemaire et al. | Jun 2011 | A1 |
| 20110152111 | Fan et al. | Jun 2011 | A1 |
| 20110172115 | Thompson et al. | Jul 2011 | A1 |
| 20110177518 | Kartalov et al. | Jul 2011 | A1 |
| 20110201515 | Webster et al. | Aug 2011 | A1 |
| 20110207134 | Faham et al. | Aug 2011 | A1 |
| 20110223613 | Gut | Sep 2011 | A1 |
| 20110244448 | Shirai et al. | Oct 2011 | A1 |
| 20110245101 | Chee et al. | Oct 2011 | A1 |
| 20110245111 | Chee | Oct 2011 | A1 |
| 20110275077 | James | Nov 2011 | A1 |
| 20110287435 | Grunenwald et al. | Nov 2011 | A1 |
| 20120021930 | Schoen et al. | Jan 2012 | A1 |
| 20120046175 | Rodesch et al. | Feb 2012 | A1 |
| 20120046178 | Van Den Boom et al. | Feb 2012 | A1 |
| 20120065081 | Chee | Mar 2012 | A1 |
| 20120077693 | Cazalis et al. | Mar 2012 | A1 |
| 20120129248 | Chee et al. | May 2012 | A1 |
| 20120135871 | van Eijk et al. | May 2012 | A1 |
| 20120142014 | Cai | Jun 2012 | A1 |
| 20120156728 | Li et al. | Jun 2012 | A1 |
| 20120157322 | Myllykangas | Jun 2012 | A1 |
| 20120160683 | Ye et al. | Jun 2012 | A1 |
| 20120195810 | Cohen et al. | Aug 2012 | A1 |
| 20120196297 | Yost et al. | Aug 2012 | A1 |
| 20120202698 | van Eijk et al. | Aug 2012 | A1 |
| 20120202704 | Fan et al. | Aug 2012 | A1 |
| 20120220479 | Ericsson et al. | Aug 2012 | A1 |
| 20120245053 | Shirai et al. | Sep 2012 | A1 |
| 20120252702 | Muratani et al. | Oct 2012 | A1 |
| 20120258871 | Kozlov et al. | Oct 2012 | A1 |
| 20120270305 | Reed et al. | Oct 2012 | A1 |
| 20120270748 | Chee et al. | Oct 2012 | A1 |
| 20120279954 | Ceremony et al. | Nov 2012 | A1 |
| 20120289414 | Mitra et al. | Nov 2012 | A1 |
| 20120301925 | Belyaev | Nov 2012 | A1 |
| 20120322099 | Lapen et al. | Dec 2012 | A1 |
| 20130005594 | Terbrueggen et al. | Jan 2013 | A1 |
| 20130005600 | Olek | Jan 2013 | A1 |
| 20130035239 | Kong et al. | Feb 2013 | A1 |
| 20130052331 | Kram et al. | Feb 2013 | A1 |
| 20130065768 | Zheng et al. | Mar 2013 | A1 |
| 20130065788 | Glezer et al. | Mar 2013 | A1 |
| 20130079232 | Kain et al. | Mar 2013 | A1 |
| 20130096033 | Routenberg | Apr 2013 | A1 |
| 20130109595 | Routenberg | May 2013 | A1 |
| 20130122516 | Hong et al. | May 2013 | A1 |
| 20130171621 | Luo et al. | Jul 2013 | A1 |
| 20130202718 | Pepin et al. | Aug 2013 | A1 |
| 20130211249 | Barnett et al. | Aug 2013 | A1 |
| 20130244884 | Jacobson et al. | Sep 2013 | A1 |
| 20130260372 | Buermann et al. | Oct 2013 | A1 |
| 20130261019 | Lin et al. | Oct 2013 | A1 |
| 20130296174 | Peumans | Nov 2013 | A1 |
| 20130302801 | Asbury et al. | Nov 2013 | A1 |
| 20130338042 | Shen et al. | Dec 2013 | A1 |
| 20140065609 | Hicks et al. | Mar 2014 | A1 |
| 20140066318 | Frisen et al. | Mar 2014 | A1 |
| 20140079923 | George et al. | Mar 2014 | A1 |
| 20140080715 | Lo et al. | Mar 2014 | A1 |
| 20140121118 | Warner | May 2014 | A1 |
| 20140155274 | Xie et al. | Jun 2014 | A1 |
| 20140155295 | Hindson et al. | Jun 2014 | A1 |
| 20140213533 | Suthanthiran et al. | Jul 2014 | A1 |
| 20140227705 | Vogelstein et al. | Aug 2014 | A1 |
| 20140243224 | Barnard et al. | Aug 2014 | A1 |
| 20140270435 | Dunn | Sep 2014 | A1 |
| 20140274731 | Raymond et al. | Sep 2014 | A1 |
| 20140296081 | Diehn et al. | Oct 2014 | A1 |
| 20140323330 | Glezer et al. | Oct 2014 | A1 |
| 20140342921 | Weiner | Nov 2014 | A1 |
| 20140378345 | Hindson et al. | Dec 2014 | A1 |
| 20150000854 | Gann-Fetter et al. | Jan 2015 | A1 |
| 20150005447 | Berti et al. | Jan 2015 | A1 |
| 20150051085 | Vogelstein et al. | Feb 2015 | A1 |
| 20150072867 | Soldatov | Mar 2015 | A1 |
| 20150087027 | Makarov et al. | Mar 2015 | A1 |
| 20150125053 | Vieveli et al. | May 2015 | A1 |
| 20150148239 | Jon | May 2015 | A1 |
| 20150219618 | Krishnan et al. | Aug 2015 | A1 |
| 20150246336 | Somoza et al. | Sep 2015 | A1 |
| 20150292988 | Bharadwaj et al. | Oct 2015 | A1 |
| 20150344942 | Frisen et al. | Dec 2015 | A1 |
| 20150376609 | Hindson et al. | Dec 2015 | A1 |
| 20160003812 | Porreca et al. | Jan 2016 | A1 |
| 20160019337 | Roberts et al. | Jan 2016 | A1 |
| 20160024555 | Church et al. | Jan 2016 | A1 |
| 20160024576 | Chee | Jan 2016 | A1 |
| 20160033496 | Chou et al. | Feb 2016 | A1 |
| 20160108458 | Frei et al. | Apr 2016 | A1 |
| 20160122817 | Jarosz et al. | May 2016 | A1 |
| 20160138091 | Chee et al. | May 2016 | A1 |
| 20160145677 | Chee et al. | May 2016 | A1 |
| 20160194692 | Gore et al. | Jul 2016 | A1 |
| 20160253584 | Fodor et al. | Sep 2016 | A1 |
| 20160289669 | Fan et al. | Oct 2016 | A1 |
| 20160289740 | Fu et al. | Oct 2016 | A1 |
| 20160298180 | Chee | Oct 2016 | A1 |
| 20160299165 | Zhou | Oct 2016 | A1 |
| 20160304952 | Boyden et al. | Oct 2016 | A1 |
| 20160305856 | Boyden et al. | Oct 2016 | A1 |
| 20160333403 | Chee | Nov 2016 | A1 |
| 20160369329 | Cai et al. | Dec 2016 | A1 |
| 20160376642 | Landegren et al. | Dec 2016 | A1 |
| 20170009278 | Söderberg et al. | Jan 2017 | A1 |
| 20170016053 | Beechem et al. | Jan 2017 | A1 |
| 20170016909 | Beechem et al. | Jan 2017 | A1 |
| 20170029872 | Bhattacharyya et al. | Feb 2017 | A1 |
| 20170029875 | Zhang et al. | Feb 2017 | A1 |
| 20170058339 | Chee | Mar 2017 | A1 |
| 20170058340 | Chee | Mar 2017 | A1 |
| 20170058345 | Chee | Mar 2017 | A1 |
| 20170067096 | Wassie et al. | Mar 2017 | A1 |
| 20170081489 | Rodriques et al. | Mar 2017 | A1 |
| 20170088881 | Chee | Mar 2017 | A1 |
| 20170089811 | Tillberg et al. | Mar 2017 | A1 |
| 20170101672 | Luo et al. | Apr 2017 | A1 |
| 20170166962 | van Eijk et al. | Jun 2017 | A1 |
| 20170220733 | Zhuang et al. | Aug 2017 | A1 |
| 20170233722 | Seelig et al. | Aug 2017 | A1 |
| 20170241911 | Rockel et al. | Aug 2017 | A1 |
| 20170242020 | Yamauchi et al. | Aug 2017 | A1 |
| 20170253918 | Kohman | Sep 2017 | A1 |
| 20170275669 | Weissleder et al. | Sep 2017 | A1 |
| 20170283860 | Kool et al. | Oct 2017 | A1 |
| 20170335297 | Ha et al. | Nov 2017 | A1 |
| 20170335410 | Driscoll et al. | Nov 2017 | A1 |
| 20170343545 | Hadrup et al. | Nov 2017 | A1 |
| 20170349940 | Morin et al. | Dec 2017 | A1 |
| 20180051322 | Church et al. | Feb 2018 | A1 |
| 20180052081 | Kohman | Feb 2018 | A1 |
| 20180057873 | Zhou et al. | Mar 2018 | A1 |
| 20180074039 | Soper et al. | Mar 2018 | A1 |
| 20180080876 | Rockel et al. | Mar 2018 | A1 |
| 20180094316 | Scott et al. | Apr 2018 | A1 |
| 20180095067 | Huff et al. | Apr 2018 | A1 |
| 20180104694 | Huff et al. | Apr 2018 | A1 |
| 20180105808 | Mikkelsen et al. | Apr 2018 | A1 |
| 20180112209 | Eshoo | Apr 2018 | A1 |
| 20180112261 | Van Driel et al. | Apr 2018 | A1 |
| 20180114316 | Lele et al. | Apr 2018 | A1 |
| 20180127817 | Borchert et al. | May 2018 | A1 |
| 20180156784 | Usmani et al. | Jun 2018 | A1 |
| 20180163265 | Zhang et al. | Jun 2018 | A1 |
| 20180179591 | van Eijk | Jun 2018 | A1 |
| 20180180601 | Pedersen et al. | Jun 2018 | A1 |
| 20180201925 | Steemers et al. | Jul 2018 | A1 |
| 20180201980 | Chee et al. | Jul 2018 | A1 |
| 20180208967 | Larman et al. | Jul 2018 | A1 |
| 20180216161 | Chen et al. | Aug 2018 | A1 |
| 20180216162 | Belhocine et al. | Aug 2018 | A1 |
| 20180217094 | Herr et al. | Aug 2018 | A1 |
| 20180237864 | Imler et al. | Aug 2018 | A1 |
| 20180245142 | So et al. | Aug 2018 | A1 |
| 20180247017 | van Eijk et al. | Aug 2018 | A1 |
| 20180251825 | Stoeckius | Sep 2018 | A1 |
| 20180251833 | Daugharthy et al. | Sep 2018 | A1 |
| 20180257075 | Yellen et al. | Sep 2018 | A1 |
| 20180282803 | Belgrader et al. | Oct 2018 | A1 |
| 20180291439 | van Eijk et al. | Oct 2018 | A1 |
| 20180305681 | Jovanovich et al. | Oct 2018 | A1 |
| 20180320226 | Church et al. | Nov 2018 | A1 |
| 20190017106 | Frisen et al. | Jan 2019 | A1 |
| 20190024153 | Frisen et al. | Jan 2019 | A1 |
| 20190024154 | Frisen et al. | Jan 2019 | A1 |
| 20190032121 | Daugharthy et al. | Jan 2019 | A1 |
| 20190055594 | Samusik et al. | Feb 2019 | A1 |
| 20190064173 | Bharadwaj et al. | Feb 2019 | A1 |
| 20190071796 | Parikh et al. | Mar 2019 | A1 |
| 20190085324 | Regev et al. | Mar 2019 | A1 |
| 20190112599 | Church et al. | Apr 2019 | A1 |
| 20190119735 | Deisseroth et al. | Apr 2019 | A1 |
| 20190135774 | Orbai | May 2019 | A1 |
| 20190155835 | Daugharthy et al. | May 2019 | A1 |
| 20190177718 | Church et al. | Jun 2019 | A1 |
| 20190177777 | Chee | Jun 2019 | A1 |
| 20190177778 | Chee | Jun 2019 | A1 |
| 20190177789 | Hindson et al. | Jun 2019 | A1 |
| 20190177800 | Boutet et al. | Jun 2019 | A1 |
| 20190194709 | Church et al. | Jun 2019 | A1 |
| 20190203275 | Friesen et al. | Jul 2019 | A1 |
| 20190218276 | Regev et al. | Jul 2019 | A1 |
| 20190218608 | Daugharthy et al. | Jul 2019 | A1 |
| 20190262831 | West et al. | Aug 2019 | A1 |
| 20190264268 | Frisen et al. | Aug 2019 | A1 |
| 20190264270 | Zhuang et al. | Aug 2019 | A1 |
| 20190271028 | Khafizov et al. | Sep 2019 | A1 |
| 20190271030 | Chee | Sep 2019 | A1 |
| 20190271031 | Chee | Sep 2019 | A1 |
| 20190276881 | Zhuang et al. | Sep 2019 | A1 |
| 20190300943 | Chee et al. | Oct 2019 | A1 |
| 20190300944 | Chee et al. | Oct 2019 | A1 |
| 20190300945 | Chee et al. | Oct 2019 | A1 |
| 20190309353 | Chee | Oct 2019 | A1 |
| 20190309354 | Chee | Oct 2019 | A1 |
| 20190309355 | Chee | Oct 2019 | A1 |
| 20190323071 | Chee | Oct 2019 | A1 |
| 20190330617 | Church et al. | Oct 2019 | A1 |
| 20190338353 | Belgrader et al. | Nov 2019 | A1 |
| 20190367982 | Belhocine et al. | Dec 2019 | A1 |
| 20190367997 | Bent et al. | Dec 2019 | A1 |
| 20200002763 | Belgrader et al. | Jan 2020 | A1 |
| 20200002764 | Belgrader et al. | Jan 2020 | A1 |
| 20200010891 | Beechem et al. | Jan 2020 | A1 |
| 20200024641 | Nolan et al. | Jan 2020 | A1 |
| 20200040382 | Beechem et al. | Feb 2020 | A1 |
| 20200048690 | Chee | Feb 2020 | A1 |
| 20200049599 | Alexander et al. | Feb 2020 | A1 |
| 20200061064 | Maciejewski et al. | Feb 2020 | A1 |
| 20200063195 | Chee | Feb 2020 | A1 |
| 20200063196 | Chee | Feb 2020 | A1 |
| 20200080136 | Zhang et al. | Mar 2020 | A1 |
| 20200109443 | Chee | Apr 2020 | A1 |
| 20200140920 | Pierce et al. | May 2020 | A1 |
| 20200140934 | Chee | May 2020 | A1 |
| 20200140935 | Chee | May 2020 | A1 |
| 20200208205 | Chee | Jul 2020 | A1 |
| 20200208206 | Chee | Jul 2020 | A1 |
| 20200224244 | Nilsson et al. | Jul 2020 | A1 |
| 20200224256 | Chee | Jul 2020 | A1 |
| 20200239946 | Dewal | Jul 2020 | A1 |
| 20200256867 | Hennek et al. | Aug 2020 | A1 |
| 20200277663 | Ramachandran Iyer et al. | Sep 2020 | A1 |
| 20200277664 | Frenz | Sep 2020 | A1 |
| 20200283852 | Oliphant et al. | Sep 2020 | A1 |
| 20200299757 | Chee et al. | Sep 2020 | A1 |
| 20200325531 | Chee | Oct 2020 | A1 |
| 20200332368 | Ferree et al. | Oct 2020 | A1 |
| 20200354774 | Church et al. | Nov 2020 | A1 |
| 20200370106 | Chee | Nov 2020 | A1 |
| 20200399687 | Frisen et al. | Dec 2020 | A1 |
| 20200407781 | Schnall-Levin et al. | Dec 2020 | A1 |
| 20210002713 | Chee et al. | Jan 2021 | A1 |
| 20210010068 | Chee et al. | Jan 2021 | A1 |
| 20210010070 | Schnall-Levin et al. | Jan 2021 | A1 |
| 20210017583 | Chee et al. | Jan 2021 | A1 |
| 20210017586 | Chee | Jan 2021 | A1 |
| 20210017587 | Cai et al. | Jan 2021 | A1 |
| 20210062249 | Chee | Mar 2021 | A1 |
| 20210123095 | Chee | Apr 2021 | A1 |
| 20210130883 | Chee et al. | May 2021 | A1 |
| 20210130884 | Chee et al. | May 2021 | A1 |
| 20210140982 | Uytingco | May 2021 | A1 |
| 20210172007 | Chee et al. | Jun 2021 | A1 |
| 20210189475 | Tentori et al. | Jun 2021 | A1 |
| 20210190770 | Delaney et al. | Jun 2021 | A1 |
| 20210198741 | Williams | Jul 2021 | A1 |
| 20210199660 | Williams et al. | Jul 2021 | A1 |
| 20210207202 | Chee | Jul 2021 | A1 |
| 20210214785 | Stoeckius | Jul 2021 | A1 |
| 20210222235 | Chee | Jul 2021 | A1 |
| 20210222241 | Bharadwaj | Jul 2021 | A1 |
| 20210222242 | Ramachandran Iyer | Jul 2021 | A1 |
| 20210222253 | Uytingco | Jul 2021 | A1 |
| 20210223227 | Stoeckius | Jul 2021 | A1 |
| 20210230681 | Patterson et al. | Jul 2021 | A1 |
| 20210230692 | Daugharthy et al. | Jul 2021 | A1 |
| 20210237022 | Bava | Aug 2021 | A1 |
| 20210238664 | Bava | Aug 2021 | A1 |
| 20210238675 | Bava | Aug 2021 | A1 |
| 20210238680 | Bava | Aug 2021 | A1 |
| 20210247316 | Bava | Aug 2021 | A1 |
| 20210255175 | Chee et al. | Aug 2021 | A1 |
| 20210262019 | Alvarado Martinez et al. | Aug 2021 | A1 |
| 20210269864 | Chee | Sep 2021 | A1 |
| 20210270822 | Chee | Sep 2021 | A1 |
| 20210285036 | Yin et al. | Sep 2021 | A1 |
| 20210285046 | Chell et al. | Sep 2021 | A1 |
| 20210292748 | Frisen et al. | Sep 2021 | A1 |
| 20210292822 | Frisen et al. | Sep 2021 | A1 |
| 20210317510 | Chee et al. | Oct 2021 | A1 |
| 20210317524 | Lucero et al. | Oct 2021 | A1 |
| 20210324457 | Ramachandran Iyer et al. | Oct 2021 | A1 |
| 20210332424 | Schnall-Levin | Oct 2021 | A1 |
| 20210332425 | Pfeiffer et al. | Oct 2021 | A1 |
| 20210348221 | Chell et al. | Nov 2021 | A1 |
| 20220002791 | Frisen et al. | Jan 2022 | A1 |
| 20220003755 | Chee | Jan 2022 | A1 |
| 20220010367 | Ramachandran Iyer et al. | Jan 2022 | A1 |
| 20220017951 | Ramachandran Iyer et al. | Jan 2022 | A1 |
| 20220025446 | Shah | Jan 2022 | A1 |
| 20220025447 | Tentori et al. | Jan 2022 | A1 |
| 20220033888 | Schnall-Levin et al. | Feb 2022 | A1 |
| 20220049293 | Frenz et al. | Feb 2022 | A1 |
| 20220049294 | Uytingco et al. | Feb 2022 | A1 |
| 20220064630 | Bent et al. | Mar 2022 | A1 |
| 20220081728 | Williams | Mar 2022 | A1 |
| 20220090058 | Frisen et al. | Mar 2022 | A1 |
| 20220090175 | Uytingco et al. | Mar 2022 | A1 |
| 20220090181 | Gallant et al. | Mar 2022 | A1 |
| 20220098576 | Dadhwal | Mar 2022 | A1 |
| 20220098661 | Chew et al. | Mar 2022 | A1 |
| 20220106632 | Galonska et al. | Apr 2022 | A1 |
| 20220106633 | Engblom et al. | Apr 2022 | A1 |
| 20220112486 | Ramachandran Iyer et al. | Apr 2022 | A1 |
| 20220112545 | Chee | Apr 2022 | A1 |
| 20220119869 | Ramachandran Iyer et al. | Apr 2022 | A1 |
| 20220127659 | Frisen et al. | Apr 2022 | A1 |
| 20220127666 | Katiraee et al. | Apr 2022 | A1 |
| 20220127672 | Stoeckius | Apr 2022 | A1 |
| 20220145361 | Frenz et al. | May 2022 | A1 |
| 20220154255 | Chee et al. | May 2022 | A1 |
| 20220170083 | Khaled et al. | Jun 2022 | A1 |
| 20220195422 | Gallant et al. | Jun 2022 | A1 |
| 20220195505 | Frisen et al. | Jun 2022 | A1 |
| 20220196644 | Chee | Jun 2022 | A1 |
| 20220213526 | Frisen et al. | Jul 2022 | A1 |
| 20220241780 | Tentori et al. | Aug 2022 | A1 |
| 20220267844 | Ramachandran Iyer et al. | Aug 2022 | A1 |
| 20220282329 | Chell et al. | Sep 2022 | A1 |
| 20220290217 | Frenz et al. | Sep 2022 | A1 |
| 20220290219 | Chee | Sep 2022 | A1 |
| 20220298560 | Frisen et al. | Sep 2022 | A1 |
| 20220325325 | Chee et al. | Oct 2022 | A1 |
| 20220326251 | Uytingco et al. | Oct 2022 | A1 |
| 20220333171 | Chee | Oct 2022 | A1 |
| 20220333192 | Uytingco | Oct 2022 | A1 |
| 20220333195 | Schnall-Levin et al. | Oct 2022 | A1 |
| 20220334031 | Delaney et al. | Oct 2022 | A1 |
| 20220348905 | Dadhwal | Nov 2022 | A1 |
| 20220348992 | Stoeckius et al. | Nov 2022 | A1 |
| 20220356464 | Kim et al. | Nov 2022 | A1 |
| 20220364163 | Stahl et al. | Nov 2022 | A1 |
| 20220389491 | Chee | Dec 2022 | A1 |
| 20220389504 | Chew et al. | Dec 2022 | A1 |
| 20220403455 | Ramachandran Iyer et al. | Dec 2022 | A1 |
| 20220404245 | Chell et al. | Dec 2022 | A1 |
| 20230002812 | Stoeckius et al. | Jan 2023 | A1 |
| 20230014008 | Shastry | Jan 2023 | A1 |
| 20230033960 | Gallant et al. | Feb 2023 | A1 |
| 20230034039 | Shahjamali | Feb 2023 | A1 |
| 20230034216 | Bava | Feb 2023 | A1 |
| 20230040363 | Chee | Feb 2023 | A1 |
| 20230042088 | Chee | Feb 2023 | A1 |
| 20230042817 | Mignardi | Feb 2023 | A1 |
| 20230047782 | Tentori et al. | Feb 2023 | A1 |
| 20230056549 | Dadhwal | Feb 2023 | A1 |
| 20230064372 | Chell et al. | Mar 2023 | A1 |
| 20230069046 | Chew et al. | Mar 2023 | A1 |
| 20230077364 | Patterson et al. | Mar 2023 | A1 |
| 20230080543 | Katiraee et al. | Mar 2023 | A1 |
| 20230081381 | Chew et al. | Mar 2023 | A1 |
| 20230100497 | Frisen et al. | Mar 2023 | A1 |
| 20230107023 | Chee | Apr 2023 | A1 |
| 20230111225 | Chew et al. | Apr 2023 | A1 |
| 20230113230 | Kim et al. | Apr 2023 | A1 |
| 20230135010 | Tentori et al. | May 2023 | A1 |
| 20230143569 | Iyer et al. | May 2023 | A1 |
| 20230145575 | Gallant et al. | May 2023 | A1 |
| 20230151412 | Chee | May 2023 | A1 |
| 20230159994 | Chee | May 2023 | A1 |
| 20230159995 | Iyer et al. | May 2023 | A1 |
| 20230160008 | Chell et al. | May 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 2003200718 | Oct 2006 | AU |
| 1273609 | Nov 2000 | CN |
| 1425133 | Jun 2003 | CN |
| 1537953 | Oct 2004 | CN |
| 1680604 | Oct 2005 | CN |
| 1749752 | Mar 2006 | CN |
| 1898398 | Jan 2007 | CN |
| 1981188 | Jun 2007 | CN |
| 101142325 | Mar 2008 | CN |
| 101221182 | Jul 2008 | CN |
| 101522915 | Sep 2009 | CN |
| 102851369 | Jan 2013 | CN |
| 104513785 | Apr 2015 | CN |
| 0901631 | Mar 1999 | EP |
| 0961110 | Dec 1999 | EP |
| 1782737 | May 2007 | EP |
| 1878502 | Jan 2008 | EP |
| 1910562 | Apr 2008 | EP |
| 1923471 | May 2008 | EP |
| 1929039 | Jun 2008 | EP |
| 1966393 | Sep 2008 | EP |
| 2002017 | Dec 2008 | EP |
| 2292788 | Mar 2011 | EP |
| 2302070 | Mar 2011 | EP |
| 2350648 | Aug 2011 | EP |
| 2363504 | Sep 2011 | EP |
| 2580351 | Apr 2013 | EP |
| 2789696 | Oct 2014 | EP |
| 2881465 | Jun 2015 | EP |
| 2963127 | Jan 2016 | EP |
| 3013984 | May 2016 | EP |
| 3045544 | Jul 2016 | EP |
| 3239304 | Nov 2017 | EP |
| 3541956 | Sep 2019 | EP |
| 3425053 | Aug 2020 | EP |
| 2520765 | Jun 2015 | GB |
| 2007-014297 | Jan 2007 | JP |
| 2007-074967 | Mar 2007 | JP |
| 2009-036694 | Feb 2009 | JP |
| 2011-182702 | Sep 2011 | JP |
| 2013-544498 | Dec 2013 | JP |
| 2014-217381 | Nov 2014 | JP |
| 10-2009-0000812 | Jan 2009 | KR |
| 10-2009-0081260 | Jul 2009 | KR |
| 2145635 | Feb 2000 | RU |
| 2270254 | Feb 2006 | RU |
| 2410439 | Jan 2011 | RU |
| WO 1989010977 | Nov 1989 | WO |
| WO 1991006678 | May 1991 | WO |
| WO 1993004199 | Mar 1993 | WO |
| WO 1995023875 | Sep 1995 | WO |
| WO 1995025116 | Sep 1995 | WO |
| WO 1995035505 | Dec 1995 | WO |
| WO 1997031256 | Aug 1997 | WO |
| WO 1998044151 | Oct 1998 | WO |
| WO 1999032654 | Jul 1999 | WO |
| WO 1999044062 | Sep 1999 | WO |
| WO 1999044063 | Sep 1999 | WO |
| WO 1999063385 | Dec 1999 | WO |
| WO 2000017390 | Mar 2000 | WO |
| WO 2000018957 | Apr 2000 | WO |
| WO 2000024940 | May 2000 | WO |
| WO 2001006012 | Jan 2001 | WO |
| WO 2001007915 | Feb 2001 | WO |
| WO 2001009363 | Feb 2001 | WO |
| WO 2001012862 | Feb 2001 | WO |
| WO 2001042796 | Jun 2001 | WO |
| WO 2001046402 | Jun 2001 | WO |
| WO 2001059161 | Aug 2001 | WO |
| WO 2001090415 | Nov 2001 | WO |
| WO 2001096608 | Dec 2001 | WO |
| WO 2002024952 | Mar 2002 | WO |
| WO 2002040874 | May 2002 | WO |
| WO 2002059355 | Aug 2002 | WO |
| WO 2002059364 | Aug 2002 | WO |
| WO 2002077283 | Oct 2002 | WO |
| WO 2002088396 | Nov 2002 | WO |
| WO 2003002979 | Jan 2003 | WO |
| WO 2003003810 | Jan 2003 | WO |
| WO 2003008538 | Jan 2003 | WO |
| WO 2003010176 | Feb 2003 | WO |
| WO 2003102233 | Dec 2003 | WO |
| WO 2003106973 | Dec 2003 | WO |
| WO 2004015080 | Feb 2004 | WO |
| WO 2004028955 | Apr 2004 | WO |
| WO 2004055159 | Jul 2004 | WO |
| WO 2004067759 | Aug 2004 | WO |
| WO 2004081225 | Sep 2004 | WO |
| WO 2004108268 | Dec 2004 | WO |
| WO 2005007814 | Jan 2005 | WO |
| WO 2005010145 | Feb 2005 | WO |
| WO 2005026387 | Mar 2005 | WO |
| WO 2005042759 | May 2005 | WO |
| WO 2005065814 | Jul 2005 | WO |
| WO 2005067648 | Jul 2005 | WO |
| WO 2005113804 | Dec 2005 | WO |
| WO 2006020515 | Feb 2006 | WO |
| WO 2006056861 | Jun 2006 | WO |
| WO 2006064199 | Jun 2006 | WO |
| WO 2006065597 | Jun 2006 | WO |
| WO 2006074351 | Jul 2006 | WO |
| WO 2006084130 | Aug 2006 | WO |
| WO 2006117541 | Nov 2006 | WO |
| WO 2006124771 | Nov 2006 | WO |
| WO 2006137733 | Dec 2006 | WO |
| WO 2007000669 | Jan 2007 | WO |
| WO 2007010251 | Jan 2007 | WO |
| WO 2007030373 | Mar 2007 | WO |
| WO 2007037678 | Apr 2007 | WO |
| WO 2007041689 | Apr 2007 | WO |
| WO 2007060599 | May 2007 | WO |
| WO 2007073165 | Jun 2007 | WO |
| WO 2007073171 | Jun 2007 | WO |
| WO 2007073271 | Jun 2007 | WO |
| WO 2007076128 | Jul 2007 | WO |
| WO 2007076726 | Jul 2007 | WO |
| WO 2007114693 | Oct 2007 | WO |
| WO 2007120241 | Oct 2007 | WO |
| WO 2007139766 | Dec 2007 | WO |
| WO 2007145612 | Dec 2007 | WO |
| WO 2008022332 | Feb 2008 | WO |
| WO 2008069906 | Jun 2008 | WO |
| WO 2008157801 | Dec 2008 | WO |
| WO 2009032167 | Mar 2009 | WO |
| WO 2009036525 | Mar 2009 | WO |
| WO 2009152928 | Dec 2009 | WO |
| WO 2009156725 | Dec 2009 | WO |
| WO 2010019826 | Feb 2010 | WO |
| WO 2010027870 | Mar 2010 | WO |
| WO 2010053587 | May 2010 | WO |
| WO 2010126614 | Nov 2010 | WO |
| WO 2010127186 | Nov 2010 | WO |
| WO 2011008502 | Jan 2011 | WO |
| WO 2011014879 | Feb 2011 | WO |
| WO 2011062933 | May 2011 | WO |
| WO 2011068088 | Jun 2011 | WO |
| WO 2011071943 | Jun 2011 | WO |
| WO 2011094669 | Aug 2011 | WO |
| WO 2011102903 | Aug 2011 | WO |
| WO 2011127006 | Oct 2011 | WO |
| WO 2011127099 | Oct 2011 | WO |
| WO 2011143583 | Nov 2011 | WO |
| WO 2011155833 | Dec 2011 | WO |
| WO 2012022975 | Feb 2012 | WO |
| WO 2012048341 | Apr 2012 | WO |
| WO 2012049316 | Apr 2012 | WO |
| WO 2012058096 | May 2012 | WO |
| WO 2012071428 | May 2012 | WO |
| WO 2012083225 | Jun 2012 | WO |
| WO 2012129242 | Sep 2012 | WO |
| WO 2012139110 | Oct 2012 | WO |
| WO 2012140224 | Oct 2012 | WO |
| WO 2012142213 | Oct 2012 | WO |
| WO 2012148477 | Nov 2012 | WO |
| WO 2012159089 | Nov 2012 | WO |
| WO 2012168003 | Dec 2012 | WO |
| WO 2013033271 | Mar 2013 | WO |
| WO 2013090390 | Jun 2013 | WO |
| WO 2013123442 | Aug 2013 | WO |
| WO 2013131962 | Sep 2013 | WO |
| WO 2013138510 | Sep 2013 | WO |
| WO 2013142389 | Sep 2013 | WO |
| WO 2013150082 | Oct 2013 | WO |
| WO 2013150083 | Oct 2013 | WO |
| WO 2013155119 | Oct 2013 | WO |
| WO 2013158936 | Oct 2013 | WO |
| WO 2014044724 | Mar 2014 | WO |
| WO 2014060483 | Apr 2014 | WO |
| WO 2014085725 | Jun 2014 | WO |
| WO 2014128129 | Aug 2014 | WO |
| WO 2014130576 | Aug 2014 | WO |
| WO 2014142841 | Sep 2014 | WO |
| WO 2014144713 | Sep 2014 | WO |
| WO 2014152397 | Sep 2014 | WO |
| WO 2014200767 | Dec 2014 | WO |
| WO 2014210223 | Dec 2014 | WO |
| WO 2014210225 | Dec 2014 | WO |
| WO 2014210233 | Dec 2014 | WO |
| WO 2015031691 | Mar 2015 | WO |
| WO 2015069374 | May 2015 | WO |
| WO 2015085275 | Jun 2015 | WO |
| WO 2015117163 | Aug 2015 | WO |
| WO 2015128272 | Sep 2015 | WO |
| WO 2015161173 | Oct 2015 | WO |
| WO 2016040476 | Mar 2016 | WO |
| WO 2016044313 | Mar 2016 | WO |
| WO 2016057552 | Apr 2016 | WO |
| WO 2016077763 | May 2016 | WO |
| WO 2016126871 | Aug 2016 | WO |
| WO 2016138496 | Sep 2016 | WO |
| WO 2016138500 | Sep 2016 | WO |
| WO 2016162309 | Oct 2016 | WO |
| WO 2016166128 | Oct 2016 | WO |
| WO 2016168825 | Oct 2016 | WO |
| WO 2016172362 | Oct 2016 | WO |
| WO 2017015097 | Jan 2017 | WO |
| WO 2017015099 | Jan 2017 | WO |
| WO 2017019456 | Feb 2017 | WO |
| WO 2017019481 | Feb 2017 | WO |
| WO 2017027367 | Feb 2017 | WO |
| WO 2017027368 | Feb 2017 | WO |
| WO 2017048871 | Mar 2017 | WO |
| WO 2017075265 | May 2017 | WO |
| WO 2017075293 | May 2017 | WO |
| WO 2017112957 | Jun 2017 | WO |
| WO 2017096158 | Jul 2017 | WO |
| WO 2017124101 | Jul 2017 | WO |
| WO 2017144338 | Aug 2017 | WO |
| WO 2017147483 | Aug 2017 | WO |
| WO 2017156336 | Sep 2017 | WO |
| WO 2017177308 | Oct 2017 | WO |
| WO 2017184984 | Oct 2017 | WO |
| WO 2017192633 | Nov 2017 | WO |
| WO 2017222453 | Dec 2017 | WO |
| WO 2018022809 | Feb 2018 | WO |
| WO 2018023068 | Feb 2018 | WO |
| WO 2018045181 | Mar 2018 | WO |
| WO 2018045186 | Mar 2018 | WO |
| WO 2018057999 | Mar 2018 | WO |
| WO 2018064640 | Apr 2018 | WO |
| WO 2018075436 | Apr 2018 | WO |
| WO 2018075693 | Apr 2018 | WO |
| WO 2018085599 | May 2018 | WO |
| WO 2018091676 | May 2018 | WO |
| WO 2018102577 | Jun 2018 | WO |
| WO 2018107054 | Jun 2018 | WO |
| WO 2018136397 | Jul 2018 | WO |
| WO 2018136856 | Jul 2018 | WO |
| WO 2018144582 | Aug 2018 | WO |
| WO 2018148471 | Aug 2018 | WO |
| WO 2020053655 | Mar 2020 | WO |
| WO 2020061064 | Mar 2020 | WO |
| WO 2020061066 | Mar 2020 | WO |
| WO 2020061108 | Mar 2020 | WO |
| WO 2020076979 | Apr 2020 | WO |
| WO 2020123305 | Jun 2020 | WO |
| WO 2020123309 | Jun 2020 | WO |
| WO 2020123311 | Jun 2020 | WO |
| WO 2020123316 | Jun 2020 | WO |
| WO 2020123317 | Jun 2020 | WO |
| WO 2020123318 | Jun 2020 | WO |
| WO 2020123319 | Jun 2020 | WO |
| WO 2016126882 | Aug 2020 | WO |
| WO 2020167862 | Aug 2020 | WO |
| WO 2020176788 | Sep 2020 | WO |
| WO 2020176882 | Sep 2020 | WO |
| WO 2020190509 | Sep 2020 | WO |
| WO 2020198071 | Oct 2020 | WO |
| WO 2020219901 | Oct 2020 | WO |
| WO 2021091611 | May 2021 | WO |
| WO 2021092433 | May 2021 | WO |
| WO 2021097255 | May 2021 | WO |
| WO 2021133842 | Jul 2021 | WO |
| WO 2021133849 | Jul 2021 | WO |
| WO 2021142233 | Jul 2021 | WO |
| WO 2021168261 | Aug 2021 | WO |
| WO 2021168278 | Aug 2021 | WO |
| WO 2021207610 | Oct 2021 | WO |
| WO 2021216708 | Oct 2021 | WO |
| WO 2021225900 | Nov 2021 | WO |
| WO 2021236625 | Nov 2021 | WO |
| WO 2021236929 | Nov 2021 | WO |
| WO 2021237056 | Nov 2021 | WO |
| WO 2021237087 | Nov 2021 | WO |
| WO 2021242834 | Dec 2021 | WO |
| WO 2021247543 | Dec 2021 | WO |
| WO 2021247568 | Dec 2021 | WO |
| WO 2021252499 | Dec 2021 | WO |
| WO 2021252576 | Dec 2021 | WO |
| WO 2021252591 | Dec 2021 | WO |
| WO 2021263111 | Dec 2021 | WO |
| WO 2022025965 | Feb 2022 | WO |
| WO 2022060798 | Mar 2022 | WO |
| WO 2022060953 | Mar 2022 | WO |
| WO 2022087273 | Apr 2022 | WO |
| WO 2022098810 | May 2022 | WO |
| WO 2022099037 | May 2022 | WO |
| WO 2022103712 | May 2022 | WO |
| WO 2022109181 | May 2022 | WO |
| WO 2022140028 | Jun 2022 | WO |
| WO 2022147005 | Jul 2022 | WO |
| WO 2022147296 | Jul 2022 | WO |
| WO 2022164615 | Aug 2022 | WO |
| WO 2022178267 | Aug 2022 | WO |
| WO 2022198068 | Sep 2022 | WO |
| WO 2022221425 | Oct 2022 | WO |
| WO 2022226057 | Oct 2022 | WO |
| WO 2022236054 | Nov 2022 | WO |
| WO 2022256503 | Dec 2022 | WO |
| WO 2022271820 | Dec 2022 | WO |
| WO 2023287765 | Jan 2023 | WO |
| WO 2023018799 | Feb 2023 | WO |
| WO 2023034489 | Mar 2023 | WO |
| WO 2023086880 | May 2023 | WO |
| Entry |
|---|
| U.S. Appl. No. 16/353,937, filed Mar. 14, 2019, Frisen et al. |
| U.S. Appl. No. 17/707,189, filed Mar. 29, 2022, Chell et al. |
| U.S. Appl. No. 60/416,118, filed Oct. 3, 2002, Fan et al. |
| U.S. Appl. No. 61/839,313, filed Jun. 25, 2013, Chee et al. |
| U.S. Appl. No. 61/839,320, filed Jun. 25, 2013, Chee et al. |
| U.S. Appl. No. 61/902,105, filed Nov. 8, 2013, Kozlov et al. |
| U.S. Appl. No. 62/839,575, filed Apr. 26, 2019, Bent et al. |
| [No Author Listed], “HuSNP Mapping Assay User's Manual,” Affymetrix Part No. 90094 (Affymetrix, Santa Clara, Calif,), GeneChip, 2000, 104 pages. |
| [No Author Listed], “Microarray technologies have excellent possibilities in genomics-related researches,” Science Tools From Amersham Pharmacia Biotech, 1998, 3(4): 8 pages (with English Translation). |
| [No Author Listed], “Proseek® Multiplex 96x96 User Manual,” Olink Proteomics, Olink Bioscience, Uppsala, Sweden, 2017, 20 pages. |
| Abaan et al., “The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology,” Cancer Res., Jul. 2013, 73(14):4372-82. |
| Adamson et al., “A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response,” Cell, Dec. 2016, 167(7):1867-1882.e21. |
| Adessi et al., “Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms,” Nucl. Acids Res., Oct. 2000, 28(20):E87, 8 pages. |
| Adiconis et al., “Comparative analysis of RNA sequencing methods for degraded or low-input samples,” Nat Methods, Jul. 2013, 10(7):623-9. |
| Affymetrix, “GeneChip Human Genome U133 Set,” retrieved from the Internet: on the World Wide Web at affymetrix.com/support/technical/datasheets/hgul33_datasheet.pdf, retrieved on Feb. 26, 2003. |
| Affymetrix, “Human Genome U95Av2,” Internet Citation, retrieved from the internet: on the World Wide Web affymetrix.com, retrieved on Oct. 2, 2002. |
| Agasti et al., “Photocleavable DNA Barcode-Antibody Conjugates Allow Sensitive and Multiplexed Protein Analysis in Single Cells,” Journal of the American Chemical Society, Oct. 23, 2012, 134(45):18499-18502. |
| Agbavwe et al., “Efficiency, error and yield in light-directed maskless synthesis of DNA microarrays,” Journal of Nanobiotechnology, Dec. 2011, 9:57, 17 pages. |
| Agilent.com [online], “The First Comprehensive Methylation Discovery System,” Dec. 2015, retrieved on Jan. 21, 2022, retrieved from URL<https://www.agilent.com/cs/library/datasheets/Public/SureselectXTHumanMethyl-Seq-5990-9856EN.pdf>, 2 pages. |
| Ahern et al., “Biochemical, Reagents Kits Offer Scientists Good Return on Investment,” The Scientist, 1995, 9(15):20, 7 pages. |
| Ahern, “Biochemical, Reagents Kits Offer Scientists Good Return on Investment,” The Scientist, Jul. 1995, 9(15):20, 7 pages. |
| Ahlfen et al., “Determinants of RNA quality from FFPE samples,” PLoS One, Dec. 2007, 2(12):e1261, 7 pages. |
| Ahmed et al., “Hydrogel: Preparation, characterization, and applications: A review,” J Adv Res., Mar. 2015, 6(2):105-21. |
| Akeroyd, “Click chemistry for the preparation of advanced macromolecular architectures,” Stellenbosch University, PhD Dissertation, Mar. 2010, 138 pages. |
| Albretsen et al., “Applications of magnetic beads with covalently attached oligonucleotides in hybridization: Isolation and detection of specific measles virus mRNA from a crude cell lysate”, Anal. Biochem. 189: 40-50, 1990. |
| Albretsen et al., “Optimal conditions for hybridization with oligonucleotides: a study with myc-oncogene DNA probes,” Anal Biochem., Apr. 1988, 170(1):193-202. |
| Ali et al., “Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study,” PLoS Med., Dec. 2016, 13(12):e1002194, 24 pages. |
| Allawi and SantaLucia, “Thermodynamics and NMR of Internal GâT Mismatches in DNA,” Biochemistry, 1996, 36:10581-10594. |
| Altaras et al., “Production and formulation of adenovirus vectors,” Adv Biochem Eng Biotechnol., Nov. 2005, 99:193-260. |
| Altschul et al., “Basic local alignment search tool,” J. Mol. Biol., Oct. 5, 1990, 215(3):403-410. |
| Amidzadeh et al., “Assessment of different permeabilization methods of minimizing damage to the adherent cells for detection of intracellular RNA by flow cytometry,” Avicenna J Med Biotechnol., Jan. 2014, 6(1):38-46. |
| Anderson et al., “Microarrayed Compound Screening to Identify Activators and Inhibitors of AMP-Activated Protein Kinase,” J. of Biomolecular Screening, 2004, 9:112. |
| Andersson et al., “Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics.,” J Histochem Cytochem., 4(12): 1413-1423, 2006. |
| Andresen et al., “Deciphering the Antibodyome—Peptide Arrays for Serum Antibody Biomarker Diagnostics,” Current Proteomics, 6(1), 1-12, 2009. |
| Andresen et al., “Helicase-dependent amplification: use in OnChip amplification and potential for point-of-care diagnostics,” Expert Rev Mol Diagn., Oct. 2009, 9(7):645-650. |
| Angenendt et al., “Cell-free Protein expression and functional assay in a nanowell chip format,” Analytical Chemistry, 2004, 76(7):1844-49. |
| Angenendt et al., “Generation of High Density Protein Microarrays by Cell-free in Situ Expression of Unpurified PCR Products,” Molecular and Cellular Proteomics, (2006) Ch. 5.9, pp. 1658-1666. |
| Appella, “Non-natural nucleic acids for synthetic biology,” Current Opinion in Chemical Biology, Dec. 2009, 13(5-6): 687-696. |
| Archer et al., “Selective and flexible depletion of problematic sequences from RNA-seq libraries at the cDNA stage,” BMC Genomics, May 2014, 15(1):401, 9 pages. |
| Armani et al., “2D-PCR: a method of mapping DNA in tissue sections,” Lab on a Chip, 2009, 9(24):3526-34. |
| Arslan et al., “Engineering of a superhelicase through conformational control (Supplementary Materials),” Science, Apr. 17, 2015, 348(6232):344-347 18 pages. |
| Arslan et al., “Engineering of a superhelicase through conformational control,” Science, Apr. 17, 2015, 348(6232):344-347. |
| Asp et al., “Spatial detection of fetal marker genes expressed at low level in adult human heart tissue”, Scientific Reports, 7: 12941, 10 pages, 2017. |
| Atkinson and Wells, “An Updated Protocol for High Throughput Plant Tissue Sectioning.”, Front Plant Sci, 8: 1721, 2017. |
| Atkinson, Overview of Translation: Lecture Manuscript, U of Texas (2000) DD. 6.1-6.8. |
| Azioune et al., “Simple and rapid process for single cell micro-patterning,” Lab Chip, Jun. 2009, 9(11):1640-1642. |
| Bains et al, “A Novel Method for Nucleic Acid Sequence Determination”, Journal of Theoretical Biology, 1988, 135(3), 303-7. |
| Baird et al., “Rapid SNP Discovery and Genetic Mapping Using Sequenced RAD markers,” PLOS One, 2008, 3(10):e3376. |
| Bajar et al., “A Guide to Fluorescent Protein FRET Pairs,” Sensors (Basel), Sep. 2016, 16(9):1488, 24 pages. |
| Balakrishnan et al., “Flap endonuclease 1,” Annu Rev Biochem., Jun. 2013, 82:119-138. |
| Baner et al., “Signal amplification of padlock probes by rolling circle replication,” Nucleic Acids Res., 1998, 26(22):5073-5078. |
| Banerjee et al., “Viral glycoproteins: biological role and application in diagnosis,” Virusdisease, Mar. 2016, 27(1):1-11. |
| Barbie et al., “Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1,” Nature, Nov. 2009, 462(7269):108-12. |
| Barnes, “PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates.,” Proc. Natl. Acad. Sci USA, 91: 2216-2220, 1994. |
| Baugh et al., “Quantitative analysis of mRNA amplification by in vitro transcription,” Nucleic Acids Res., 2001, 29:5:e29. |
| Beattie et al., “Advances in genosensor research,” Clin Chem., May 1995, 41(5):700-6. |
| Bechara et al., “Cell-penetrating peptides: 20 years later, where do we stand?,” FEBS Lett., Jun. 2013, 587(12):1693-702. |
| Beier et al., “Versatile derivatisation of solid support media for covalent bonding on DNA-microchips,” Nucleic Acids Res., May 1999, 27(9):1970-7. |
| Bell, “A Simple Way to Treat PCR Products Prior to Sequencing Using ExoSAP-IT,” Biotechniques, 2008, vol. 44, No. 6. |
| Bentley et al, “Accurate whole human genome sequencing using reversible terminator chemistry”, Nature, 2008, 456:53-59. |
| Berger et al., “Universal bases for hybridization, replication and chain termination,” Nucleic Acid Res., Aug. 2000, 28(15):2911-2914. |
| Bielas et al., “Human cancers express a mutator phenotype,” Proc. Natl. Acad. Sci. USA, 2006, 103(48): 18238-18242. |
| Bielas et al., “Quantification of random genomic mutations,” Nat. Methods, 2005, 2(4):285-290. |
| Biol.wwu.edu [online], “Principles of Di-Base Sequencing and the Advantages of Color Space Analysis in the SOLiD System,” 2008, retrieved on Mar. 11, 2022, retrieved from URL<https://biol.wwu.edu//young/470/stuff/abi-solid.pdf>, 4 pages. |
| Birney, et al, “Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project,” Nature, 2007, 447:799-816. |
| Blair et al., “Microarray temperature optimization using hybridization kinetics,” Methods Mol Biol., 2009, 529:171-96. |
| Blanchard et al., “High-density oligonucleotide arrays,” Biosensors & Bioelectronics, 1996, 11(6-7):687-690. |
| Blanco et al., “A practical approach to FRET-based PNA fluorescence in situ hybridization,” Methods, Dec. 2010, 52(4):343-51. |
| Blandini et al., “Animal models of Parkinson's disease,” FEBS J., Apr. 2012, 279(7):1156-66. |
| Blokzijl et al., “Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine,” J Intern. Med., 2010, 268:232-245. |
| Blow, “Tissue Issues,” Nature, 448(23), 959-962, 2007. |
| Boeke et al., “Transcription and reverse transcription of retrotransposons,” Annu Rev Microbiol, 1989, 43:403-34. |
| Bolotin et al., “MiXCR: software for comprehensive adaptive immunity profiling,” Nat Methods., May 2015, 12(5):380-1. |
| Bonfield et al., “The application of numerical estimates of base calling accuracy to DNA sequencing projects,” Nucleic Acids Research, 1995, 23(8):1406-1410. |
| Bootman et al., “Loading fluorescent Ca2+ indicators into living cells,” Cold Spring Harb Protoc., Feb. 2013, 2013(2):122-5. |
| Bos et al., “In Vitro Evaluation of DNA-DNA Hybridization as a Two-Step Approach in Radioimmunotherapy of Cancer,” Cancer Res., Jul. 1, 1994, 54(13):3479-3486. |
| Boulé et al., “Terminal deoxynucleotidyl transferase indiscriminately incorporates ribonucleotides and deoxyribonucleotides,” J Biol Chem., Aug. 2001, 276(33):31388-93. |
| Boulgakov et al., “From Space to Sequence and Back Again: Iterative DNA Proximity Ligation and its Applications to DNA-Based Imaging”, bioRxiv, 24 pages, 2018. |
| Boutros et al., “The art and design of genetic screens: RNA interference,” Nat Rev Genet., Jul. 2008, 9(7):554-66. |
| Bowtell, “The genesis and evolution of high-grade serous ovarian cancer,” Nat. Rev. Cancer, 2010, (11 ):803-808 Abstract. |
| Brandon et al., “Mitochondrial mutations in cancer,” Oncogene, 2006, 25(34):4647-4662. |
| Brenner et al, “In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs,” Proc. Natl. Acad. Sci. USA, 2000, 97, 1665-1670. |
| Brenner et al., “Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays”, Nat. Biotech, 18: 630-634, 2000. |
| Brockman et al., “Quality scores and SNP detection in sequencing-by-synthesis systems,” Methods, 2008, 18:763-770. |
| Brow, “35—The Cleavase I enzyme for mutation and polymorphism scanning,” PCR Applications Protocols for Functional Genomics, 1999, pp. 537-550. |
| Brown et al., “Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein,” Proc Natl Acad Sci USA, Apr. 1989, 86(8):2525-9. |
| Buenrostro et al., “Transposition of native chromatin for multimodal regulatory analysis and personal epigenomics,” Nat Methods, Dec. 2013, 10(12):1213-1218. |
| Bugada et al., “Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients,” Biomed Res Int., 2014, 2014:142425, 12 pages. |
| Bullard et al., “Direct comparison of nick-joining activity of the nucleic acid ligases from bacteriophage T4,” Biochem. J. 2006, 398:135-144. |
| Burgess, “A space for transcriptomics”, Nature Reviews Genetics | Published online Jul. 15, 2016; doi:10.1038/nrg.2016.94. |
| Burgess, “Finding structure in gene expression”, Nature Reviews Genetics | Published online Apr. 13, 2018; doi:10.1038/nrg.2018.19. |
| Burns et al., “Well-less, gel-permeation formats for ultra-HTS,” DDT, 2001, 6(12):S40-S47. |
| Burton et al., “Coverslip Mounted-Immersion Cycled in Situ RT-PCR for the Localization of mRNA in Tissue Sections,” Biotechniques, 1998, 24; pp. 92-100. |
| Cabrera-Fuentes et al., “RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury,” Thromb Haemost., Dec. 2014, 112(6):1110-9. |
| Caliari et al., “A practical guide to hydrogels for cell culture,” Nat Methods., Apr. 2016, 13(5):405-14. |
| Calvert, “Materials science. Printing cells,” Science, Oct. 2007, 318(5848):208-209. |
| Camacho et al., “Small mammalian animal models of heart disease,” Am. J Cardiovasc. Dis., Sep. 2016, 6(3):70-80. |
| Cancernetwork.com, [online], Allison et al., “Heterogeneity and cancer,” Oncology (Williston Park), Sep. 15, 2014, 28(9):772-8, via Internet Archive: Wayback Machine URL<The Wayback Machine—https://web.archive.org/web/20190129000357/http://www.cancernetwork.com:80/oncology-journal/heterogeneity-and-cancer>, retrieved on Oct. 21, 2021, URL<http://www.cancernetwork.com:80/oncology-journal/heterogeneity-and-cancer>, 3 pages. |
| Cardona et al., “TrakEM2 0.9a User Manual,” Sep. 8, 2011, retrieved on Jul. 29, 2022, retrieved from URL <https://www.ini.uzh.ch/˜acardona/trakem2_manual.html>, 38 pages. |
| Carlson et al., “Function and Structure of a Prokaryotic Formylglycine-generating Enzyme,” J. of Biological Chemistry, 2008, 283(29):20117-125. |
| Carter et al., “Stabilization of an optical microscope to 0.1 nm in three dimensions,” Applied Optics, 2007, 46:421-427. |
| Carter, “Porphyrin-phospholipid liposomes premeablizied by near-infrared light,” Nat. Commun., Apr. 2014, 5:3546, p. 1-11. |
| Cerritelli et al., “Ribonuclease H: the enzymes in eukaryotes,” FEBS Journal, Mar. 2009, 276(6):1494-505. |
| Cerutti et al., “Generation of sequence-specific, high affinity anti-DNA antibodies,” Journal of Biological Chemistry, 2001, 276(16):12769-12773. |
| Cha et al., “Specificity, Efficiency and Fidelity of PCR,” Genome Res., 1993, 3:518-29. |
| Chandra et al., “Cell-free synthesis-based protein microarrays and their applications,” Proteomics, 2009, 5(6):717-30. |
| Chatterjee et al., “Protein Microarray on-Demand: A Novel Protein Microarray System,” PLos One, 2008, 3(9):e3265. |
| Chatterjee, et al., “Mitochondrial DNA mutations in human cancer. Oncogene,” 2006, 25(34):4663-4674. |
| Chen et al., “A Homogeneous, Ligase-mediated DNA diagnostic test,” Genome research, 1998, 8(5):549-556. |
| Chen et al., “DNA hybridization detection in a microfluidic Channel using two fluorescently labelled nucleic acid probes,” Biosensors and Bioelectronics, 2008, 23:1878-1882. |
| Chen et al., “ExpansionMicroscopy,” 2015, Science. 347(6221):543-548. |
| Chen et al., “Fusion protein linkers: Property, design and functionality,” Advanced Drug Delivery Reviews, Oct. 15, 2013, 65(10):1357-1369, 32 pages. |
| Chen et al., “Geometric control of cell life and death,” Science, May 1997, 276(5317):1425-1428. |
| Chen et al., “Gray-scale photolithography using microfluidic photomasks,” PNAS, Feb. 2003, 100(4):1499-1504. |
| Chen et al., “High PLTP activity is associated with depressed left ventricular systolic function,” Atherosclerosis, Jun. 2013, 228(2):438-42. |
| Chen et al., “Nanoscale imaging of RNA with expansion microscopy,” Nat Methods, Aug. 2016, 13(8):679-84. |
| Chen et al., “Parallel single nucleotide polymorphism genotyping by surface invasive cleavage with universal detection,” Anal Chem., Apr. 2005, 77(8):2400-5. |
| Chen et al., “RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells,” Science, Apr. 2015, 348(6233):aaa6090, 21 pages. |
| Chen et al., “Spatially resolved, highly multiplexed RNA profiling in single cells”, Science 348(6233), 36 pages, 2015. |
| Chen et al., “ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing,” Nature Methods, Dec. 2016, 13(12):1013-1024. |
| Cheng et al., “Sensitive Detection of Small Molecules by Competitive Immunomagnetic-Proximity Ligation Assay,” Anal Chem, 2012, 84:2129-2132. |
| Cheng, “The Contrast Formation in Optical Microscopy,” Handbook of Biological Confocal Microscopy, 2006, Chapter 8, pp. 162-206. |
| Chester et al., “Dimethyl sulfoxide-mediated primer Tm reduction: a method for analyzing the role of renaturation temperature in the polymerase chain reaction,” Anal Biochem, Mar. 1993, 209(2):284-90. |
| Cheung et al., “Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications,” Mar Drugs, Aug. 2015, 13(8):5156-86. |
| Chial, “DNA Sequencing Technologies Key to the Human Genome Project,” Nature Education, 2008, 1(1):219, 7 pages. |
| Chiang et al., “NFkappaB translocation in human microvessel endothelial cells using a four-compartment subcellular protein redistribution assay,” J Biochem Biophys Methods, Nov. 2000, 46(1-2):53-68. |
| Chrisey et al., “Covalent attachment of synthetic DNA to self-assembled monolayer films,” Nucleic Acids Res., Aug. 1996, 24(15):3031-9. |
| Chung et al., “Imaging single-cell signaling dynamics with a deterministic high-density single-cell trap array,” Anal Chem, Sep. 2011, 83(18):7044-7052. |
| Chung et al., “Structural and molecular interrogation of intact biological systems,” Nature, May 16, 2013, 497:332-337. |
| Ciaccio et al., “Systems analysis of EGF receptor signaling dynamics with microwestern arrays,” Nat Methods, Feb. 2010, 7(2):148-55. |
| Clevers, “Modeling Development and Disease with Organoids,” Cell, Jun. 2016, 165(7):1586-1597. |
| Cockroft et al., “A single-molecule nanopore device detects DNA polymerase activity with single-nucleotide resolution,” J Am Chem Soc., Jan. 2008, 130(3):818-20. |
| Colegio et al., “In vitro transposition system for efficient generation of random mutants of Campylobacter jejuni,” J Bacteriol., Apr. 2001, 183(7):2384-8. |
| Colin et al., “Enzyme engineering in biomimetic compartments,” Curr Opin Street Biol., Aug. 2015, 33:42-51. |
| Collins et al., “Two-dimensional single-cell patterning with one cell per well driven by surface acoustic waves,” Nature Communications, Nov. 2015, 6:8686, 11 pages. |
| Condina et al., “A sensitive magnetic bead method for the detection and identification of tyrosine phosphorylation in proteins by MALDI-TOF/TOF MS,” Proteomics, 2009, 9:3047-3057. |
| Constantine et al., “Use of genechip high-density oligonucleotide arrays for gene expression monitoring,” Life Sceience News, Amersham Life Science; 11-14, 1998. |
| Cook et al., “The effects of secondary structure and O2 on the formation of direct strand breaks upon UV irradiation of 5-bromodeoxyuridine-containing oligonucleotides,” Chem Biol., Jul. 1999, 6(7):451-9. |
| Copeland et al., “Mitochondrial DNA Alterations in Cancer,” Cancer Invest., 2002, 557-569. |
| Corces et al., “An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues”, Nat. Methods. vol. 14(10):959-962, 2017. |
| Corces et al., “Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution,” nature genetics, Oct. 2016, 48(10):1193-1203. |
| Cornett et al., “MALDI imaging mass spectrometry: molecular snapshots of biochemical systems,” Nature Methods, 2007, 4(10):828-833. |
| Cox et al., “Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics,” Nat Protoc., 2006, 1(4):1872-8. |
| Craig, “Transposon Tn7,” Curr Top Microbiol Immunol., 1996, 204:27-48. |
| Craig, “V(D)J recombination and transposition: closer than expected,” Science, Mar. 1996, 271(5255):1512, 1 page. |
| Crosetto et al, “Spatially resolved transcriptomics and beyond,” Nature Review Genetics, 2015, 57-66. |
| Cujec et al. “Selection of v-abl tyrosine kinase substate sequences from randomized peptide and cellular proteomic libraries using mRNA display,” Chemistry and Biology, 2002, 9:253-264. |
| Curtis et al., “Adhesion of cells to polystyrene surfaces,” J Cell Biol., Nov. 1983, 97(5):1500-1506. |
| Czarnik, “Encoding methods for combinatorial chemistry,” Curr Opin Chem Biol., Jun. 1997, 1(1):60-6. |
| Dahl et al., “Circle-to-circle amplification for precise and sensitive DNA analysis,” Proc. Natl. Acad. Sci., 2004, 101:4548-4553. |
| Dalma-Weiszhausz et al., “The affymetrix GeneChip platform: an overview,” Methods Enzymol., 2006, 410:3-28. |
| Dalmeijer et al., “Matrix Gla Protein Species and Risk of Cardiovascular Events in Type 2 Diabetic Patients,” Diabetes Care, Nov. 2013, 36(11):3766-71. |
| Dandapani et al., “Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening,” Curr Protoc Chem Biol., Sep. 2012, 4:177-191. |
| Darmanis, et al., “ProteinSeq: High-Performance Proteomic Analyses by Proximity, Ligation and Next Generation Sequencing,” PLos One, 2011, 6(9):e25583. |
| Darnell, Jr., “Reflections on the history of pre-mRNA processing and highlights of current knowledge: A unified picture,” RNA, Feb. 2013, 19:443-460, 19 pages. |
| Datlinger et al., “Pooled CRISPR screening with single-cell transcriptome readout,” Nat Methods, Mar. 2017, 14(3):297-301. |
| Daubendiek et al., “Rolling-Circle RNA Synthesis: Circular Oligonucleotides as Efficient Substrates for T7 RNA Polymerase,” J. Am. Chem. Soc., 1995, 117:77818-7819. |
| Davies et al., “How best to identify chromosomal interactions: a comparison of approaches.”, Nat. Methods 14, 125-134, 2017. |
| Dawson et al., “Genetic animal models of Parkinson's disease,” Neuron, Jun. 2010, 66(5):646-661. |
| De Clercq et al., “Approved Antiviral Drugs over the Past 50 Years,” Clinical Microbiology Reviews, Jul. 2016, 29(3):695-747. |
| De Clercq, “A 40-year journey in search of selective antiviral chemotherapy,” Annu Rev Pharmacol Toxicol., 2011, 51:1-24. |
| Deamer et al., “Characterization of nucleic acids by nanopore analysis,” Acc Chem Res., Oct. 2002, 35(10):817-25. |
| Deamer et al., “Nanopores and nucleic acids: prospects for ultrarapid sequencing,” Trends Biotechnol., Apr. 2000, 18(4):147-51. |
| Dean et al., “Comprehensive human genome amplification using multiple displacement amplification,” Proc Natl. Acad. Sci. USA 99:5261-66, 2002. |
| Dean et al., “Rapid Amplification of Plasmid and Phage DNA Using Phi29 DNA Polymerase and Multiply-Primed Rolling Circle Amplification,” Genome Research, Jun. 2001, 11:1095-1099. |
| Deibel et al., “Biochemical properties of purified human terminal deoxynucleotidyltransferase,” J Biol Chem., May 1980, 255(9):4206-12. |
| Deo et al., “Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides,” Dev Dyn., Sep. 2006, 235(9):2538-48. |
| Devine et al., “Efficient integration of artificial transposons into plasmid targets in vitro: a useful tool for DNA mapping, sequencing and genetic analysis,” Nucleic Acids Res., Sep. 1994, 22(18):3765-72. |
| Dhindsa et al., “Virtual Electrowetting Channels: Electronic Liquid Transport with Continuous Channel Functionality,” Lab Chip, 2010, 10:832-836. |
| Diez-Roux et al., “A high-resolution anatomical atlas of the transcriptome in the mouse embryo,” PLoS Biol., Jan. 2011, 9(1):e1000582, 14 pages. |
| Ding et al., “On-chip manipulation of single microparticles, cells, and organisms using surface acoustic waves,” PNAS, Jul. 2012, 109(28):11105-11109. |
| Dixit et al., “Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens,” Cell, Dec. 2016, 167(7):1853-1866.e17. |
| Doddridge et al., “UV-induced strand break damage in single stranded bromodeoxyuridine-containing DNA oligonucleotides,” Chem Commun., 1998, p. 1997-1998. |
| Doshi et al., “In vitro nanobody discovery for integral membrane protein targets,” Scientific Reports, Oct. 4, 2014, 4:6760, 8 pages. |
| Dressman et al., “Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations,” Proc. Natl. Acad. Sci. USA, 2003, 100:8817-8822. |
| Drmanac et al., “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,” Nature Biotechnology, 16:54-58, 1998. |
| Druley et al., “Quantification of rare allelic variants from pooled genomic DNA,” Nat. Methods 6: 263-65, 2009. |
| Duhr et al., “Why molecules move along a temperature gradient,” Proc Natl Acad Sci USA, Dec. 2006, 103(52): 19678-19682. |
| Duncan et al., “Affinity chromatography of a sequence-specific DNA binding protein using teflon-linked oligonucleotides”, Anal. Biochem. 169: 104-108, 1988. |
| Dundas et al., “Reference genes for measuring mRNA expression,” Theory Biosci., May 17, 2012, 131:215-223. |
| Eagen, “Principles of Chromosome Architecture Revealed by Hi-C”, Trends in Biochemical Sciences, vol. 43, No. 6, 10 pages, 2018. |
| Eberwine et al., “Analysis of gene expression in single live neurons,” Proc. Natl. Acad. Sci., USA 89, 3010-3014, 1992. |
| Eberwine, “Amplification of mRNA Populations Using aRNA Generated from Immobilized Qligo(dT)-T7 Primed cDNA,” BioTechniques 20 (4), 584, 1996. |
| Ebihara et al., “Molecular detection of dermatophytes and nondermatophytes in onychomycosis by nested polymerase chain reaction based on 28S ribosomal RNA gene sequences,” Br J Dermatol., Nov. 2009, 161(5):1038-44. |
| Eguiluz et al., “Multitissue array review: A chronological description of tissue array techniques, applications and procedures,” Pathology Research and Practice, 2006, 202:561-568. |
| Eisenberg et al., “Corrigendum to: Human housekeeping genes, revisited: [Trends in Genetics 29 (2013), 569-574],” Trends in Gen., Mar. 2014, 30(3):119-20. |
| Ekins et al., “Microarrays: their origins and applications,” Trends in Biotechnology, Jun. 1999, 17(6):217-218. |
| Eldridge et al. “An in vitro selection strategy for conferring protease resistance to ligand binding peptides,” Protein Eng Des Sel., 22(11): 691-698, 2009. |
| Ellington et al., “Antibody-based protein multiplex platforms: technical and operational challenges,” Clin Chem 56(2): 186-193, 2010. |
| Emmert-Buck et al., “Laser capture microdissection,” Science, Nov. 1996, 274(5289):998-1001. |
| Eng et al., “Profiling the transcriptome by RNA SPOTs”, Nat Methods., 14(12): 1153-1155, 2017. |
| Ergin et al., “Proteomic Analysis of PAXgene-Fixed Tissues,” J Proteome Res., 2010, 9(10):5188-96. |
| Escholarship.org [online], “Methods and devices for fabricating and assembling DNA and protein arrays for high-throughput analyses [electronic resource],” 2010, retrieved on Jun. 8, 2022, retrieved from URL<https://escholarship.org/uc/item/6tf7p46s>, 155 pages. |
| Espina et al., “Laser-capture microdissection,” Nat Protoc, 2006, 1(2):586-603. |
| Evers et al., “The effect of formaldehyde fixation on RNA: optimization of formaldehyde adduct removal,” J Mol Diagn., May 2011, 13(3):282-8. |
| Extended European Search Report in European Appln. No. 19159432.4, dated Jul. 10, 2019, 6 pages. |
| Extended European Search Report in European Appln. No. 21164281.4, dated Sep. 9, 2021, 5 pages. |
| Extended European Search Report in European Appln. No. 21164322.6, dated Sep. 6, 2021, 5 pages. |
| Extended European Search Report in European Appln. No. 22190953.4, dated Jan. 27, 2023, 6 pages. |
| Extended European Search Report in European Appln. No. 22190961.7, dated Dec. 6, 2022, 6 pages. |
| Extended European Search Report issued in European Appln. No. 19159432.4, dated Jul. 19, 2019, 6 pages. |
| Fahy et al., “Design and synthesis of polyacrylamide-based oligonucleotide supports for use in nucleic acid diagnostics,” Nucleic Acids Res., Apr. 1993, 21(8):1819-26. |
| Falconnet et al., “Surface engineering approaches to micropattern surfaces for cell-based assays,” Biomaterials, Jun. 2006, 27(16):3044-3063. |
| Fan et al., “Highly parallel SNP genotyping,” Cold Spring Symp. Quant. Biol., 68: 69-78, 2003. |
| Fang et al., “Fluoride-cleavable biotinylation phosphoramidite for 5′-end-labeling and affinity purification of synthetic oligonucleotides,” Nucleic Acids Res., Jan. 2003, 31(2):708-715. |
| Faruqi et al., “High-throughput genotyping of single nucleotide polymorphisms with rolling circle amplification,” BMC Genomics, Aug. 2001, 2:4, 10 pages. |
| Fehlmann et al., “cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs,” Clin Epigenetics, Nov. 2016, 8:123, 11 pages. |
| Ferreira et al., “Photocrosslinkable Polymers for Biomedical Applications,” Biomedical Engineering-Frontiers and Challenges, Prof. Reza, 2011, 22 pages. |
| Fire and Xu, “Rolling replication of short DNA circles,” Proc. Natl. Acad. Sci., 92: 4641-4645, 1995. |
| Fischer et al., “Hematoxylin and eosin staining of tissue and cell sections,” CSH Protoc., May 2008, 3(5):1-3. |
| Flanigon et al., “Multiplex protein detection with DNA readout via mass spectrometry,” N. Biotechnol., 30(2): 153-158, 2013. |
| Flicek et al., “Ensembl 2014,” Nucleic Acids Res., Jan. 2014, 42(Database issue):D749-D755. |
| Fluidigm, “Equivalence of Imaging Mass Cytometry and Immunofluorescence on FFPE Tissue Sections,” White Paper, 2017, 12 pages. |
| Fodor et al., “Light-Directed, Spatially Addressable Parallel Chemical Synthesis,” Science, 251(4995), 767-773, 1995. |
| Folch et al., “Microfabricated elastomeric stencils for micropatterning cell cultures,” J Biomed Mater Res, Nov. 2000, 52(2):346-353. |
| Forcucci et al., “All-plastic miniature fluorescence microscope for point-of-care readout of bead-based bioassays.,” J. Biomed Opt. 20 (10): 105010, 15 pages, 2015. |
| Fredriksson et al., “Multiplexed protein detection by proximity ligation for cancer detection,” Nature Methods, 4(4): 327-29, 2007. |
| Fredriksson et al., “Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer,” Clin. Chem., 5(3): 582-89, 2008. |
| Fredriksson et al., “Protein detection using proximity-dependent DNA ligation assays,” Nature Biotech., 20: 473-77, 2002. |
| Frese et al., “Formylglycine Aldehyde Tag-Protein Engineering through a Novel Posttranslational Modification,” ChemBioChem., 10: 425-27, 2009. |
| Fu et al., “Counting individual DNA molecules by the stochastic attachment of diverse labels,” PNAS, 108:9026-9031, 2011. |
| Fu et al., “Repeat subtraction-mediated sequence capture from a complex genome,” Plant J., Jun. 2010, 62(5):898-909. |
| Fullwood et al., “Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses,” Genome Res., 19: 521-532, 2009. |
| Galon et al., “The immune score as a new possible approach for the classification of cancer,” J Transl Med., Jan. 2012, 10:1, 4 pages. |
| Gamper et al., “Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis,” BMC Genomics, Apr. 28, 2009, 10(199):1-17. |
| Gans et al., “Inkjet Printing of Polymers: State of the Art and Future Developments,” Advanced Materials, Feb. 2004, 16(3):203-213. |
| Gao et al., “High density peptide microarrays. In situ synthesis and applications,” Molecular Diversity, 8, 177-187, 2004. |
| Gao et al., “Q&A: Expansion microscopy”, BMC Biology, 15: 50, 9 pages, 2017. |
| Gaspar, “Strength in numbers: quantitative single-molecule RNA detection assays,” Wiley Interdiscip Rev DevBiol., Mar.-Apr. 2015,4(2):135-50. |
| Geiss et al., “Direct multiplexed measurement of gene expression with color-coded probe pairs,” nature biotechnology, 2008, 26(3):317-325. |
| Genbank Accession No. AC009495.1, “Homo sapiens clone NH0490I02, *** Sequencing in Progress ***, 12 unordered pieces,” Aug. 24, 1999, 53 pages. |
| Genbank Accession No. AC009495.5, “Homo sapiens BAC clone RP11-49012 from 2, complete sequence,” Apr. 21, 2005, 32 pages. |
| Genbank Accession No. AC037198.2, “Homo sapiens chromosome 15 clone CTD-2033D15 map 15ql4, *** Sequencing in Progress ***, 62 unordered pieces,” Apr. 25, 2000, 39 pages. |
| Genbank Accession No. AC087379.2, “Homo sapiens chromosome 11 clone RP11-396020 map 11, *** Sequencing in Progress ***, 5 ordered pieces,” Jul. 6, 2002, 47 pages. |
| Genbank Accession No. AC087741.1, “Homo sapiens chromosome 17 clone RP11-334C17 map 17, Low-Pass Sequence Sampling,” Jan. 22, 2001, 18 pages. |
| Genbank Accession No. AC100826.1, “Homo sapiens chromosome 15 clone RP11-279F6 map 15, Low-Pass Sequence Sampling,” Nov. 22, 2001, 21 pages. |
| Genbank Accession No. AL445433.14, “Human DNA sequence from clone RP11-234N17 on chromosome 1, complete sequence,” Jan. 24, 2013, 32 pages. |
| Genbank Accession No. AL445524.1, “Homo sapiens chromosome 1 clone RP11-295G20, Working Draft Sequence, 19 unordered pieces,” Oct. 14, 2000, 47 pages. |
| Gene@arrays[online], BeadArray Technology, available on or before Feb. 14, 2015, via Internet Archive: Wayback Machine URL <https://web.archive.org/web/20150214084616/http://genearrays.com/services/microarrays/illumina/beadarray-technology/>, [retrieved on Jan. 30, 2020], 3 pages. |
| Genome.ucsc.edu, [online], “Genome Browser Gateway,” 2000, retrieved on Jun. 11, 2021, retrieved from URL<https://genome.ucsc.edu/cgi-bin/hgGateway>, 3 pages. |
| Gerard et al., “Excess dNTPs minimize RNA hydrolysis during reverse transcription,” Biotechniques, Nov. 2002, 33(5):984, 986, 988, 990. |
| Gerdtsson et al., “Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays”, Microarrays (2016) 5:16, 2016. |
| Giacomello et al., “Spatially resolved transcriptome profiling in model plant species”, Nature Plants 3, 17061, 11 pages, 2017. |
| Giam et al., “Scanning probe-enabled nanocombinatorics define the relationship between fibronectin feature size and stem cell fate,” PNAS, Mar. 2012, 109(12):4377-4382. |
| Gibson et al., “Enzymatic assembly of DNA molecules up to several hundred kilobases,” Nat Methods., May 2009, 6(5):343-5. |
| Gibson-Corley et al., “Principles for valid histopathologic scoring in research,” Vet Pathol., Nov. 2013, 50(6): 1007-15. |
| Gilar et al., “Study of phosphorothioate-modified oligonucleotide resistance to 3′-exonuclease using capillary electrophoresis,” J Chromatogr B Biomed Sci Appl., Aug. 28, 1998, 714(1):13-20. |
| Gill et al., “Nucleic acid isothermal amplification technologies: a review,” Nucleosides Nucleotides Nucleic Acids, Mar. 2008, 27(3):224-43. |
| Gilles et al., “Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips,” Nat Biotechnol, Apr. 1999, 17(4):365-70. |
| Glass et al., “SIMPLE: a sequential immunoperoxidase labeling and erasing method,” J. Histochem. Cytochem., Oct. 2009, 57(10):899-905. |
| Gloor, “Gene targeting in Drosophila,” Methods Mol Biol., 2004, 260:97-114. |
| Gnanapragasam, “Unlocking the molecular archive: the emerging use of formalin-fixed paraffin-embedded tissue for biomarker research in urological cancer,” BJU International, 105, 274-278, 2009. |
| Goebl et al., “Development of a sensitive and specific in situ hybridization technique for the cellular localization of antisense oligodeoxynucleotide drugs in tissue sections,” Toxicologic Pathology, Jun. 2007, 35(4):541-548. |
| Goldkom and Prockop, “A simple and efficient enzymatic method for covalent attachment of DNA to cellulose. Application for hybridization-restriction analysis and for in vitro synthesis of DNA probes.”, Nucleic Acids Res. 14:9171-9191, 1986. |
| Goransson et al., “A single molecule array for digital targeted molecular analyses,” Nucleic Acids Res., Nov. 25, 2009, 37(1):e7, 9 pages. |
| Goryshin et al., “Tn5 in vitro transposition,” J Biol Chem., Mar. 1998, 273(13):7367-74. |
| Gotz et al., “Animal models of Alzheimer's disease and frontotemporal dementia,” Nat Rev Neurosci., Jul. 2008, 9(7):532-44. |
| Govan et al., “Optochemical control of RNA interference in mammalian cells,” Nucleic Acids Research, Dec. 2013, 41(22):10518-10528. |
| Grant et al., “Pathways and mechanisms of endocytic recycling,” Nat. Rev. Mol. Cell Biol., Sep. 2009, 10(9):597-608. |
| Grokhovsky, “Specificity of DNA cleavage by ultrasound,” Molecular Biology, 2006, 40(2):276-283. |
| Gross et al., “Technologies for Single-Cell Isolation,” Int. J Mol. Sci., Jul. 2015, 16(8):16897-16919. |
| Grünweller et al., “Locked Nucleic Acid Oligonucleotides,” BioDrugs, Jul. 2007, 21(4): 235-243. |
| Gu et al., “Multiplex single-molecule interaction profiling of DNA-barcoded proteins,” Nature, Sep. 21, 2014, 515:554-557. |
| Gu et al., “Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation,” N Biotechnol., 30(2): 144-152, 2013. |
| Gudjonsson et al., “Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia,” J Mammary Gland Biol Neoplasia, Jul. 2005, 10(3):261-72. |
| Gunderson et al., “Decoding Randomly Ordered DNA Arrays,” Genome Research 14: 870-877, 2004. |
| Guo et al., “Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports,” Nucleic Acids Res., Dec. 1994, 22(24):5456-65. |
| Guo et al., “RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining,” Int J Genomics, 2016, 2016:9837310, 11 pages. |
| Habib et al., “Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons,” Science, Aug. 2016, 353(6302):925-8. |
| Hadley et al: “Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics”, ELIFE, Sep. 2015, 4(e09579): pp. 1-12. |
| Hafner et al., “Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing,” Methods, Jan. 2008, 44(1):3-12. |
| Hahnke et al., “Striptease on glass: validation of an improved stripping procedure for in situ microarrays,” J Biotechnol., Jan. 2007, 128(1):1-13. |
| Hajduk et al., “Drug discovery: A question of library design,” Nature, Feb. 2011, 470(7332):42-43. |
| Halova et al., “Mast cell chemotaxis—chemoattractants and signaling pathways,” Front Immunol., May 2012, 3:119, 20 pages. |
| Hamaguchi et al., “Direct reverse transcription-PCR on oligo(dT)-immobilized polypropylene microplates after capturing total mRNA from crude cell lysates,” Clin Chem., Nov. 1998, 44(11):2256-63. |
| Hammond et al., “Profiling cellular protein complexes by proximity ligation with dual tag microarray readout,” PLoS ONE, 2012, 7(7):e40405. |
| Han et al., “3C and 3C-based techniques: the powerful tools for spatial genome organization deciphering”, Molecular Cytogenetics (2018) 11:21, 10 pages, 2018. |
| Hanauer et al., “Separation of nanoparticles by gel electrophoresis according to size and shape,” Nano Lett., Sep. 2007, 7(9):2881-5. |
| Hardenbol et al., “Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay,” Genome Res., Feb. 2005, 15(2):269-75. |
| Hardenbol et al., “Multiplexed genotyping with sequence-tagged molecular inversion probes,” Nature Biotechnol., Jun. 2003, 21(6):673-678. |
| Harris et al., “Chloroplast ribosomes and protein synthesis,” Microbiol. Mol. Biol. Rev., Dec. 1, 1994, 58(4): 700-754. |
| Harris et al., “The design and application of target-focused compound libraries,” Comb Chem High Throughput Screen, Jul. 2011, 14(6):521-531. |
| Harrow et al., “GENCODE: The reference human genome annotation for the ENCODE Project,” Genome Res., Sep. 2012, 22(9):1760-1774. |
| Hattersley et al., “Development of a microfluidic device for the maintenance and interrogation of viable tissue biopsies,” Lab Chip., Nov. 2008, 8(11):1842-6. |
| Hayes et al., “Electrophoresis of proteins and nucleic acids: I-Theory,” BMJ, Sep. 1989, 299(6703):843-6. |
| He et al., “In situ synthesis of protein arrays,” Current Opinion in Biotechnology, 19:4-9, 2008. |
| He et al., “Printing protein arrays from DNA arrays,” Nature Methods, 5:175-77, 2008. |
| He, “Cell-free protein synthesis: applications in proteomics and biotechnology,” New Biotechnology 25: 126-132, 2008. |
| Healy, “Nanopore-based single-molecule DNA analysis,” Nanomedicine (Lond), Aug. 2007, 2(4):459-81. |
| Hedskog et al., “Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected using Ultra-Deep Pyrosequencinq,” PLoS One, 5(7):e11345, 2010. |
| Hein et al., “Click Chemistry, A Powerful Tool for Pharmaceutical Sciences”, Pharm Res., 25(10): 2216-2230, 2008. |
| Hejatko et al., “In Situ Hybridization Techniques for mRNA Detection in Whole Mount Arabidopsis Samples,” Nature Protocols, 2006, 1(4):1939-1946. |
| Hendrickson et al., “High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction,” Nucleic Acid Research, Feb. 11, 1995, 23(3):522-529. |
| Hernandez et al., “Solution-phase and solid-phase sequential, selective modification of side chains in KDYWEC and KDYWE as models for usage in single-molecule protein sequencing,” New J Chem., Jan. 2017, 41(2):462-469. |
| Hessner et al., “Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes,” Clin Chem., Aug. 2000, 46(8 Pt 1):1051-6. |
| Hiatt et al., “Parallel, tag-directed assembly of locally-derived short sequence reads,” Nature Methods, 7(2): 119-25, 2010. |
| Hipp et al., “A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo,” Leukemia, Oct. 2017, 31(10):2278, 31 pages. |
| Hlubek et al., “Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer,” Int J Cancer., Nov. 2007, 121(9):1941-8. |
| Ho et al., “Bacteriophage T4 RNA ligase 2 (gp24.1) exemplifies a family of RNA ligases found in all phylogenetic domains,” PNAS, Oct. 2002, 99(20):12709-14. |
| Ho et al., “Characterization of an ATP-Dependent DNA Ligase Encoded by Chlorella Virus PBCV-1,” Journal of Virology, Mar. 1997, 71(3):1931-1937. |
| Hober et al., “Human protein atlas and the use of microarray technologies,” Curr Opin Biotechnol., Feb. 2008, 19(1):30-35. |
| Hoffman et al., “Formaldehyde crosslinking: a tool for the study of chromatin complexes,” J Biol Chem., Oct. 2015, 290(44):26404-11. |
| Holmstrøm et al., “A highly sensitive and fast nomadioactive method for detection of polymerase chain reaction products,” Anal Biochem, Mar. 1993, 209(2):278-83. |
| Hoyer et al., “Electrostatic spraying: a novel technique for preparation of polymer coatings on electrodes,” Anal Chem, Nov. 1996, 68(21):3840-4. |
| Hsuih et al., “Novel, Ligation-Dependent PCR Assay for Detection of Hepatitis C Virus in Serum,” Journal of Clinical Microbiology, Mar. 1996, 34(3):501-507. |
| Hu et al., “High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays,” Biotechniques, Jan. 2005, 38(1):121-4. |
| Hughes et al., “Microfluidic Western blotting,” PNAS, Dec. 2012, 109(52):21450-21455. |
| Hycultbiotech.com, [online], “Immunohistochemistry, Paraffin” Apr. 2010, retrieved on Apr. 16, 2020, retrieved from URL<https://www.hycultbiotech.com/media/wysiwyg/Protocol_Immunohistochemistry_Paraffin_2.pdf>, 3 pages. |
| Hytönen et al., “Design and construction of highly stable, protease-resistant chimeric avidins,” J Biol Chem., Mar. 2005, 280(11):10228-33. |
| Ichikawa et al., “In vitro transposition of transposon Tn3,” J Biol. Chem., Nov. 1990, 265(31):18829-32, Abstract. |
| Illumina.com [online], “Array-Based Gene Expression Analysis,” 2011, retrieved on Dec. 13, 2021, retrieved from URL<https://www.illumina.com/documents/products/datasheets/datasheet_gene_exp_analysis.pdf>, 5 pages. |
| Illumina.com [online], “Ribo-Zero® rRNA Removal Kit Reference Guide,” Aug. 2016, retrieved on Apr. 26, 2022, retrieved from URL<https://jp.support.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/ribosomal-depletion/ribo-zero/ribo-zero-reference-guide-15066012-02.pdf>, 36 pages. |
| Im et al., “An Introduction to Performing Immunofluorescence Staining,” Biobanking: Methods and Protocols, Method in Molecular Biology, Yong (ed.), 2019, 1897, Chapter 26, 299-311. |
| Imbeaud et al., “Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces,” Nucleic Acids Res., Mar. 2005, 33(6):e56, 12 pages. |
| Inoue and Wittbrodt, “One for All—A Highly Efficient and Versatile Method for Fluorescent Immuno staining in Fish Embryos,” PLoS One 6, e19713, 2011. |
| Invitrogen, Immune Response Biomarker Profiling Service Report, Invitrogen, 2009, 1-33. |
| Jabara et al., Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. PNAS 108(50); 20166-20171, 2011. |
| Jain, “Transport of molecules, particles, and cells in solid tumors,” Annu. Rev. Biomed. Eng., 1999, 1:241-263. |
| Jaitin et al., “Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq,” Cell, Dec. 2016, 167(7):1883-1896.e15. |
| Jamur and Oliver, “Permeabilization of cell membranes.,” Method Mal. Biol., 588: 63-66, 2010. |
| Jawhar et al., “Tissue Microarray: A rapidly evolving diagnostic and research tool,” Annals of Saudi Medicine, Mar. 2009, 29(2):123-7. |
| Jemt et al., “An automated approach to prepare tissue-derived spatially barcoded RNA-sequencing libraries”, Scientific Reports, 6: 37137, 10 pages, 2016. |
| Jennane et al., “Photolithography of self-assembled monolayers: optimization of protecting groups by an electroanalytical method,” Can. J Chem., Dec. 1996, 74(12):2509-2517. |
| Jensen et al., “Zinc fixation preserves flow cytometry scatter and fluorescence parameters and allows simultaneous analysis of DNA content and synthesis, and intracellular and surface epitopes,” Cytometry A., Aug. 2010, 77(8):798-804. |
| Jensen, “Technical review: In situ hybridization,” Anat Rec (Hoboken)., Aug. 2014, 297(8):1349-1353. |
| Jones et al., Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA 105(11): 4283-4288, 2008. |
| Joos et al., “Covalent attachment of hybridizable oligonucleotides to glass supports,” Anal Biochem., Apr. 1997, 247(1):96-101. |
| Jucá et al., “Effect of dimethyl sulfoxide on reverse transcriptase activity,” Braz. J. Med. Biol. Res., Mar. 1995, 28(3):285-90. |
| Juliano, “The delivery of therapeutic oligonucleotides,” Nucleic Acids Res., Aug. 2016, 44(14):6518-6548. |
| Kainkaryam et al., “Pooling in high-throughput drug screening” Curr Opin Drug Discov Devel., May 2009, 12(3):339-50. |
| Kalantari et al., “Deparaffinization of formalin-fixed paraffin-embedded tissue blocks using hot water instead of xylene,” Anal Biochem,, Aug. 2016, 507:71-3. |
| Kandoth et al., “Mutational landscape and significance across 12 major cancer types,” Nature, Oct. 2013, 502(7471):333-339, 20 pages. |
| Kanehisa, “Use of statistical criteria for screening potential homologies in nucleic acid sequences”, Nucleic Acids Res. 12: 203-213, 1984. |
| Kansal et al., “The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research,” Psychiatr Clin North Am., Jun. 2015, 38(2):309-22. |
| Kap et al., “Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents,” PLoS One 6, e27704, 10 pages, 2011. |
| Kapteyn et al., “Incorporation of Non-Natural Nucleotides Into Template-Switching Oligonucleotides Reduces Background and Improves cDNA Synthesis From Very Small RNA Samples,” BMC Genomics, 2010, 11(413): 1-9. |
| Karlin et al., “Applications and statistics for multiple high-scoring segments in molecular sequences,” Proc. Natl. Acad. Sci., Jun. 15, 1993, 90:5873-7. |
| Karmakar et al., “Organocatalytic removal of formaldehyde adducts from RNA and DNA bases,” Nature Chemistry, Aug. 2015, 7(9):752-758. |
| Kashyap et al., “Selective local lysis and sampling of live cells for nucleic acid analysis using a microfluidic probe,” Sci Rep., Jul. 2016, 6:29579, 10 pages. |
| Ke et al., “In situ sequencing for RNA analysis in preserved tissue and cells,” Nat Methods., Sep. 2013, 10(9):857-60. |
| Ke et al., “In situ sequencing for RNA analysis in preserved tissue and cells,” Nat Methods., Sep. 2013, Supplementary Materials, 29 pages. |
| Kelleher et al., “Characterization of RNA Strand Displacement Synthesis by Moloney Murine Leukemia Virus Reverse Transcriptase,” J Biol Chem, Apr. 1998, 273(16):9976-86. |
| Kennedy-Darling et al., “Measuring the Formaldehyde Protein-DNA Cross-Link Reversal Rate,” Analytical Chemistry, 2014, 86(12):5678-5681. |
| Kent et al., “Polymerase θ is a robust terminal transferase that oscillates between three different mechanisms during end-joining” Elife, Jun. 2016, 5:e13740, 25 pages. |
| Kibbe, “OligoCalc: an online oligonucleotide properties calculator,” Nucleic Acids Res., Jul. 2007, 35:W43-6. |
| Kirby et al., “Cryptic plasmids of Mycobacterium avium: Tn552 to the rescue,” Mol Microbiol., Jan. 2002, 43(1):173-86. |
| Kleckner et al., “Tn10 and IS10 transposition and chromosome rearrangements: mechanism and regulation in vivo and in vitro,” Curr Top Microbiol Immunol., 1996, 204:49-82. |
| Koch et al., “Photochemical immobilization of anthraquinone conjugated oligonucleotides and PCR amplicons on solid surfaces,” Bioconjugate Chem., Jul. 2000, 11(4):474-483. |
| Kokkat et al., “Archived formalin-fixed paraffin-embedded (FFPE) blocks: A valuable underexploited resource for extraction of DNA, RNA, and protein,” Apr. 2013, 11(2):101-6. |
| Kolb et al., “Click Chemistry: Diverse Chemical Function from a Few Good Reactions,” Angew. Chem. Int. Ed., 40(11): 2004-2021, 2001. |
| Kolbert et al., “Ribosomal DNA sequencing as a tool for identification of bacterial pathogens,” Curr Opin Microbiol, Jun. 1999, 2(3):299-305. |
| Kolovos et al., “Investigation of the spatial structure and interactions of the genome at sub-kilobasepair resolution using T2C,” Nat. Protoc. 13, 459-477, 2018. |
| König et al., “iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution,” Nat Struct Mol Biol., Jul. 2010, 17(7):909-915. |
| Korbel et al., “Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome,” Science, 318(5849): 420-426, 2007. |
| Korlach et al., “Selective aluminum passivation for targeted immobilization of single DNA polymerase molecules in zero-mode waveguide nanostructures,” Proc. Natl. Acad. Sci. USA 105, 1176-1181, 2008. |
| Kourou et al., “Machine learning applications in cancer prognosis and prediction,” Computational and Structural Biotechnology Journal, Jan. 2015, 13:8-17. |
| Kozlov et al., “A High-Complexity Multiplexed Solution-Phase Assay for Profiling Protease Activity on Microarrays,” Comb Chem High Throughput Screen, 11: 24-35, 2008. |
| Kozlov et al., “A Highly Scalable Peptide-Based Assay System for Proteomics,” PLoS ONE, 7(6): e37441, 2012. |
| Kozlov et al., “A Method for Rapid Protease Substrate Evaluation and Optimization,” Comb Chem High Throughput Screen, 9: 481-87, 2006. |
| Kretschy et al., “Next-Generation o-Nitrobenzyl Photolabile Groups for Light-Directed Chemistry and Microarray Synthesis,” Angewandte Chemie International Edition, Jul. 2015, 54(29):8555-8559. |
| Kristensen et al., “High-Throughput Methods for Detection of Genetic Variation,” BioTechniques, Feb. 2001, 30(2):318-332. |
| Kuijpers et al. “Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer,” Bioconjugate Chem., Jan. 1, 1993, 4(1):94-102. |
| Kumar et al., “Template-directed oligonucleotide strand ligation, covalent intramolecular DNA circularization and catenation using click chemistry,” J Am Chem Soc., May 2007, 129(21):6859-64. |
| Kurz et al., “cDNA-Protein Fusions: Covalent Protein-Gene Conjugates for the In Vitro Selection of Peptides and Proteins,” ChemBioChem., 2: 666-72, 2001. |
| Kwok, “High-throughput genotyping assay approaches,” Pharmocogenomics, Feb. 2000, 1(1):95-100. |
| Kwon, “Single-molecule fluorescence in situ hybridization: Quantitative imaging of single RNA molecules,” Department of Biomedical Engineering, Oregon Health & Science University, Feb. 2013, 46:65-72. |
| Lacar et al., “Nuclear RNA-seq of single neurons reveals molecular signatures of activation,” Nat Commun., Apr. 2016, 7:11022, 12 pages. |
| LaFerla et al., “Animal models of Alzheimer disease,” Cold Spring Harb Perspect Med., Nov. 2012, 2(11):a006320, 14 pages. |
| Lage et al., “Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array-CGH,” Genome Research 13: 294-307, 2003. |
| Lake et al., “Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain,” Science, Jun. 2016, 352(6293):1586-90. |
| Lakhin et al., “Aptamers: problems, solutions and prospects,” Acta Naturae, Oct. 2013, 5(4):34-43. |
| Lampe et al., “A purified mariner transposase is sufficient to mediate transposition in vitro,” EMBO J., Oct. 1996, 15(19):5470-9. |
| Lamture et al., “Direct detection of nucleic acid hybridization on the surface of a charge coupled device,” Nucleic Acid Res., Jun. 1994, 22(11):2121-5. |
| Landegren et al., “Reading bits of genetic information: methods for single-nucleotide polymorphism analysis,” Genome Res., Aug. 1998, 8(8):769-76. |
| Langdale et al., “A rapid method of gene detection using DNA bound to Sephacryl”, Gene 36: 201-210, 1985. |
| Larman et al., “Autoantigen discovery with a synthetic human peptidome,” Nature Biotechnology, doi:1 0.1038/nbt.1856, vol. 29, No. 6, pp. 535-541, 2011. |
| Larman et al., “Sensitive, multiplex and direct quantification of RNA sequences using a modified RASL assay,” Nucleic Acids Research, 2014, 42(14):9146-9157. |
| Larsen et al., “Characterization of a recombinantly expressed proteinase K-like enzyme from a psychrotrophic Serratia sp,” FEBS J., Jan. 2006, 273(1):47-60. |
| Larsson et al., “In situ detection and genotyping of individual mRNA molecules,” Nat Methods, May 2010, 7(5):395-7. |
| Larsson et al., “In situ genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock probes,” Nat Methods, Dec. 2004, 1(3):227-32. |
| Lassmann et al., A Novel Approach for Reliable Microarray Analysis of Microdissected Tumor Cells From Formalin-Fixed and Paraffin-Embedded Colorectal Cancer Resection Specimens, J Mol Med, 87, 211-224, 2009. |
| Laurell et al., “Chip integrated strategies for acoustic separation and manipulation of cells and particles,” Chem. Soc. Rev., Mar. 2007, 36(3):492-506. |
| Le Reste et al., “Characterization of dark quencher chromophores as nonfluorescent acceptors for single-molecule FRET,” Biophysical Journal, Jun. 2012, 102(11):2658-2668. |
| Lee et al., “A novel COL3A1 gene mutation in patient with aortic dissected aneurysm and cervical artery dissections,” Heart Vessels, Mar. 2008, 23(2):144-8. |
| Lee et al., “Cytokines in cancer immunotherapy,” Cancers (Basel), Oct. 2011, 3(4):3856-3893. |
| Lee et al., “Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues”, Nature Protec, 10(3): 442-458, 2015. |
| Lee et al., “Highly multiplexed subcellular RNA sequencing in situ”, Science, 343(6177): 1360-1363, 2014. |
| Lee et al., “Identifying T Cell Receptors from High-Throughput Sequencing: Dealing with Promiscuity in TCRα and TCRβ Pairing,” PLoS Comput Biol., Jan. 2017, 13(1):e1005313, 25 pages. |
| Lee et al., “Improving the efficiency of genomic loci capture using oligonucleotide arrays for high throughput resequencing,” BMC Genomics, Dec. 2009, 10:646, 12 pages. |
| Lee et al., “Protein nanoarrays generated by dip-pen nanolithography,” Science, Mar. 2002, 295(5560):1702-1705. |
| Lein et al., “The promise of spatial transcriptomics for neuroscience in the era of molecular cell typing”, Science 358, 64-69, 2017. |
| Lenard, “Viral Membranes,” Encyclopedia of Virology, Jul. 2008, pp. 308-314. |
| Leriche et al., “Cleavable linkers in chemical biology.”, Bioorganic & Medicinal Chemistry, 20: 571-582, 2012. |
| Levene et al., “Zero-Mode Waveguides for Single-Molecule Analysis at High Concentrations,” Science 299, 682-686, 2003. |
| Li et al., “A photocleavable fluorescent nucleotide for DNA sequencing and analysis,” Proc. Natl. Acad. Sci., 100: 414-419, 2003. |
| Li et al., “DNA molecules and configurations in a solid-state nanopore microscope,” Nat Mater., Sep. 2003, 2(9):611-5. |
| Li et al., “RASL-seq for Massively Parallel and Quantitative Analysis of Gene Expression,” Curr Protoc Mol Biol., Apr. 2012, 4(13):1-10. |
| Liberali et al., “Single-cell and multivariate approaches in genetic perturbation screens,” Nat Rev Genet., Jan. 2015, 16(1):18-32. |
| Lin et al., “Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method,” Nat Commun., Sep. 2015, 6:8390, 7 pages. |
| Lin et al., “Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis,” Mol Med Rep., Apr. 2015, 11(4):2421-2428. |
| Lin et al., “Microfluidic cell trap array for controlled positioning of single cells on adhesive micropattems,” Lab Chip, Feb. 2013, 13(4):714-721. |
| Linnarsson, “Recent advances in DNA sequencing methods—general principles of sample preparation,” Experimental Cell Research, 316: 1339-1343, 2010. |
| Lipinski et al., “Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine,” Trends Cancer, Jan. 2016, 2(1):49-63. |
| Liu et al. “Barcoded oligonucleotides ligated on RNA amplified for multiplexed and parallel in situ analyses,” Nucleic Acids Res., Mar. 8, 2021, 49(10):e58, 15 pages. |
| Liu et al., “Method for Quantitative Proteomics Research by Using Metal Element Chelated Tags Coupled with Mass Spectrometry,” Analytical Chemistry, 2006, 78:6614-6621. |
| Liu et al., “Optochemical control of deoxyoligonucleotide function via a nucleobase-caging approach,” Acc. Chem. Res., Jan. 2014, 47(1):45-55. |
| Liu et al., “Surface and interface control on photochemically initiated immobilization,” J Am Chem Soc., Nov. 2006, 128(43):14067-72. |
| Liu et al., An integrated and sensitive detection platform for biosensing application based on Fe@Au magnetic nanoparticles as bead array carries Biosensors and Bioelectronics, 2010, 26(4):1442-1448. |
| Lizardi et al., “Mutation detection and single-molecule counting using isothermal rolling-circle amplification,” Nat. Genet. 19: 225-232, 1998. |
| Lopez-Otín et al., “Protease degradomics: a new challenge for proteomics,” Nat Rev Mol Cell Biol., Jul. 2002, 3(7):509-19. |
| Lou et al., “A review of room temperature storage of biospecimen tissue and nucleic acids for anatomic pathology laboratories and biorepositories,” Clin Biochem., Mar. 2014, 47(4-5):267-73. |
| Lovatt et al., “Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue.”, Nature Methods 11, 190-196, 2014. |
| Lu et al., “A microfluidic electroporation device for cell lysis,” Lab Chip., Jan. 2005, 5(1):23-29. |
| Lubeck et al., “Single cell systems biology by super-resolution imaging and combinatorial labeling,” Nature Methods, Jan. 2013, 9(7):743-748, 18 pages. |
| Lubeck et al., “Single-cell in situ RNA profiling by sequential hybridization,” Nature Methods, Apr. 2014, 11(4):360-361, 2 pages (Supplemental Materials). |
| Lund et al., “Assessment of methods for covalent binding of nucleic acids to magnetic beads, Dynabeads, and the characteristics of the bound nucleic acids in hybridization reactions.”, Nucleic Acids Res., 16: 10861-80, 1988. |
| Lundberg et al., “High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus.,” Gene., 108(1): 1-6, 1991. |
| Lundberg et al., “Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood,” Nucleic Acids Res., 39(15): e102, 2011. |
| Lundberg et al., “Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material,” Mol Cell Proteomics, 10(4): M110.004978, 2011. |
| Lundin et al., “Increased throughput by parallelization of library preparation for massive sequencing,” PLoS One, Apr. 2010, 5(4):e10029, 7 pages. |
| Lundquist et al., “Parallel confocal detection of single molecules in real time,” Opt. Lett. 33, 1026-1028, 2008. |
| Lyamichev et al., “Invader assay for SNP genotyping,” Methods Mol Biol., 2003, 212:229-40. |
| Lyamichev et al., “Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes,” Nat Biotechnol,, Mar. 1999, 17(3):292-6. |
| Lyck, et al., “Immunohistochemical Markers for Quantitative Studies of Neurons and Glia in Human Neocortex,” J Histochem Cytochem 56, 201-21, 2008. |
| Lykidis et al., “Novel zinc-based fixative for high quality DNA, RNA and protein analysis,” Nucleic Acids Res., Jun. 2007, 35(12):e85, 10 pages. |
| Ma et al., “Isothermal amplification method for next-generation sequencing,” PNAS, Aug. 12, 2013, 110(35):14320-14323. |
| MacBeath et al., “Printing proteins as microarrays for high-throughput function determination,” Science, Sep. 2000, 289(5485):1760-1763. |
| MacIntyre, “Unmasking antigens for immunohistochemistry.,” Br J Biomed Sci. 58, 190-6, 2001. |
| Macosko et al., “Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets,” Cell 161, 1202-1214, May 2015. |
| Magaki et al., “An introduction to Performance of Immunohistochemistry,” Biobanking: Methods and Protocols, Method in Molecular Biology, Yong (ed.), 2019, 1897, Chapter 25, 289-298. |
| Malkov et al., “Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter™ Assay System.” BMC research notes., 2009, 2:80. |
| Maniatis et al., “Spatiotemporal Dynamics of Molecular Pathology in Amyotrophic Lateral Sclerosis”, 54 pages, 2018. |
| Marras, “Selection of fluorophore and quencher pairs for fluorescent nucleic acid hybridization probes,” Methods Mol Biol., 2006, 335:3-16. |
| Martin, “Cutadapt removes adapter sequences from high-throughput sequencing reads,” EMBnet Journal, 2011, 17(1):10-12. |
| Marzo et al., “Holographic acoustic elements for manipulation of levitated objects,” Nature Communications, Oct. 2015, 6:8661, 7 pages. |
| Massey et al., “Fluorescence resonance energy transfer (FRET) for DNA biosensors: FRET pairs and Förster distances for various dye-DNA conjugates,” Anal Chim Acta., May 2006, 568(1-2):181-9. |
| Masuda et al., “Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples,” Nucleic Acids Research, Nov. 1999, 27(22):4436-4443. |
| Materna et al., “High accuracy, high-resolution prevalence measurement for the majority of locally expressed regulatory genes in early sea urchin development,” Gene Expr Patterns., 2010, 10(4-5):177-184. |
| Mathieson et al., “A Critical Evaluation of the PAXgene Tissue Fixation System: Morphology, Immunohistochemistry, Molecular Biology, and Proteomics,” Am J Clin Pathol., Jul. 8, 2016, 146(1):25-40. |
| Mattheyses et al., “Imaging with total internal reflection fluorescence microscopy for the cell biologist,” J Cell Sci., Nov. 2010, 123(Pt 21):3621-3628. |
| Mauleon et al., “Precise Spatial and Temporal Control of Oxygen within In Vitro Brain Slices via Microfluidic Gas Channels,” PLoS One, Aug. 2012, 7(8):e43309, 9 pages. |
| McCloskey et al., “Encoding PCR Products with Batch-stamps and Barcodes,” Biochem. Genet. 45: 761-767, 2007. |
| McDade et al., “Practical Considerations for Using Pooled Lentiviral CRISPR Libraries,” Curr Protoc Mol Biol., Jul. 2016, 115:31.5.1-31.5.13. |
| Mcgee, “Structure and Analysis of Affymetrix Arrays,” UTSW Microarray Analysis Course, Oct. 28, 2005, 68 pages. |
| McGinn et al., “New technologies for DNA analysis—a review of the READNA Project,” N Biotechnol., May 3, 2016, 33(3): 311-30. |
| McGrath et al., “Building towards precision medicine: empowering medical professionals for the next revolution,” BMC Medical Genomics, May 2016, 9(1):23, 6 pages. |
| McKernan et al., “Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding,” Genome Res., 19: 1527-41, 2009. |
| Megason et al., “Imaging in Systems Biology,” Cell 130, Sep. 7, 2007, pp. 784-795. |
| Mele et al., “The Human Transcriptome Across Tissues and Individuals,” Science, May 2015, 348(6235):660-5. |
| Metzker “Sequencing technologies—the next generation,” Nature Reviews Genetics, 11: 31-46, 2010. |
| Meyer et al., “Fast evolving 18S rRNA sequences from Solenogastres (Mollusca) resist standard PCR amplification and give new insights into mollusk substitution rate heterogeneity,” BMC Evol. Biol., Mar. 2010, 10:70, 12 pages. |
| Micke et al., “Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens,” Lab Invest., Feb. 2006, 86(2):202-11. |
| Miele et al., “Mapping cis- and trans-chromatin interaction networks using chromosome conformation capture (3C),” Methods Mol Biol., 2009, 464:105-21. |
| Mignardi et al., “Oligonucleotide gap-fill ligation for mutation detection and sequencing in situ,” Nucleic Acids Research, Aug. 3, 2015, 43(22):e151, 12 pages. |
| Miller et al., “Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology,” Clinical Microbiology Reviews, vol. 22, No. 4, pp. 611-633, 2009. |
| Miller et al., “Chapter 11—Solid and Suspension Microarrays for Microbial Diagnostics,” Methods in Microbiology, 2015, 42:395-431. |
| Miner et al., “Molecular barcodes detect redundancy and contamination in hairpin-bisulfite PCR,” Nucleic Acids Res., Sep. 2004, 32(17):e135, 4 pages. |
| Mir et al., “Sequencing by cyclic ligation and cleavage (CycliC) directly on a microarray captured template,” Nucleic Acids Research, 37(1):e5, 8 pages, 2009. |
| Mishra, “Three-dimensional genome architecture and emerging technologies: looping in disease”, Genome Medicine, 9: 87, 14 pages, 2017. |
| Mitra et al., “Digital genotyping and haplotyping with polymerase colonies,” Proc. Natl. Acad. Sci. USA, May 2003, 100(10):5926-5931. |
| Mitra et al., “Fluorescent in situ sequencing on polymerase colonies,” Anal Biochem, Sep. 2003, 320(1):55-65. |
| Mitra et al., “In situ localized amplification and contact replication of many individual DNA molecules,” Nucleic Acids Res., Dec. 1999, 27(24):e34, 6 pages. |
| Mitsuhashi et al., “Gene manipulation on plastic plates,” Nature 357: 519-520, 1992. |
| Mizusawa et al., “A bacteriophage lambda vector for cloning with BamHI and Sau3A,” Gene, 20: 317-322, 1982. |
| Mlecinik et al., “Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction,” J Clin Oncol., Feb. 2011, 29(6):610-8. |
| Moffitt et al., “RNA Imaging with Multiplexed Error-Robust Fluorescence In Situ Hybridization (MERFISH),” Methods Enzymol., 2016, 572:1-49. |
| Mohsen et al., “The Discovery of Rolling Circle Amplification and Rolling Circle Transcription,” Acc Chem Res., Nov. 15, 2016, 49(11):2540-2550, 25 pages. |
| Moncada et al., “Building a tumor atlas: integrating single-cell RNA-Seq data with spatial transcriptomics in pancreatic ductal adenocarcinoma”, Institute for Computational Medicine, bioRxiv, 28 pages, 2018. |
| Moor et al., “Spatial transcriptomics: paving the way for tissue-level systems biology”, Science Direct, Current Opinion in Biotechnology, 46: 126-133, 2017. |
| Morlan et al., “Selective depletion of rRNA enables whole transcriptome profiling of archival fixed tissue,” PLoS One, Aug. 2012, 7(8):e42882, 8 pages. |
| Mortazavi et al., “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nature Methods, 5(7): 621-8, 2008. |
| Moshrefzadeh et al., “Nonuniform photobleaching of dyed polymers for optical waveguides,” Applied Physics Letters, 1993, 62:16-18. |
| Motea et al., “Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase,” Biochim Biophys Acta., May 2010, 1804(5):1151-66. |
| Mueller et al., “RNA Integrify Number (RIN)—Standardization of RNA Quality Control,” Agilent Technologies, 2004, 8 pages. |
| Mukherjee et al., “Insects as models to study the epigenetic basis of disease,” Prog Biophys Mol Biol., Jul. 2015, 118(1-2):69-78. |
| Nadji et al., “Immunohistochemistry of tissue prepared by a molecular-friendly fixation and processing system,” Appl Immunohistochem Mol Morphol., Sep. 2005, 13(3):277-82. |
| Nagahara et al., “Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease,” Nat Med., Mar. 2009, 15(3):331-337. |
| Nagai et al., “Site-specific DNA cleavage by antisense oligonucleotides covalently linked to phenazine di-N-oxide,” J Biol. Chem., Dec. 1991, 266(35):23994-4002. |
| Nakamura et al., “Biocompatible inkjet printing technique for designed seeding of individual living cells,” Tissue Eng, Nov. 2005, 11(11-12):1658-1666. |
| Nakao et al., “Myosin heavy chain gene expression in human heart failure,” J Clin Invest., Nov. 1997, 100(9):2362-70. |
| Nallur et al., “Signal amplification by rolling circle amplification on DNA microarrays,” Nucleic Acids Res., Dec. 1, 2001, 29(23):e118, 9 pages. |
| Nam et al., “Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins,” Science, Sep. 26, 2003, 301(5641):1884-1886. |
| Nandakumar et al., “How an RNA Ligase Discriminates RNA versus DNA Damage,” Molecular Cell, 2004, 16(2):211-221. |
| Nandakumar et al., “RNA Substrate Specificity and Structure-guided Mutational Analysis of Bacteriophage T4 RNA Ligase 2,” Journal of Biological Chemistry, Jul. 2004, 279(30):31337-31347. |
| Nawy, “Spatial transcriptomics”, Nature Methods, vol. 15, No. 1, 2018. |
| NCBI Reference Sequence: NR_003286.2, “Homo sapiens RNA, 18S ribosomal 5 (RNA18S5), ribosomal RNA,” dated Feb. 4, 2017, 2 pages. |
| Ncbi.nlm.nih.gov, [online], “Molecular Inversion Probe Assay,” available on or before Oct. 14, 2014, via Internet Archive: Wayback Machine URL<https://web.archive.org/web/20141014124037/https://www.ncbi.nlm.nih.gov/probe/docs/techmip/>, retrieved on Jun. 16, 2021, retrieved from URL<https://www.ncbi.nlm.nih.gov/probe/docs/techmip/>, 2 pages. |
| Nelson et al., “Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions,” J Virol., Jul. 2016, 90(16):7268-7284. |
| Newman et al., “Robust enumeration of cell subsets from tissue expression profiles,” Nature Methods, May 2015, 12(5):453-457. |
| Ng et al., “Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation,” Nature Methods, 2(2): 105-111, 2005. |
| Ng et al., “Massively parallel sequencing and rare disease,” Human Malec. Genetics, 19(2): R119-R124, 2010. |
| Ng et al., “Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes,” Nucleic Acids Research, Jul. 2006, 34(12): e84, 10 pages. |
| Nichols et al., “RNA Ligases,” Curr Protoc Mol Biol., Oct. 2008, 84(1):3.15.1-3.15.4. |
| Nicholson, “Diffusion and related transport mechanisms in brain tissue,” Rep. Prog. Phys., Jun. 2001, 64(7):815-884. |
| Niedringhaus et al., “Landscape of next-generation sequencing technologies,” Anal Chem., Jun. 2011, 83(12):4327-41. |
| Niemeyer, “The developments of semisynthetic DNA-protein conjugates,” Trends Biotechnol, Sep. 2002, 20(9): 395-401. |
| Niimi et al., “Melting Temperature Mapping Method: A Novel Method for Rapid Identification of Unknown Pathogenic Microorganisms within Three Hours of Sample Collection,” Sci. Rep., Jul. 2015, 5:12543, 13 pages. |
| Nikiforov et al., “The use of 96-well polystyrene plates for DNA hybridization-based assays: an evaluation of different approaches to oligonucleotide immobilization,” Anal Biochem, May 1995, 227(1):201-9. |
| Niklas et al., “Selective permeabilization for the high-throughput measurement of compartmented enzyme activities in mammalian cells,” Anal Biochem, Sep. 2011, 416(2):218-27. |
| Nilsson et al., “Padlock Probes: Circularizing Oligonucleotides for Localized DNA Detection,” Science, Sep. 30, 1994, 265(5181):2085-2088. |
| Nilsson et al., “RNA-templated DNA ligation for transcript analysis,” Nucleic Acids Res., Jan. 2001, 29(2):578-81. |
| Nuovo, “In situ PCR: protocols and applications.,” Genome Res, Feb. 1995, 4 (4):151-167. |
| Ohtsubo et al., “Bacterial insertion sequences,” Curr Top Microbiol Immunol., 1996, 204:1-26. |
| Oleinikov et al., “Self-assembling protein arrays using electronic semiconductor microchips and in vitro translation,” J Proteome Res, May-Jun. 2003, 2(3): 313-319. |
| Olink Proteomics AB, Proseek® Multiplex 96x96 User Manual, 2016, 12 pages. |
| Olivier, “The Invader assay for SNP genotyping,” Mutat. Res., Jun. 2005, 573(1-2):103-110. |
| Oren et al., “Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study,” Biochemistry, Feb. 1997, 36(7):1826-35. |
| Osada et al., “Epitope mapping using ribosome display in a resconstituted cell-free protein synthesis system,” J Biochem, May 2009, 145(5): 693-700. |
| O-Shannessy et al., “Detection and quantitation of hexa-histidine-tagged recombinant proteins on western blots and by a surface plasmon resonance biosensor technique,” Anal Biochem, 229(1): 119-124, 1995. |
| Ostuni et al., “Patterning Mammalian Cells Using Elastomeric Membranes,” Langmuir, Aug. 2000, 16(20):7811-7819. |
| Ozsolak et al., “Digital transcriptome profiling from attomole-level RNA samples,” Genome Res., Apr. 2010, 20(4):519-25. |
| Palamanda et al., “Evaluation of CYP1A1 and CYP2B1/2 m-RNA Induction in Rat Liver Slices Using the NanoString® Technology: A Novel Tool for Drug Discovery Lead Optimization,” Drug metabolism letters, Nov. 3, 2009, 3(3):171-175. |
| Pandey et al., “Inhibition of terminal deoxynucleotidyl transferase by adenine dinucleotides. Unique inhibitory action of Ap5A,” FEBS Lett., Mar. 1987, 213(1):204-8. |
| Park et al., “Cancer gene therapy using adeno-associated virus vectors,” Front Biosci., Jan. 2008, 13:2653-59. |
| Park et al., “The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility,” Cancer Res. Treat., Feb. 2003, 35(1):35-51, Abstract. |
| Patil et al., “DNA-based therapeutics and DNA delivery systems: a comprehensive review,” AAPS J, Apr. 2005, 7(1):E61-77. |
| Patton et al., “Rainbow's end: the quest for multiplexed fluorescence quantitative analysis in proteomics.” Current Opinion in Chemical Biology, Feb. 1, 2002, 6(1):63-69. |
| PCT International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/057355, dated Oct. 10, 2017, 7 pages. |
| PCT International Search Report and Written Opinion issued in International Appln. No. PCT/EP2016/057355, dated Aug. 5, 2016, 8 pages. |
| Pearson et al., “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci., May 1988, 85:2444-2448. |
| Pellestor et al., “The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics,” Eur J Hum Genet., Sep. 2004, 12(9):694-700. |
| Pemov et al., “DNA analysis with multiplex microarray-enhanced PCR,” Nucl. Acids Res., Jan. 2005, 33(2):e11, 9 pages. |
| Penland et al., “RNA expression analysis of formalin-fixed paraffin-embedded tumors,” Laboratory Investigation, Apr. 2007, 87(4):383-391. |
| Perler et al., “Intervening sequences in an Archaea DNA polymerase gene,” PNAS USA, Jun. 1992, 89(12): 5577-5581. |
| Perocchi et al., “Antisense artifacts in transcriptome microarray experiments are resolved by actinomycin D,” Nucleic Acids Res., 2007, 35(19):e128, 7 pages. |
| Petterson et al., “Generations of sequencing technologies,” Genomics, 2009, 105-111. |
| Picelli et al., “Full-length RNA-seq from single cells using Smart-seq2,” Nat Protoc., Jan. 2014, 9(1):171-81. |
| Picelli et al., “Tn5 transposase and tagmentation procedures for massively scaled sequencing projects,” Genome Res., Dec. 2014, 24(12):2033-40. |
| Pipenburg et al., “DNA detection using recombination proteins,” PLoS Biol., Jul. 2006, 4(7):e204, 7 pages. |
| Pirici et al., “Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtypem,” J. Histochem. Cytochem., Jun. 2009, 57(6):567-75. |
| Piston et al., “Fluorescent protein FRET: the good, the bad and the ugly,” Trends Biochem Sci., Sep. 2007, 32(9):407-14. |
| Plasterk, “The Tc1/mariner transposon family,” Curr Top Microbiol Immunol., 1996, 204:125-43. |
| Plongthongkum et al., “Advances in the profiling of DNA modifications: cytosine methylation and beyond,” Nature Reviews Genetics, Aug. 2014, 15(10):647-661. |
| Pluen et al., “Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations,” Biophys J., Jul. 1999, 77(1):542-552. |
| Polsky-Cynkin et al., “Use of DNA Immobilizedon Plastic and Agarose Supports to Detect DNA by Sandwich Hybridization,” Clin. Chem. 31: 1438-1443, 1985. |
| Porreca et al., “Polony DNA sequencing,” Curr Protoc Mol Biol., Nov. 2006, Chapter 7, Unit 7.8, pp. 7.8.1-7.8.22. |
| Primebioscience.com, [online], “Brain Slice Systems, Recording Chambers, Stage Adapters, Temperature Controller,” 2017, retrieved on Dec. 28, 2021, retrieved from URL<http://primebioscience.com/pb-applications/brain-slice-systems-recording-chambers-stage-adapterstemperature-controller/>, 7 pages. |
| Promega, “GoScript™ Reverse Transcription System—Technical Manual,” promega.com, revised Dec. 2012, 24 pages. |
| U.S. Appl. No. 61/267,363, filed Dec. 7, 2009 (Year: 2009). |
| Punwaney et al., “Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction,” Head & Neck, Jan. 1999, 21(1):21-29. |
| Qiu et al., “Combination probes with intercalating anchors and proximal fluorophores for DNA and RNA detection,” Nucleic Acids Research, Sep. 2016, 44(17):e138, 12 pages. |
| Raab et al., “Human tRNA genes function as chromatin insulators,” EMBO J., Jan. 2012, 31(2):330-50. |
| Raj et al., “Imaging individual mRNA molecules using multiple singly labeled probes,” Nature Methods, Oct. 2008, 5(10):877-879, 9 pages. |
| Rajeswari et al., “Multiple pathogen biomarker detection using an encoded bead array in droplet PCR,” J. Microbial Methods, Aug. 2017, 139:22-28. |
| Ramachandran et al., “Next-generation high-density self-assembling functional protein arrays,” Nature Methods, Jun. 2008, 5(6):535-538. |
| Ramanujan et al., “Diffusion and convection in collagen gels: implications for transport in the tumor interstitium,” Biophys. J., Sep. 2002, 83(3):1650-1660. |
| Ranki et al., “Sandwich hybridization as a convenient method for the detection of nucleic acids in crude samples”, Gene 21: 77-85, cellulose, 1983. |
| Raouane et al., “Lipid conjugated oligonucleotides: a useful strategy for delivery,” Bioconjug Chem., Jun. 2012, 23(6):1091-104. |
| Razonable, “Antiviral drugs for viruses other than human immunodeficiency virus,” Mayo Clinic Proceedings, Oct. 2011, 86(10):1009-26. |
| Reijenga et al., “Buffer Capacity, Ionic Strength and Heat Dissipation in Capillary Electrophoresis,” Journal of Chromatography A, Sep. 13, 1996, 744(1-2):147-153. |
| Reinartz et al., “Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organisms,” Brief Funct Genomic Proteomic, Feb. 2002, 1(1):95-104. |
| Ren et al., “Star Polymers,” Chem Rev., Jun. 2016, 116(12):6743-836. |
| Rettig et al., “Large-scale single-cell trapping and imaging using microwell arrays,” Anal Chem, Sep. 2005, 77(17):5628-5634. |
| Reznikoff, “Tn5 as a model for understanding DNA transposition,” Mol Microbiol., Mar. 2003, 47(5):1199-206. |
| Richardson et al., “Clarifying Tissue Clearing,” Cell, Jul. 2015, 162(2):246-257. |
| Ripoli et al., “A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay,” Int. J. Mol. Sci., May 2016, 17(5):724, 11 pages. |
| Ristic et al., “Detection of Protein-Protein Interactions and Posttranslational Modifications Using the Proximity Ligation Assay: Application to the Study of the SUMO Pathway,” Methods Mol. Biol., 2016, 1449:279-90. |
| Ristova et al., “Study of hydrogenated amorphous silicon thin films as a potential sensor for He—Ne laser light detection,” Applied Surface Science, Sep. 2003, 218(1-4):44-53. |
| Roberts et al., “RNA-peptide fusions for the in vitro selection of peptides and proteins,” PNAS USA, Nov. 1997, 94: 12297-122302. |
| Robinson et al., “Small-sample estimation of negative binomial dispersion, with applications to SAGE data,” Biostatistics, Apr. 2008, 9(2):321-332. |
| Rogers et al., “Immobilization of oligonucleotides onto a glass support via disulfide bonds: A method for preparation of DNA microarrays,” Anal Biochem., Jan. 1999, 266(1):23-30. |
| Rogers et al., “Use of a novel cross-linking method to modify adenovirus tropism,” Gene Ther., Dec. 1997, 4(12):1387-92. |
| Ronaghi et al., “A sequencing method based on real-time pyrophosphate,” Science, Jul. 1998, 281(5375): 363-365. |
| Ronaghi et al., “Real-time DNA sequencing using detection of pyrophosphate release,” Analytical Biochemistry, Nov. 1996, 242(1 ): 84-89. |
| Ronaghi, “Pyrosequencing sheds light on DNA sequencing,” Genome Res, Jan. 2001, 11(1):3-11. |
| Rosenthal et al., “Cell patterning chip for controlling the stem cell microenvironment,” Biomaterials, Jul. 2007, 28(21):3208-3216. |
| Rouillard et al., “OligoArray 2.0: design of oligonucleotide probes for DNA microarrays using a thermodynamic approach,” Nuc. Acid Research, Jun. 2003, 31(12): 3057-3062. |
| Rountenberg et al., “Microfluidic probe: a new tool for integrating microfluidic environments and electronic wafer-probing,” Lab Chip, Oct. 2009, 10(1):123-127. |
| Roy et al., “Assessing long-distance RNA sequence connectivity via RNA-templated DNA-DNA ligation,” eLife, Apr. 2015, 4:e03700. |
| Rubin et al., “Whole-genome resequencing reveals loci under selection during chicken domestication.,” Nature, Mar. 2010, 464: 587-591. |
| Rubina et al., “Hydrogel-based protein microchips: manufacturing, properties, and applications,” Biotechniques, May 2003, 34(5):1008-14. |
| Running et al., “A procedure for productive coupling of synthetic oligonucleotides to polystyrene microtiter wells for hybridization capture,” Biotechniques, Mar. 1990, 8(3):276-279. |
| Rush et al., “New Aldehyde Tag Sequences Identified by Screening Formylglycine Generating Enzymes in Vitro and in Vivo,” J. of American Chemical Society, Aug. 2008, 130(37): 12240-12241. |
| Rusk, “Spatial transcriptomics,” Nature Methods, Sep. 2016, 13(9):710-711. |
| Russell et al., “Molecular mechanisms of late endosome morphology, identity and sorting,” Curr. Opin. Cell Bio., Aug. 2006, 18(4):422-428. |
| Sack et al., “Express photolithographic DNA microarray synthesis with optimized chemistry and high-efficiency photolabile groups,” Journal of Nanobiotechnology, Mar. 2016, 14:14, 13 pages. |
| Salem et al., “Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors”, bioRxiv, 41 pages, 2018. |
| Sambrook and Russell, “Chapter 5, Gel Electrophoresis of DNA and Pulsed-field Agarose Gel Electrophoresis: Protocol 13, Preparation of DNA for Pulsed-field Gel Electrophoresis: Isolation of DNA from Mammalian Cells and Tissues,” Molecular Cloning: A Laboratory Manual, 2001, 5 pages. |
| San Paulo et al., “High-resolution imaging of antibodies by tapping-mode atomic force microscopy: attractive and repulsive tip-sample interaction regimes,” Biophys J., Mar. 2000, 78(3):1599-1605. |
| Sano et al., “Immuno-PCR: Very Sensitive Antigen Detection by Means of Specific Antibody-DNA Conjugates,” Science, Oct. 2, 1992, 258(5079):120-122. |
| Sasagawa et al., “Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension,” Front Pharmacol., Jun. 2016, 7:142, 13 pages. |
| Satija et al., “Spatial reconstruction of single-cell gene expression data,” Nature, Apr. 13, 2015, 33(5):495-402, 14 pages. |
| Schaus et al., “A DNA nanoscope via auto-cycling proximity recording,” Nat. Commun. 8, 696, 10 pages, 2017. |
| Schellings et al., “Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction,” J Exp Med., Jan. 2009, 206(1):113-23. |
| Schena et al., “Quantitative monitoring of gene expression patterns with a complementary DNA microarray,” Science, Oct. 1995, 270(5235):467-470. |
| Schena et al., “Entering the Postgenome Era,” Science, 1995, 270:368-9, 371. |
| Schlapak et al., “Glass surfaces grafted with high-density poly (ethylene glycol) as substrates for DNA oligonucleotide microarrays,” Langinuir, Jan. 2006, 22: 277-285. |
| Schmidt et al., “Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease,” PloS one, May 2013, 8(5):e63136, 6 pages. |
| Schmitt et al., “Detection of ultra-rare mutations by next-generation sequencing,” PNAS (2012) 109:14508-14523. |
| Scholz et al., “The Molecular Chaperone Hsp90 Is Required for Signal Transduction by Wild-Type Hck and Maintenance of Its Constitutively Active Counterpart1,” Cell Growth Differ., Aug. 2001, 12(8):409-417. |
| Schouten et al., “Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification,” Nucleic Acids Res., Jun. 2002, 30(12):e57, 13 pages. |
| Schroeder et al., “The RIN: an RNA integrity number for assigning integrity values to RNA measurements,” BMC Molecular Biology, Jan. 2006, 7:3, 14 pages. |
| Schwartz et al., “Capturing native long-range contiguity by in situ library construction and optical sequencing,” PNAS, Nov. 13, 2012, 109(46):18749-18754. |
| Schweitzer et al., “Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection,” Proc. Natl Acad. Sci. USA, May 22, 2000, 97:10113-119. |
| Schweitzer et al., “Multiplexed protein profiling on microarrays by rolling-circle amplification,” Nature Biotechnology, Apr. 2002, 20(4):359-365. |
| Schwers et al., “A high-sensitivity, medium-density, and target amplification-free planar waveguide microarray system for gene expression analysis of formalin-fixed and paraffin-embedded tissue,” Clin. Chem., Nov. 2009, 55(11):1995-2003. |
| ScienceDirect.com [online], “Plant Fibers,” Definition, 2011, retrieved on Apr. 13, 2022, retrieved from URL<https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/plant-fibers>, 9 pages. |
| Sekar et al., “Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations,” J Cell Biol., Mar. 2003, 160(5):629-33. |
| Sergeeva et al., “Display technologies: Application for the discovery of drug and gene delivery aaents,” Advanced Drug Delivery Reviews (2006) 58(15):1622-1654. |
| Seurynck-Servoss et al., “Evaluation of Surface Chemistries for Antibody Microarrays”, Anal Biochem., 371(1): 105-115, 2007. |
| Shalon et al., “A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization,” Genome Res., Jul. 1996, 6(7):639-45. |
| Shelbourne et al., “Fast copper-free click DNA ligation by the ring-strain promoted alkyne-azide cycloaddition reaction,”, Chem. Commun., 47: 6257-6259, 2011. |
| Shendure et al., “Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome,” Science, 2005, 309:1728-1732. |
| Shi et al., “The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements,” Nature Biotechnology, 2006, 24(9):1151-61. |
| Shi, “Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies,” Clin. Chem., Feb. 2001, 47(2):164-172. |
| Shibata et al., “Detection of human papilloma vims in paraffin-embedded tissue using the polymerase chain reaction,” J Exp Med., Jan. 1988, 167(1):225-30. |
| Shirai et al., “Novel Tools for Analyzing Gene Expressions in Single Cells,” The 5th International Workshop on Approaches to Single-Cell Analysis, The University of Tokyo, Mar. 3-4, 2011, 1 page. |
| Shirai et al., “Photocrosslinkable polymers with degradable properties,” Polymer Journal, Sep. 2014, 46:859-865. |
| Shoemaker et al., “Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy,” Nature genetics (1996) 14:450-456. |
| Shrestha et al., “Understanding FRET as a research tool for cellular studies,” Int J Mol Sci., Mar. 2015, 16(4):6718-56. |
| Shults et al., “A multiplexed protein kinase assay,” Chem Bio Chem (2007) 8:933-942. |
| Sievertzon et al., “Transcriptome analysis in primary neural stem cells using a tag cDNA amplification method,” BMC Neuroscience, Dec. 2005, 6: 28. |
| Simonis et al., “Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C),” Nat Genet., Nov. 2006, 38(11):1348-54. |
| Skene et al., “An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites,” Elife, Jan. 2017, 6:e21856, 35 pages. |
| Skipper et al., “DNA transposon-based gene vehicles—scenes from an evolutionary drive,” J Biomed Sci., Dec. 2013, 20(1):92, 23 pages. |
| Slomovic et al., “Addition of poly (A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells,” Proc Natl Acad Sci USA, Apr. 2010, 107(16):7407-12. |
| Slonim and Yanai, “Getting started in gene expression microarray analysis,” Plos Computational Biology, 2009, 5(10):e1000543. |
| Smejkal et al., “Microfluidic isotachophoresis: a review,” Electrophoresis, Jun. 2013, 34(11):1493-1509. |
| Smolock et al., “Ribosomal Protein L17, RpL17, is an Inhibitor of Vascular Smooth Muscle Growth and Carotid Intima Formation,” Circulation, Nov. 2012, 126(20):2418-2427. |
| Soderberg et al. “Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay,” Methods, Jul. 2008, 45(3):227-232. |
| Soderberg et al., “Direct observation of individual endogenous protein complexes in situ by proximity ligation,” Nature Methods, 2006, 3:995-1000. |
| Son et al., “A platform for ultrasensitive and selective multiplexed marker protein assay toward early-stage cancer diagnosis,” Nanomedicine, Feb. 7, 2007, 2(1):79-82. |
| Soni and Meller, “Progress toward ultrafast DNA sequencing using solid-state nanopores,” Clin Chem., 2007, 53: 1996-2001. |
| Sparrer et al., “Intracellular detection of viral nucleic acids,” Curr. Opin. Microbiol., Aug. 2015, 26:1-9. |
| Spiess et al., “A highly efficient method for long-chain cDNA synthesis using trehalose and betaine,” Anal. Biochem., Feb. 2002, 301(2):168-74. |
| Spille et al., “Labelling and imaging of single endogenous messenger RNA particles in vivo,” Journal of Cell Science, Oct. 2015, 128(20):3695-3706. |
| Spitale et al., “Structural imprints in vivo decode RNA regulatory mechanisms”, Nature, 519(7544): 486-90, 2015. |
| Spurgeon et al., “High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array,” Plos ONE, 2008, 3(2):e1662. |
| Stahl et al., “Visualization and analysis of gene expression in tissue sections by spatial transcriptomics,” Science, Jul. 2016, 353(6294):78-82. |
| Stahl et al., “Visualization and analysis of gene expression in tissue sections by spatial transcriptomics,” Science, Jun. 2016, Supplementary Materials, 353(6294):78-82, 41 pages. |
| Stevens Jr. et al., “Enhancement of phosphoprotein analysis using a fluorescent affinity tag and mass spectrometry,” Rapid Commun Mass Spectrom, 2005, 19(15):2157-62. |
| Stimpson et al., “Real-time detection of DNA hybridization and melting on oligonucleotide arrays by using optical wave guides,” Proc Natl Acad Sci USA, Jul. 1995, 92(14):6379-83. |
| Stoddart et al., “Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore,” PNAS U S A., May 2009, 106(19):7702-7707. |
| Strell et al., “Placing RNA in context and space—methods for spatially resolved transcriptomics”, The FEBS Journal, 14 pages, 2017. |
| Stroh et al., “Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo,” Nat Med., Jun. 2005, 11(6):678-82. |
| Subramanian et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” PNAS, Oct. 2005, 102(43):15545-15550. |
| Suh et al., “A simple soft lithographic route to fabrication of poly (ethylene glycol) microstructures for protein and cell patterning,” Biomaterials, Feb. 2004, 25(3):557-563. |
| Sumida et al., “Complement C1q-induced activation of β-catenin signalling causes hypertensive arterial remodelling,” Nat Commun,, Feb. 2015, 6:6241, 12 pages. |
| Sumitomo et al., “Ca2+ ion transport through channels formed by -hemolysin analyzed using a microwell array on a Si substrate,” Biosensors and Bioelectronics, 2012, 31(1):445-450. |
| Summersgill et al., “Fluorescence In Situ Hybridization Analysis of Formalin Fixed Paraffin Embedded Tissues, Including Tissue Microarrays,” Chapter 4, Bridger, J. Ed., Methods in Molecular Biology 659, 2010, 51-70, 2010. |
| Sun et al., “Direct immobilization of DNA probes on non-modified plastics by UV irradiation and integration in microfluidic devices for rapid bioassay,” Anal. Bio. Chem., 402: 741-748, 2012. |
| Surzhik et al., “Template-dependent biosynthesis of poly(G) x poly (C) and its antiviral activity in vitro and in vivo,” Antiviral Res., May 1988, 38(2):131-40. |
| Sutherland et al., “Utility of formaldehyde cross-linking and mass spectrometry in the study of protein-protein interactions,” J. Mass Spectrom., Jun. 2008, 43(6):699-715. |
| Swartz et al., “Interstitial flow and its effects in soft tissues,” Annu Rev Biomed Eng., 2007, 9:229-56. |
| Syková et al., “Diffusion in brain extracellular space,” Physiol Rev., Oct. 2008, 88(4):1277-340. |
| Tai et al., “Replication-competent retrovirus vectors for cancer gene therapy,” Front Biosci., Jan. 2008, 13:3083-95. |
| Takahashi et al., “In Vitro Selection of Protein and Peptide Libraries Using mRNA Display,” Nucleic Acid and Peptide Aptamers: Methods and Protocols (2009) 535:293-314 (Ch. 17). |
| Tan et al., “Parylene peel-off arrays to probe the role of cell-cell interactions in tumour angiogenesis,” Integr Biol (Camb), Oct. 2009, 1(10):587-594. |
| Tang et al., “RNA-Seq analysis to capture the transcriptome landscape of a single cell.,” Nat Protoc., 5: 516-35, 2010. |
| Taniguchi et al., “Quantitative analysis of gene expression in a single cell by qPCR,” Nature Methods, 6, pp. 503-506, 2009. |
| Tawfik et al., “Man-made cell-like compartments for molecular evolution,” Nat Biotechnol., Jul. 1998, 16(7):652-6. |
| Taylor et al., “Microfluidic local perfusion chambers for the visualization and manipulation of synapses,” Neuron., Apr. 2010, 66(1):57-68, 25 pages. |
| Taylor et al., “Mitochondrial DNA mutations in human disease.” Nature Reviews Genetics. May 2005, 6(5):389-402. |
| Tegtmeyer et al., “Alternative Interactions of the SV40 A Protein with DNA,” Virology, 1981, 115:75-87. |
| Tentori et al., “Detection of Isoforms Differing by a Single Charge Unit in Individual Cells.”, Chem. Int. Ed., 55, 12431, 2016. |
| Thacker et al., “Alkaline Hydrolysis—Carcass Disposal: A Comprehensive Review,” National Agriculture Biosecurity Center, Aug. 2004, Chapter 6, pp. 1-12. |
| Thi Be Tu et al., “The serum/PDGF-dependent “melanogenic” role of the minute level of the oncogenic kinase PAK1 in melanoma cells proven by the highly sensitive kinase assay,” Drug Discov Ther., Jan. 2017, 10(6):314-322. |
| Thiery et al., “Multiplex target protein imaging in tissue sections by mass spectrometry—TAMSIM,” Rapid Commun. Mass Spectrom., 2007, 21:823-829. |
| Thorne et al., “In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space,” Proc Natl Acad Sci USA, Apr. 2006, 103(14):5567-5572. |
| Thornton, “High rate thick film growth.” Annual review of materials science, Aug. 1977, 7(1):239-60. |
| Tian et al., “Antigen peptide-based immunosensors for rapid detection of antibodies and antigens,” Anal Chem May 26, 2009, 81 (13):5218-5225. |
| Tijssen et al., “Overview of principles of hybridization and the strategy of nucleic acid assays” in Techniques in Biochemistry and Molecular Biology—Hybridization with Nucleic Acid Probes, 1993, 24(Chapter 2), 65 pages. |
| Timofeev et al., “Regioselective immobilization of short oligonucleotides to acrylic copolymer gels,” Nucleic Acids Res., Aug. 1996, 24(16):3142-8. |
| Tolbert et al., “New Methods for Proteomic Research: Preparation of Proteins with N-Terminal Cysteines for Labeling and Conjugation,” Angewandte Chemie International Edition, Jun. 17, 2002, 41(12):2171-4. |
| Toseland, “Fluorescent labeling and modification of proteins,” J Chem Biol., Apr. 2013, 6(3):85-95. |
| Toss et al., “Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?,” Histopathology, Apr. 2017, 70(5):681-692. |
| Totet et al., “Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene,” J Eukaryot Microbiol., 2003, pp. 668-669. |
| Toubanaki et al., “Dry-reagent disposable biosensor for visual genotyping of single nucleotide polymorphisms by oligonucleotide ligation reaction: application to pharmacogenetic analysis,” Hum Mutat., Aug. 2008, 29(8):1071-8. |
| Toy et al., “A Simple Plastic Perfusion Chamber for Continuous Maintenance and Cinematography of Tissue Cultures,” Experimental Cell Research, 1958, 14:97-103. |
| Tseng et al., “Magnetic nanoparticle-mediated massively parallel mechanical modulation of single-cell behavior,” Nat Methods, Nov. 2012, 9(11):1113-1119. |
| Twyman et al., “Techniques Patents for SNP Genotyping,” Pharmacogenomics, Jan. 2003, 4(1):67-79. |
| Tzanetakis et al., “The use of reverse transcriptase for efficient first- and second-strand cDNA synthesis from single- and double-stranded RNA templates,” J Virol Methods, Mar. 2005, 24(1-2):73-7. |
| Ueno et al., “cDNA Display: Rapid Stabilitzation of mRNA Display,” Antibody-Drug Conjugates, Methods in Molecular Biology, Jan. 2012, pp. 113-135. |
| Ulery et al., “Biomedical Applications of Biodegradable Polymers,” J Polym Sci B Polym Phys., Jun. 2011, 49(12):832-864. |
| U.S. Appl. No. 60/416,118 Fan et al., Multiplex Nucleic Acid Analysis Using Archived or Fixed Samples, filed Oct. 3, 2002, 22 pages. |
| Valencia et al., “mRNA-Display-Based Selections for Proteins with Desired Functions: A Protease-Substrate Case Study.” Biotechnology progress, May 2008, 24(3):561-9. |
| Valley et al., “Optoelectronic tweezers as a tool for parallel single-cell manipulation and stimulation,” IEEE Trans Biomed Circuits Syst, Dec. 2009, 3(6):424-31. |
| Van Gelder et al., “Amplified RNA synthesized from limited quantities of heterogeneous cDNA,” Proc. Natl. Acad. Sci. USA 87, 1663-1667, 1990. |
| Van Ness et al., “A versatile solid support system for oligodeoxynucleotide probe-based hybridization assays”, Nucleic Acids Res. 19: 3345-3350, 1991. |
| Van Vught et al., “Site-specific functionalization of proteins and their applications to therapeutic antibodies,” Comput Struct Biotechnol J., Feb. 2014, 9:e201402001, 13 pages. |
| Vandenbroucke et al., “Quantification of splice variants using real-time PCR,” Nucleic Acids Research, 2001, 29(13):e68, 7 pages. |
| Vandernoot et al., “cDNA normalization by hydroxyapatite chromatography to enrich transcriptome diversity in RNA-seq applications,” Biotechniques, Dec. 2012, 53(6):373-80. |
| Vasiliskov et al., “Fabrication of microarray of gel-immobilized compounds on a chip by copolymerization,” Biotechniques, Sep. 1999, 27(3):592-606. |
| Velculescu et al., “Serial analysis of gene expression.” Science, Oct. 20, 1995, 270(5235):484-7. |
| Veneziano et al., “Designer nanoscale DNA assemblies programmed from the top down,” Science, Jun. 2016, 352(6293):1534, 10 pages. |
| Vermesh et al., “High-density, multiplexed patterning of cells at single-cell resolution for tissue engineering and other applications,” Angew Chem Int Ed Engl, Aug. 2011, 50(32):7378-7380. |
| Vickovic et al., “Massive and parallel expression profiling using microarrayed single-cell sequencing,” Nat. Commun. Oct. 14, 2016, 7:13182, 9 pages. |
| Vickovic et al., “Massive and parallel expression profiling using microarrayed single-cell sequencing,” Nature Communications, 2016, 7(13182):1-9. |
| Vincent et al., “Helicase-dependent isothermal DNA amplification,” EMBO Rep., Aug. 2004, 5(8):795-800. |
| Viollet et al., “T4 RNA ligase 2 truncated active site mutants: improved tools for RNA analysis,” BMC Biotechnol., Jul. 2011, 11:72, 14 pages. |
| Vlassakis et al., “Effect of Polymer Hydration State on In-Gel Immunoassays,” Anal Chem., Nov. 2015, 87(21): 11030-8. |
| Vogelstein et al., “Digital PCR,” Proceedings of the National Academy of Sciences, Aug. 3, 1999, 96:9236-9241. |
| Wade et al., “Genome sequence, comparative analysis, and population genetics of the domestic horse.,” Science., 326: 865-7, 2009. |
| Waichman et al., “Functional immobilization and patterning of proteins by an enzymatic transfer reaction,” Analytical chemistry, Jan. 21, 2010, 82(4):1478-85. |
| Walker et al., “Strand displacement amplification—an isothermal, in vitro DNA amplification technique.” Nucleic acids research, Apr. 11, 1992, 1992, 20(7):1691-1696. |
| Walker et al., Ed., “Chapter 1: Basic Techniques in Molecular Biology,” Medical Biomethods Handbook, Humana Press, Totowa, New Jersey, 2005, 19 pages. |
| Wang et al., “Concentration gradient generation methods based on microfluidic systems,” RSC Adv., 2017, 7:29966-29984. |
| Wang et al., “Imaging plasma membranes without cellular internalization: multisite membrane anchoring reagents based on glycol chitosan derivatives,” J Master Chem B., Aug. 2015, 3(30):6165-6173. |
| Wang et al., “Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy,” Am J Hum Genet, Nov. 2010, 87(5):687-93. |
| Wang et al., “Optimization of Process Conditions for Infected Animal Tissues by Alkaline Hydrolysis Technology,” Procedia Environmental Sciences, 2016, 31:366-374. |
| Wang et al., “Paramagnetic microspheres with core-shell-ed structures,” Journal of Materials Science, Apr. 2012, 47(16):5946-54. |
| Wang et al., “Single cell analysis: the new frontier in ‘omics’,” Trends Biotechnol., 28: 281-90, 2010. |
| Wang et al., “Tagmentation-based whole-genome bisulfite sequencing,” Nature Protocols, Oct. 2013, 8(10):2022-2032. |
| Wang et al., “Three-dimensional intact-tissue sequencing of single-cell transcriptional states”, Science, 361(6400), 22 pages, 2018. |
| Wang et al., “High-fidelity mRNA amplification for gene profiling.” Nature biotechnology. Apr. 2000, 18(4):457-459. |
| Wang, “RNA amplification for successful gene profiling analysis,” J Transl Med., Jul. 2005, 3:28, 11 pages. |
| Watanabe et al., “Cellular networks involved in the influenza virus life cycle,” Cell Host & Microbe, Jun. 2010, 7(6):427-39. |
| Waxman et al., “De-regulation of common housekeeping genes in hepatocellular carcinoma,” BMC Genomics, 2007, 1-9. |
| Weichhart et al., “Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro,” Infection and Immunity, 2003, 71 (8):4333-4641. |
| Weinreich et al., “Evidence that the cis Preference of the Tn5 Transposase is Caused by Nonproductive Multimerization,” Genes and Development, Oct. 1994, 8(19):2363-2374. |
| Weinstein et al., “DNA microscopy: Optics-free spatio-genetic imaging by a stand-alone chemical reaction”, bioRxiv, 41 pages, 2018. |
| Wheeler et al., “Microfluidic device for single-cell analysis,” Analytical Chemistry, Jul. 2003, 75(14):3581-3586. |
| Wiedmann et al., “Ligase chain reaction (LCR)—overview and applications,” PCR Methods Appl., Feb. 1994, 3(4):S51-64. |
| Wikipedia.org [online], “Random hexamer,” Jan. 2012, Retrieved on Jan. 21, 2022, retrieved from URL<https://en.wikipedia.org/w/index.php?title=Random_hexamer&oldid=473042236>, 1 page. |
| Williams, “RAC reviews serious adverse event associated with AAV therapy trial,” Mol Ther., Dec. 2007, 15(12):2053-54. |
| Willi-Monnerat et al., “Comprehensive spatiotemporal transcriptomic analyses of the ganglionic eminences demonstrate the uniqueness of its caudal subdivision,” Molecular and Cellular Nueorsciences 37(4):845-856, 2008. |
| Willner, “Stimuli-Controlled Hydrogels and Their Applications,” Acc Chem Res., Apr. 2017, 50(4):657-658. |
| Wilson et al., “New transposon delivery plasmids for insertional mutagenesis in Bacillus anthracis,” J Microbiol Methods, Dec. 2007, 71(3):332-5. |
| Wolf et al., “Rapid hybridization kinetics of DNA attached to submicron latex particles”, Nucleic Acids Res. 15: 2911-2926, 1987. |
| Wong et al., “Direct Site-Selective Covalent Protein Immobilization Catalyzed by a Phosphopantetheinyl Transferase,” J. Am. Chem Soc., 2008, 130:12456-64. |
| Woo et al., “A Comparison of cDNA, Oligonucleotide, and Affymetrix GeneChip Gene Expression Microarray Platforms,” Journal of Biomolecular Techniques, 2004, 15(4), 276-284. |
| Wood et al., “Single cell trapping and DNA damage analysis using microwell arrays,” PNAS, Jun. 2010, 107(22):10008-10013. |
| Worthington et al., “Cloning of random oligonucleotides to create single-insert plasmid libraries,” Analyt. Biochem, 2001, 294:169-175. |
| Wright et al., “Reusable, reversibly sealable parylene membranes for cell and protein patterning,” J Biomed Mater Res A., May 2008, 85(2):530-538. |
| Wu et al., “Detection DNA Point Mutation with Rolling-Circle Amplification Chip,” Bioinformatics and Biomedical Engineering (ICBBE), 2010 4th International Conference on IEEE, Piscatway, NJ, USA, Jun. 18, 2010, 1-4 pages. |
| Wu et al., “Ribogenomics: the science and knowledge of RNA,” Genomics Proteomics Bioinformatics, Apr. 2014, 12(2):57-63. |
| Xiao et al., “Direct determination of haplotypes from single DNA molecules,” Nature Methods, 2009, 6(3):199-201. |
| Xie et al., “CryoFISH: Fluorescence In Situ Hybridization on Ultrathin Cryosections,” Fluorescence in situ Hybridization (FISH), Jul. 2010, pp. 221-230. |
| Yamauchi et al., “Subcellular western blotting of single cells,” Microsyst Nanoeng., 2017, 3:16079, 9 pages. |
| Yan et al., “Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways,” Hum Gene Ther., Oct. 2009, 20(10):1190-200. |
| Yang et al., “The role of tumor-associated macrophages in breast carcinoma invasion and metastasis,” Int J Clin Exp Pathol., Jun. 2015, 8(6):6656-64. |
| Yasukawa et al., “Effects of organic solvents on the reverse transcription reaction catalyzed by reverse transcriptases from avian myeloblastosis virus and Moloney murine leukemia virus,” Biosci Biotechnol Biochem., 2010, 74(9): 1925-30. |
| Ye et al., “Triggered self-assembly of magnetic nanoparticles,” Sci Rep., Mar. 2016, 6:23145, 9 pages. |
| Yeakley et al., “Profiling alternative splicing on fiber-optic arrays,” Nature Biotechnology, Apr. 2002, 20(4):353-358. |
| Yershov et al., “DNA analysis and diagnostics on oligonucleotide microchips,” Proc. Natl. Acad. Sci. USA, May 1996, 93(10):4913-4918. |
| Yet et al., “Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice,” Circ Res., Jul. 2001, 89(2):168-73. |
| Yin et al., “Genetically encoded short peptide tag for versatile protein labeling by Sfp phosphopantetheinyl transferase,” PNAS, 2005, 102(44):15815-20. |
| Yonezawa et al., “DNA display for in vitro selection of diverse peptide libraries,” Nucleic Acids Research, 2003, 31 (19):e118. |
| Yu et al., “Shrinkage estimation of dispersion in Negative Binomial models for RNA-seq experiments with small sample size,” Bioinformatics, May 2013, 29(10):1275-1282. |
| Yusof et al., “Inkjet-like printing of single-cells,” Lab Chip, Jul. 2011, 11(14):2447-2454. |
| Zahra et al., “Assessment of Different Permeabilization Methods of Minimizing Damage to the Adherent Cells for Detection of Intracellular RNA by Flow Cytometry,” Avicenna Journal of Medical Biotechnology, Jan. 1, 2014, 6(1):38-46. |
| Zhang et al., “A novel mechanism of transposon-mediated gene activation,” PLoS Genet., Oct. 2009, 5(10):e1000689, 10 pages. |
| Zhang et al., “Archaeal RNA ligase from thermoccocus kodakarensis for template dependent ligation,” RNA Biol., Jan. 2017, 14(1):36-44. |
| Zhang et al., “Assembling DNA through Affinity Binding to Achieve Ultrasensitive Protein Detection,” Angew Chem Int Ed (2013) 52:2-10. |
| Zhang et al., “Binding-induced DNA assembly and its application to yoctomole detection of proteins,” Anal Chem (2012) 84(2):877-884. |
| Zhang et al., “Block-Cell-Printing for live single-cell printing,” PNAS, Feb. 2014, 111(8):2948-2953. |
| Zhang et al., “Multiplex ligation-dependent probe amplification (MLPA) for ultrasensitive multiplexed microRNA detection using ribonucleotide-modified DNA probes†,” Chem. Commun., Nov. 2013, 49:10013-10015. |
| Zhang et al., “Single-base mutational analysis of cancer and genetic diseases using membrane bound modified oligonucleotides,” Nucleic Acids Res., Jul. 1991, 19(14):3929-33. |
| Zhang et al., “Stripping custom microRNA microarrays and the lessons learned about probe-slide interactions,” Anal Biochem., Mar. 2009, 386(2):222-7. |
| Zhao et al., “Isothermal Amplification of Nucleic Acids,” Chemical Reviews, Nov. 2015, 115(22):12491-12545. |
| Zheng et al., “Massively parallel digital transcriptional profiling of single cells,” Nat Commun., Jan. 16, 2017, 8:14049, 12 pages. |
| Zheng et al., Origins of human mitochondrial point mutations as DNA polymerase mediated errors. Mutat. Res. 599(1-2): 11-20, 2006. |
| Zheng, “Spectroscopy-based quantitative fluorescence resonance energy transfer analysis,” Methods Mol Biol., 2006, 337:65-77. |
| Zhou et al., “Genetically encoded short peptide tags for orthogonal protein labeling by Sfp and AcpS phosphopantetheinyl transferases,” ACS Chemical Biol., 2007 2 5 : 337-346. |
| Zhu et al., “Reverse Transcriptase Template Switching: A SMART Approach for Full-Length cDNA Library Construction,” BioTechniques, 2001, 30(4): 892-897. |
| Zieba et al., “Bright-field microscopy visualization of proteins and protein complexes by in situ proximity ligation with peroxidase detection,” Clin Chem, Jan. 2010, 56(1):99-110. |
| Zilberman et al., “Genome-wide analysis of DNA methylation patterns,” Development (2007) 134: 3959-3965. |
| Zlobec et al., “Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types,” Journal of Translational Medicine, 2013 11(104):1-7. |
| Zuker, “Mfold web server for nucleic acid folding and hybridization prediction,” Nucleic Acids Res., Jul. 2003, 31(13):3406-15. |
| [No Author Listed], “SMARTer Stranded Total RNA-Seq Kit—Pico Input Mammalian User Manual,” Takara Bio, Dec. 31, 2016, 21 pages. |
| Advanced biophysis lab, “G5b: Supercoiling DNA by magnetic tweezers,” biophysik.physik.uni-meuchen.de, available on or before Nov. 7, 2015, retrieved on Apr. 21, 2023, retrieved from URL <https://www.biophysik.physik.uni-muenchen.de/teaching/laboratory_courses/magnetic_tweezers/index.html#top>, 1 page. |
| Akatsuka et al., “Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: Application for assessment of clonal composition,” Tissue Antigens, Jan. 5, 1999, 53:122-134. |
| Akatsuka et al., “T cell receptor clonal diversity following allogeneic marrow grafting,” Human Immunology, Jun.-Jul. 1996, 48:125-134. |
| Bessmertnykh et al., “Efficient Palladium-Catalyzed Synthesis of Aminopyridyl Phosphonates from Bromopyridines and Diethyl Phosphite,” Synthesis, 2008, 10:1575-1579. |
| Bibikova et al., “Quantitative gene expression profiling in formalin-fixed paraffin-embedded tissues using universal bead arrays,” The American Journal of Pathology, Nov. 1, 2004, 165(5):1799-1807. |
| Bowen et al., “Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans—rearrangements in ATM-deficient thymocytes,” Nucleic Acids Research, Apr. 1, 2013, 41(8):4535-4548. |
| Choi et al., “Multiplexed detection of mRNA using porosity-tuned hydrogel microparticles,” Analytical chemistry, Sep. 28, 2012, 84(21):9370-9378. |
| Crisalli et al., “Importance of ortho Proton Donors in Catalysis of Hydrazone Formation,” Org. Lett., 2013, 15(7):1646-1649. |
| Daley et al., “Predicting the molecular complexity of sequencing libraries,” Nature Methods, Apr. 2013, 10:325-327. |
| Dellet et al., “Considerations for optimization of microRNA PCR assays for molecular diagnosis,” Expert review of molecular diagnostics, Feb. 8, 2016, 16(4):407-414. |
| Falconnet et al., “Rapid, Sensitive and Real-Time Multiplexing Platform for the Analysis of Protein and Nucleic-Acid Biomarkers,” Anal. Chem., Jan. 7, 2015, 87:1582-1589. |
| Fan et al., “A versatile assay for high-throughput gene expression profiling on universal array matrices,” Genome Research, May 1, 2004, 14(5):878-885. |
| Goldmeyer et al., “Development of a novel one-tube isothermal reverse transcription thermophilic helicase-dependent amplification platform for rapid RNA detection,” Journal of Molecular Diagnostics, American Society for Investigative Pathology and the Association for Molecular Pathology, Nov. 1, 2007, 9(5):639-644. |
| Holscher et al., “Application of Laser-Assisted Microdissection for Tissue and Cell-Specific Analysis of RNA,” Progress in Botany, Jan. 2008, 69(3):141-167. |
| Hou et al., “Basic research and clinical application of immune repertoire sequencing,” Int J Clin Exp Med., Oct. 30, 2016, 9(10):18868-18882. |
| Hughes et al., “Choose Your Label Wisely: Water-Soluble Fluorophores Often Interact with Lipid Bilayers,” PLoS One, Feb. 4, 2014, 9(2):e87649, 8 pages. |
| Kim, “Development of Microdevices for Applications to Bioanalysis,” Dissertation for the degree of Doctor of Philosophy, University of Texas at Austin, Aug. 2007, 176 pages. |
| Kung et al., “Long Noncoding RNAs: Past, Present, and Future,” Genetics, Mar. 1, 2013, 193(3):651-669. |
| Kwon et al, Polyelectrolyte Gels-Fundamentals and Applications, Nov. 10, 2006, Polymer Journal, 38, pp. 1211-1219. |
| Laurent et al., “The Landscape of long noncoding RNA classification,” Trends Genet., May 2015, 31(5):239-251. |
| Noshita et al., “Diethylenetriamine-Mediated Direct Cleavage of Unactivated Carbamates and Ureas,” Org. Lett., Nov. 15, 2016, 18:6062-6065. |
| Robins et al., “Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells,” Blood, Nov. 5, 2009, 114(19):4099-4107. |
| Stubbington et al., “T cell fate and clonality inference from single cell transcriptomes,” Nature Methods, Apr. 2016, 13(4):329-332. |
| Tang et al., “Click Reactions: A Versatile Toolbox for the Synthesis of Peptide-Conjugates,” Chemical Society Reviews, Jun. 12, 2014, pp. 1-27. |
| Villa et al., “Partial V(D)J Recombination Activity Leads to Omenn Syndrome,” Cell, May 29, 1998, 93:885-896. |
| Williams et al., “Disc electrophoresis in polyacrylamide gels: extension to new conditions of pH and buffer,” Annals of the New York Academy of Sciences, Dec. 1964, 121(2):373-381. |
| Almog et al., “The crystal structures of the psychrophilic subtilisin S41 and the mesophilic subtilisin Sph reveal the same calcium-loaded state,” Proteins, Feb. 1, 2009, 74(2):489-496. |
| Cai et al, “Glutathione-mediated shedding of PEG layers based on disulfide-linked catiomers for DNA delivery,” J. Mater. Chem., Sep. 20, 2011, 21(38):14639-14645. |
| Chen et al. “Arrayed profiling of multiple glycans on whole living cell surfaces.” Analytical chemistry, Oct. 15, 2013, 85(22):11153-11158. |
| Eastburn et al., “Identification of Genetic Analysis of Cancer Cells with PCT-activatcd Cell Sorting,” Nucleic Acids Research, Jul. 16, 2014, 42(16):e128, 10 pages. |
| Eastburn et al., “Ultrahigh-throughput Mammalian Single Cell Reverse-transcriptase Polymerase Chain Reaction in Microfluiding Drops,” Analytical Chemistry, American Chemical Society, Aug. 20, 2013, 85(16):8016-8021. |
| Eisenberg et al., “Human housekeeping genes, revisited,” Trends in Genetics, Oct. 2013, 29(10):569-574. |
| Ha et al, “Self-assembly hollow nanosphere for enzyme encapsulation,” Soft Matter, Feb. 11, 2010, 6, 1405-1408, 10 pages. |
| Hu et al., “A thermo-degradable hydrogel with light-tunable degradation and drug release,” Bio materials, Jan. 2017, 112:133-140. |
| Jeffers, “A Basic Subroutine for Geary's Contiguity Ratio,” J. Royal Stat. Society, Series D, Dec. 1973, 22(4):299-302. |
| Ju et al, “Supramolecular dendrimer capsules by cooperative binding,” Chem. Commun., Jan. 7, 2011, 47(1):268-270, 8 pages. |
| Kuiper et al, “Enzymes containing porous polymersomes as nano reaction vessels for cascade reactions,” Org. Biomol, Chem, Oct. 15, 2008, 6(23):4315-4318. |
| Li et al., “Beyond Moran's I: Testing for Spatial Dependence Based on the Spatial Autoregressive Model,” Geographical Analysis, Sep. 18, 2007, 39(4):357-375. |
| Li et al., “Encapsulation of a Nerve Agent Detoxifying Enzyme by a Mesoporous Zirconium Metal-Organic Framework Engenders Thermal and Long-Term Stability,” J. Am. Chem. Soc., Jun. 24, 2016, 138(26):8052-8055, 4 pages. |
| Liu et al., “Preparation and Characterization of Temperature-Sensitive Poly(N-isopropylacrylamide)-b-poly(d,l-lactide) Microspheres for Protein Delivery,” Biomacromolecules, 2003, 4(6):1784-1793. |
| Lyu et al., “One-Pot Synthesis of Protein-Embedded Metal-Organic Frameworks with Enhanced Biological Activities,” Nano Lett., Sep. 11, 2014, 14:5761-5765. |
| Miller et al., “Rapid and Efficient Enzyme Encapsulation in a Dendrimer Silica Nanocomposite,” Macromolecular Bioscience, Oct. 25, 2006, 6(10):839-845. |
| Rahimi et al, “Synthesis and Characterization of Thermo-Sensitive Nanoparticles for Drug Delivery Applications,” J. Biomed. Nanotechnol. Dec. 2008, 4(4):482-490, 19 pages. |
| Shieh, et al., “Imparting Functionality to Biocatalysts via Embedding Enzymes into Nanoporous Materials by a de Novo Approach: Size-Selective Sheltering of Catalase in Metal-Organic Framework Microcrystals,” J Am Chem Soc., Apr. 8, 2015, 137(13):4276-4279, 4 pages. |
| Soderberg, “Droplet Microfluidics Reverse Transcription and PCR Towards Single Cell and Exosome Analysis,” Doctoral Thesis, KTH School of Biotechnology Science for Life Laboratory, 2017, 69 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20230183785 A1 | Jun 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62145874 | Apr 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15565637 | US | |
| Child | 17011923 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17834474 | Jun 2022 | US |
| Child | 18166853 | US | |
| Parent | 17693116 | Mar 2022 | US |
| Child | 17834474 | US | |
| Parent | 17479718 | Sep 2021 | US |
| Child | 17693116 | US | |
| Parent | 17237670 | Apr 2021 | US |
| Child | 17479718 | US | |
| Parent | 17011923 | Sep 2020 | US |
| Child | 17237670 | US |
